patient_id	NCTID	criterion_type	criterion_text	brief_reasoning	relevant_sentences	eligibility_label
sigir-20141	NCT01397994	inclusion	Inclusion - Patients of Chronic Stable Angina with Abnormal Exercise Myocardial Perfusion Spect Scan with Reversible and Partially Reversible Ischemic Changes.	The patient presented with new-onset chest pain, which could potentially indicate Chronic Stable Angina; however, there is no explicit diagnosis of Chronic Stable Angina confirmed in the patient note. Additionally, there is no information indicating that she underwent an Exercise Myocardial Perfusion Spect Scan to confirm reversible and partially reversible ischemic changes. Therefore, the necessary criteria for inclusion are not met.	0	not included
sigir-20141	NCT01397994	inclusion	Male and female	The patient is a 58-year-old African-American woman, who identifies as female.	0	included
sigir-20141	NCT01397994	inclusion	Age 25 to 65 years	The patient is 58 years old, which falls within the specified age range.	0	included
sigir-20141	NCT01397994	inclusion	Patient must understand and be willing, able and likely to comply with all study procedures and restrictions and comprehends the diary cards.	The patient note states that she will provide informed consent and comply with the trial protocol without any practical issues, indicating her willingness and ability to adhere to the study requirements.	8	included
sigir-20141	NCT01397994	inclusion	Patient must be able to give voluntary written informed consent.	The patient note states that the patient will provide informed consent and comply with the trial protocol without any practical issues.	8	included
sigir-20141	NCT01397994	exclusion	Hypertension of > 170/100 mm of Hg	The patient has a history of hypertension, but the note does not provide current blood pressure values to determine if they exceed 170/100 mmHg.	3	not enough information
sigir-20141	NCT01397994	exclusion	Valvular heart disease and cardiomyopathy	The patient note does not indicate any history or current diagnosis of valvular heart disease or cardiomyopathy.	0	not excluded
sigir-20141	NCT01397994	exclusion	Myocardial infarction in < 6 months	The patient reported experiencing chest pain two days prior, but there were no indicators of an acute myocardial infarction. The EKG showed nonspecific changes, and there was no mention of symptoms consistent with an active coronary event.	0, 1	not excluded
sigir-20141	NCT01397994	exclusion	Unstable angina.	The patient experienced episodic anterior chest pain that radiated to the back, lasted over 20 minutes, and was accompanied by nausea, sweating, and mild dyspnea. These symptoms are characteristic of unstable angina, meeting the exclusion criterion.	0, 1	excluded
sigir-20141	NCT01397994	exclusion	Congestive cardiac failure	The patient does not have a documented diagnosis of congestive cardiac failure. While she has risk factors such as hypertension and obesity, there is insufficient evidence indicating she currently meets the criteria for congestive cardiac failure.	0	not excluded
sigir-20141	NCT01397994	exclusion	Severe anemia (Hb < 7 g/dL)	The patient note does not provide information about the patient's hemoglobin levels.	0	not enough information
sigir-20141	NCT01397994	exclusion	Cardiac arrhythmias or II or III degree AV block	The patient's notes do not mention any history of arrhythmias or AV blocks. The physical examination and EKG results were normal, providing no indication of such conditions.	0, 1	not excluded
sigir-20141	NCT01397994	exclusion	Significant liver or renal dysfunction	The patient presented with chest pain and associated symptoms but showed no signs of liver or renal dysfunction during the assessment. There were no mentions of symptoms indicative of these conditions nor any historical information suggesting their presence.	0, 1	not excluded
sigir-20141	NCT01397994	exclusion	IDDM (Type-1 diabetes mellitus)	The patient denies having diabetes, so she does not meet the Type-1 diabetes mellitus criterion.	4	not excluded
sigir-20141	NCT01397994	exclusion	Systolic blood pressure < 100 mm Hg	The patient note indicates she has hypertension but does not provide specific blood pressure measurements. Without knowing her current systolic blood pressure, we cannot confirm if she meets the exclusion criterion.	3	not enough information
sigir-20141	NCT01397994	exclusion	Pregnant and nursing women	The patient is a 58-year-old woman who denies being pregnant or having a history ofpregnancy. There is no indication in the patient note suggesting she is currently pregnant ornursing.	0	not excluded
sigir-20141	NCT01397994	exclusion	Known hypersensitivity to nicorandil	The patient note does not mention any hypersensitivity to nicorandil or atenolol.		not excluded
sigir-20141	NCT01397994	exclusion	On calcium channel blockers	The patient denies taking any medications, specifically mentioning she currently takes none.	5	not excluded
sigir-20141	NCT01397994	exclusion	Patients aged greater than 70 years.	The patient is 58 years old, which is less than 70. Since the criterion excludes those over 70, she does not qualify.	0	not excluded
sigir-20141	NCT01397994	exclusion	Patients in whom beta blockers are contraindicated	The patient has hypertension but no information suggesting beta blockers are contraindicated. She is not currently taking any medications.	3	not enough information
sigir-20141	NCT01397994	exclusion	Geographical inaccessibility for treatment or follow-up evaluations	The patient note does not provide information about her geographic location or access to treatment/follow-up facilities.		not enough information
sigir-20141	NCT00149227	inclusion	Clinical diagnosis of hypertension	The patient reports a known diagnosis of hypertension.	3	included
sigir-20141	NCT00149227	inclusion	Clinical diagnosis of one or more risk factors, such as diabetes, smoking habit, lipid metabolism abnormality, history of ischemic heart disease (IHD) or cerebrovascular disease, obesity (BMI>25), chronic heart failure (NYHA II-III), and electrocardiogram (ECG) abnormality (LVH)	The patient has a documented diagnosis of obesity (BMI > 25). This satisfies one of the specified risk factors required for inclusion.	3	included
sigir-20141	NCT00149227	exclusion	Patients who have already been administered ARB	The patient note indicates the patient has hypertension but does not specify receipt of ARB medication.	3	not excluded
sigir-20141	NCT00149227	exclusion	Patients with IHD within 6 months after percutaneous coronary intervention(PCI), and who are stable but are going to implement PCI or coronary artery bypass grafting(CABG)	The patient does not have a history of IHD or recent PCI procedure. Additionally, she recently experienced onset of chest pain, indicating potential instability.	0, 1	not excluded
sigir-20141	NCT00149227	exclusion	Severe/malignant/secondary hypertensive patients	The patient note mentions hypertension but does not specify if it is severe, malignant, or secondary.	3	not enough information
sigir-20141	NCT00149227	exclusion	Pregnant women and women of childbearing potential	The patient is a 58-year-old woman who did not report any current or recent pregnancy. As a woman of advanced age, she is likely not of childbearing potential.	8	not excluded
sigir-20141	NCT00149227	exclusion	History of heart failure, unstable angina, myocardial infarction, PTCA, or CABG within the preceding 6 months	The patient reported episodic chest pain starting two days prior, which did not suggest recent heart failure, unstable angina, or myocardial infarction. There was no mention of PTCA or CABG.	0, 1	not excluded
sigir-20141	NCT00149227	exclusion	Arrhythmia needed to be treated or accompanied with symptoms, second or third degree AV block	The patient presented with chest pain but did not report any symptoms indicative of arrhythmia or AV block.	0	not enough information
sigir-20141	NCT00149227	exclusion	Severe renal impairment (Serum creatinine >3.0 mg/dl)	The patient note does not provide specific information about the patient's serum creatinine levels. While the patient has hypertension, which can potentially impact renal function, there is no indication of her current creatinine levels.	3	not enough information
sigir-20141	NCT00149227	exclusion	Severe hepatic impairment (Hepatic failure, Cirrhosis, etc.)	The patient note does not mention any signs or history of severe hepatic impairment, including cirrhosis or hepatomegaly.	0	not excluded
sigir-20142	NCT02618655	inclusion	patients have fever more than one week	The patient note describes a fever but does not specify its duration beyond stating it began after returning from a trip and having loose stools.	0	not enough information
sigir-20142	NCT02618655	inclusion	temperature is higher than 38℃	The patient's temperature reached 39°C, which is greater than 38°C.	0	included
sigir-20142	NCT02618655	inclusion	full of physical examination and laboratory examination have been carried out after one week，但仍然无法确定诊断	The patient note indicates that the patient presented to the ER with respiratory distress and bronchial sounds, leading to a chest X-ray showing bilateral lung infiltrates. This suggests a prompt diagnosis rather than waiting one week for exam results.	4	not included
sigir-20142	NCT02618655	exclusion	fever for non-infectious diseases such as rheumatic autoimmune disease or with tumor	The patient’s presentation includes fever, dyspnea, and cough, potentially indicating an infectious etiology. Without confirmation of a non-infectious cause, the exclusion criterion isn't met.	0	not excluded
sigir-20142	NCT02618655	exclusion	Patients who have been diagnosed with a Tick-Borne Disease within the last year.	The patient note does not indicate that the child has been diagnosed with a Tick-Borne Disease within the past year. While he traveled to Colorado, which is an area with ticks, there is no mention of a diagnosis of a Tick-Borne Disease. Without a diagnosis, the exclusion criterion is not met.	0	not excluded
sigir-20142	NCT02618655	exclusion	Patients who have been diagnosed with a Tick-Borne Disease within the past year.	The patient note does not indicate that the patient has been diagnosed with a Tick-Borne Disease within the past year. There is no mention of relevant symptoms indicative of a Tick-Borne Disease, nor is there a diagnosis recorded.	0, 1	not excluded
sigir-20142	NCT00711399	inclusion	Patient and/or parents/guardian signed informed consent	The patient note explicitly states that the patient will provide informed consent.	6	included
sigir-20142	NCT00711399	inclusion	Patients with cough or shortness of breath	The patient reports presenting with a cough and dyspnea, both of which meet the inclusion criterion.	0	included
sigir-20142	NCT00711399	exclusion	Exclude patients who have chest tubes.	The patient note does not mention anything about the presence of chest tubes. There is no indication that the patient has had a chest tube placed.		not excluded
sigir-20142	NCT00711399	exclusion	Skin lesions precluding attachment of sensors	The patient note does not mention any skin lesions that would impede the attachment of sensors.		not excluded
sigir-20142	NCT00711399	exclusion	Respiratory distress	The patient is reported to have respiratory distress according to the notes.	0, 4	excluded
sigir-20142	NCT00711399	exclusion	Pregnant women	The patient is an 8-year-old male, so they cannot be pregnant.	6	not excluded
sigir-20143	NCT01452971	inclusion	Participant is a lung cancer patient.	The patient has a left lung mass identified via chest X-ray, suggesting a potential abnormality. However, the absence of a confirmed diagnosis of lung cancer (e.g., through biopsy) prevents categorizing her as a lung cancer patient for trial eligibility.	0	not included
sigir-20143	NCT01452971	exclusion	Participant is under 18 years old.	The patient is 58 years old, which is above 18 years old, so they do not meet the exclusion criterion.	0	not excluded
sigir-20143	NCT01452971	exclusion	Participant is not a lung cancer patient.	The patient has a left lung mass, which is suggestive of lung cancer. Without explicit contraindications, this indicates she is a lung cancer patient, thus meeting the exclusion criterion.	0	excluded
sigir-20143	NCT02490059	inclusion	Pulmonary nodule on a recent CT	The patient has a left lung mass noted on a chest X-ray, but there is no information indicating that a recent CT scan was performed to confirm the presence of a pulmonary nodule.	0	not enough information
sigir-20143	NCT02490059	inclusion	non-visible on standard-size bronchoscopy	The patient note describes a left lung mass identified via chest X-ray but does not specify whether this mass is visible upon bronchoscopy.	0	not enough information
sigir-20143	NCT02490059	exclusion	missing informed consent	The patient note indicates that the individual will provide informed consent, which contradicts the exclusion criterion.	3	not excluded
sigir-20144	NCT02390596	inclusion	Patients, male and female, at any age ≥ 3 months (≥5 kg) of life, with KD according to the American Heart Association definition for complete or incomplete KD.	The patient is 2 years old, meeting the age requirement. He exhibits several clinical features of KD including conjunctivitis, strawberry tongue, inflammation of extremities, and cervical lymphadenopathy. Additionally, laboratory findings show elevated inflammatory markers and mild anemia, consistent with KD. Furthermore, echocardiogram revealed moderate coronary artery dilation, which supports the diagnosis of KD even though not all clinical signs are present. Thus, the patient meets the inclusion criteria for KD.	0, 1	included
sigir-20144	NCT02390596	inclusion	Patients who have failed to respond to standard therapy of Kawasaki disease (e.g., persistence or recrudescence of fever ≥ 38°C, 48h after the infusion of 2g/kg of IV Ig)	The patient note describes symptoms consistent with Kawasaki disease but does not specify whether the patient received IVIG or the outcome of the treatment.	5	not enough information
sigir-20144	NCT02390596	inclusion	Weight ≥5Kg	The patient's age is noted as 2 years old, but there is no specific information provided regarding the patient's weight. Without knowing the patient's weight, we cannot determine if they meet the required criterion.	0	not enough information
sigir-20144	NCT02390596	inclusion	Patient, parent or legal guardian's written informed consent is required	The patient note explicitly states that the patient will provide informed consent and comply with the trial protocol without any practical issues.	5	included
sigir-20144	NCT02390596	inclusion	Patient with health insurance	The patient note does not provide any information regarding the patient's health insurance status.		not enough information
sigir-20144	NCT02390596	inclusion	Patient agrees to have effective contraception for the duration of participation in the research	The patient note does not mention anything about contraception or family planning.		not enough information
sigir-20144	NCT02390596	exclusion	Preterm and neonates, pregnancy	The patient is a 2-year-old boy, so he is past the neonatal period and not preterm.	0	not excluded
sigir-20144	NCT02390596	exclusion	Patients suspected with another diagnosis	The patient's presentation includes symptoms and lab results suggesting various conditions, leading to suspicion of another diagnosis. However, no definitive diagnosis has been confirmed.	0, 1, 2	not excluded
sigir-20144	NCT02390596	exclusion	Patients with overt concomitant bacterial infection	The patient presents with symptoms and lab findings consistent with Kawasaki disease, which typically involves a viral illness rather than an overt bacterial infection.	0, 1, 2	not excluded
sigir-20144	NCT02390596	exclusion	Patients previously treated with another biotherapy	The patient note does not mention any prior treatment with another biotherapy.		not excluded
sigir-20144	NCT02390596	exclusion	Patients with any type of immunodeficiency or cancer	The patient note describes symptoms and findings consistent with Kawasaki Disease but does not indicate any form of immunodeficiency or cancer.	0	not excluded
sigir-20144	NCT02390596	exclusion	Increased risk of TB infection	The patient note does not mention any factors associated with an increased risk of TB infection, such as active TB, exposure to TB, or immunodeficiency.	0	not excluded
sigir-20144	NCT02390596	exclusion	Recent tuberculosis infection or with active TB	The patient note does not mention anything regarding a recent tuberculosis infection or active TB.		not excluded
sigir-20144	NCT02390596	exclusion	Close contact with a patient with TB	The patient note describes a 2-year-old boy presenting with symptoms like high fever, irritability, and physical examination findings consistent with Kawasaki Disease. None of the noted symptoms, physical exams, or laboratory results suggest a diagnosis of tuberculosis (TB). Additionally, there is no indication of close contact with a patient known to have TB.	0, 1	not excluded
sigir-20144	NCT02390596	exclusion	Patients recently arrived less than 3 months from a country with high prevalence of TB	The patient note does not provide information about the patient's travel history or residency in areas with high prevalence of TB.		not enough information
sigir-20144	NCT02390596	exclusion	A chest radiograph suggestive of TB	The patient note does not mention any chest radiographs or results indicating TB.		not enough information
sigir-20144	NCT02390596	exclusion	Patients with end stage renal disease: NKF stages ≥4; eGFR≤29mL/min/1.73 m² or diabetes mellitus or neutropenia <1500/mm³ or liver failure	The patient's note does not mention anything indicating end-stage renal disease, diabetes mellitus, neutropenia below 1500/mm³, or liver failure. Elevated WBC count and mild anemia are noted, but they do not meet the exclusion criteria.	0	not excluded
sigir-20144	NCT02390596	exclusion	Hypersensitivity to the active substance or to any of the excipients (citric acid and anhydrous; sodium chloride disodium edetate dehydrate polysorbate 80; sodium hydroxide; water for injections)	There is no mention in the patient note of any hypersensitivity reactions or allergies to Anakinra or its excipients.	5	not excluded
sigir-20144	NCT02390596	exclusion	Patient already included in a biomedical research other than observational (e.g.,; cohort, registry)	The patient note indicates the individual will provide informed consent and comply with the trial protocol without any practical issues, suggesting they have not previously participated in similar biomedical research.	5	not excluded
sigir-20144	NCT00841789	inclusion	Male Age 2 months to 20 years of age	The patient is 2 years old, which is equivalent to 24 months. Since the criterion specifies up to 20 years (or 240 months), the patient exceeds the maximum age requirement.	0	not included
sigir-20144	NCT00841789	inclusion	Informed consent is obtained from all patients.	The patient note explicitly states that the patient provides informed consent and complies with the trial protocol without practical issues.	5	included
sigir-20144	NCT00841789	inclusion	Clinical presentation consistent with Kawasaki disease.	The patient presents with high fever, irritability, conjunctivitis, strawberry tongue, hand and foot inflammation, skin desquamation, and cervical lymphadenopathy - all indicative of Kawasaki disease. Elevated labs including ALT, WBC, CRP, and ESR further support this diagnosis. An echocardiogram suggests possible coronary artery involvement, which aligns with Kawasaki findings.	0, 1	included
sigir-20144	NCT00841789	exclusion	Alanine transaminase (ALT) > 5 times upper limit of normal (ULN)	The patient note mentions elevated ALT levels but does not provide specific numerical data indicating whether ALT exceeds five times the ULN.	3	not enough information
sigir-20144	NCT00841789	exclusion	Platelet count < 100,000/mm3	The patient note does not specify the platelet count; therefore, it cannot be determined if the platelet count is below 100,000/mm³.	3	not enough information
sigir-20144	NCT00841789	exclusion	WBC count < 3,000 cells/mm3	The patient's WBC count was reported as 17,580/mm, which is significantly greater than 3,000/mm.	3	not excluded
sigir-20144	NCT00841789	exclusion	Hemoglobin, hematocrit, or red blood cell count outside 30% of the upper or lower limits of normal for the Lab	The patient has mild normochromic, normocytic anemia, indicating their hemoglobin levels are within normal ranges.	3	not excluded
sigir-20144	NCT00841789	exclusion	Subject is currently enrolled in another investigational device or drug trial(s), or subject has received other investigational agent(s) within 28 days of baseline visit.	The patient note indicates that the patient has provided informed consent and complies with the trial protocol without any practical issues. However, there is no explicit mention of the patient being currently enrolled in another trial or having received other investigational agents within 28 days prior to the baseline visit.	5	not excluded
sigir-20144	NCT00841789	exclusion	Female subjects diagnosed with KD 12 years of age and older.	The patient is a 2-year-old boy, who is male. The criterion specifies that only female subjects diagnosed with Kawasaki Disease (KD) at 12 years of age or older are eligible. As the patient is male, they do not meet the criterion and therefore should be excluded from participation.	0	excluded
sigir-20144	NCT00841789	exclusion	Subjects who have known hypersensitivity to Enbrel or any of its components or who is known to have antibodies to etanercept	The patient note describes a 2-year-old boy presenting with symptoms including high fever and irritability, potentially indicative of Kawasaki Disease. However, the exclusion criterion pertains to hypersensitivity or presence of anti-etanercept antibodies, neither of which are explicitly mentioned in the patient's condition or lab results.	0	not excluded
sigir-20144	NCT00841789	exclusion	Prior or concurrent cyclophosphamide therapy	The patient note does not mention any history of cyclophosphamide therapy.	5	not excluded
sigir-20144	NCT00841789	exclusion	Prior treatment with any TNF alpha antagonist or steroid within 48 hours prior to initiation of IVIG	The patient note does not mention any prior treatment with TNF alpha antagonist or steroid within 48 hours prior to the start of IVIG.	0	not excluded
sigir-20144	NCT00841789	exclusion	Concurrent sulfasalazine therapy	The patient note does not mention any medication, including sulfasalazine. There is insufficient information to confirm that the patient is currently receiving sulfasalazine therapy.	5	not excluded
sigir-20144	NCT00841789	exclusion	Active severe infections within 4 weeks before screening visit, or between the screening and baseline visits.	The patient has been experiencing symptoms for approximately five days prior to the emergency department visit, indicating an active infection. This places the infection well within the four-week window preceding the potential screening visit. Furthermore, the presence of elevated laboratory values such as CRP and WBC count confirms the active nature of the infection. As the patient continues to exhibit symptoms upon arrival, the infection remains active, thereby meeting the exclusion criterion.	0	excluded
sigir-20144	NCT00841789	exclusion	SLE, history of multiple sclerosis, transverse myelitis, optic neuritis, or chronic seizure disorder	The patient presents with symptoms and findings consistent with a viral illness, potentially Kawasaki disease, rather than systemic lupus erythematosus or its associated conditions.	0, 1	not excluded
sigir-20144	NCT00841789	exclusion	Known HIV-positive status or known history of any other immuno-suppressing disease.	The patient note does not mention any information regarding HIV status or a history of an immunosuppressive disease. No evidence suggests the presence of such conditions.	0, 1	not excluded
sigir-20144	NCT00841789	exclusion	Any mycobacterial disease or high risk factors for tuberculosis, such as family member with TB or taking INH	The patient note does not provide information regarding mycobacterial disease, tuberculosis exposure, family history of TB, or INH usage.	0, 1	not enough information
sigir-20144	NCT00841789	exclusion	Untreated Lyme disease	The patient note does not mention anything related to Lyme disease or tick exposure.	0	not excluded
sigir-20144	NCT00841789	exclusion	history of cancer within 5 years [other than resected cutaneous basal or squamous cell carcinoma or in situ cervical cancer]	The patient note does not mention any history of cancer within the last 5 years.		not excluded
sigir-20144	NCT00841789	exclusion	Exposure to hepatitis B or hepatitis C or high risk factors such as intravenous drug abuse in patient's mother, or history of jaundice (other than neonatal jaundice).	The patient note does not explicitly state whether the child has been exposed to hepatitis B or C or has a history of jaundice beyond the neonatal period.	0, 1, 2, 3	not excluded
sigir-20144	NCT00841789	exclusion	Use of a live vaccine (Measles Mumps Rubella or Varicella) 30 days prior to or during this study.	The patient note does not mention any information about the receipt of live vaccines within the past 30 days or during the study period. Without this information, we cannot determine if the exclusion criterion applies.	5	not enough information
sigir-20144	NCT00841789	exclusion	Any condition judged by the patient's physician to cause this clinical trial to be detrimental to the patient	The patient exhibits severe symptoms including high fever, elevated laboratory values indicative of infection/inflammation, and cardiac findings suggesting potential complications. While the patient provides informed consent and complies with protocols, the absence of explicit physician judgment regarding detriment precludes definitive exclusion.	0, 1, 2, 3, 4	not enough information
sigir-20144	NCT00841789	exclusion	History of non-compliance with other therapies	There is no information in the patient note regarding the patient's history of non-compliance with other therapies.		not enough information
sigir-20144	NCT00841789	exclusion	Must not have received immunosuppressive agents for at least three months prior to enrollment.	The patient note does not mention receipt of immunosuppressive agents, which is necessary to evaluate against the exclusion criterion.	0	not enough information
sigir-20145	NCT01935141	inclusion	No prior allergic reactions to contrast agents	The patient note does not mention anything regarding past allergic reactions to contrast agents.		not enough information
sigir-20145	NCT01935141	exclusion	Class 3 or 4 Congestive Heart Failure	There is insufficient information in the patient note regarding the presence or severity of congestive heart failure.		not enough information
sigir-20145	NCT01935141	exclusion	supraventricular tachycardia	The patient note does not indicate a diagnosis of supraventricular tachycardia.		not excluded
sigir-20145	NCT01935141	exclusion	History of contrast allergy	The patient note does not mention any history of contrast allergy.		not excluded
sigir-20145	NCT01935141	exclusion	Unable to give informed consent	The patient has provided informed consent and there are no practical issues complying with the trial protocol.	6	not excluded
sigir-20145	NCT01935141	exclusion	Patients with serum creatinine >1.28 mg/dl without referring physician approval	The patient note does not specify the serum creatinine level. While being bedridden could theoretically affect kidney function, leading to higher creatinine, there is no explicit indication of its value. Additionally, the note lacks information about whether a referring physician has approved participation despite potential renal concerns.	0, 1	not enough information
sigir-20145	NCT00163709	inclusion	all patients presenting to the ED with shortness of breath that are over 40 years old and present with an emergency department triage category of 3 or higher	The patient is a 56-year-old female presenting to the ED with shortness of breath, satisfying the age and symptom criteria. While the triage category is not explicitly stated, her condition upon arrival suggests a potential triage category of 3 or higher.	0	included
sigir-20145	NCT00163709	exclusion	Patients presenting with a traumatic cause of dyspnea	The patient's dyspnea appears to be related to her recent mastectomy and subsequent recovery rather than an acute traumatic event.	0	not excluded
sigir-20145	NCT00163709	exclusion	Patients with severe renal disease (serum creatinine level of more than 250 micro mmol/L)	The patient note does not specify the serum creatinine level. Therefore, it cannot be determined if the patient meets the exclusion criterion.	0	not enough information
sigir-20145	NCT00163709	exclusion	Patients with cardiogenic shock	The patient presented with symptoms including shortness of breath and malaise after surgery. While there are findings suggesting potential pulmonary issues, there is insufficient evidence indicating cardiogenic shock, which typically involves signs of inadequate organ perfusion.	0, 1	not excluded
sigir-20145	NCT00163709	exclusion	Patients who have an early transfer to another hospital (within 24 hrs)	The patient presented to the emergency department on the 20th day post-left mastectomy, indicating she had been discharged previously. There is no information suggesting she was transferred within 24 hours.	0	not excluded
sigir-20146	NCT02512159	inclusion	Clinical evidence of cutaneous leg ulcers due to diabetes mellitus, venous stasis, or arterial insufficiency.	The patient has a painful skin lesion on the left lower leg described as oozing, indicating a leg ulcer. Additionally, she has diabetes mellitus, which is a known risk factor for leg ulcers. While the note does not explicitly state whether the ulcer is due to venous stasis or arterial insufficiency, her obesity and noncompliance with medications suggest potential contributors to these conditions.	2, 3	included
sigir-20146	NCT02512159	inclusion	Patients of both sexes.	The patient identifies as a female, satisfying the criterion of patients of both sexes.		included
sigir-20146	NCT02512159	inclusion	Patients over 18 years.	The patient is 64 years old, which meets the criterion of being over 18 years.	0	included
sigir-20146	NCT02512159	inclusion	Patients that have basic laboratory at admission (complete blood count with differential)	The patient note does not specify whether a complete blood count with differential was performed at admission.		not enough information
sigir-20146	NCT02512159	inclusion	ClinicalTrials.gov Inclusion Criterion: Patients with comorbidities associated as [Diabetes Mellitus], [Hypertension], [stroke], [heart disease], [nephropathy], [venous insufficiency] and/or [arterial insufficiency].	The patient has been diagnosed with Diabetes Mellitus, which falls under the specified comorbidity.	0	included
sigir-20146	NCT02512159	exclusion	Hemodynamically unstable patients.	The patient note does not provide specific information about the patient's hemodynamic stability or instability. There is no mention of vital signs, blood pressure, or cardiac function that would allow determination of whether the patient is hemodynamically unstable.	0	not enough information
sigir-20146	NCT02512159	exclusion	Patients with septic shock from any source.	The patient note does not explicitly state that the patient has septic shock. There is mention of a painful skin lesion, which could potentially lead to sepsis; however, there is no indication that this has progressed to septic shock. Therefore, insufficient information is available to confirm exclusion due to septic shock.	0	not enough information
sigir-20146	NCT02512159	exclusion	patients with a history of deep skin ulcers requiring hospitalization, including those with osteomyelitis or exposing blood vessels/nerve tissue.	The patient reports a painful skin lesion on the left lower leg that is oozing, indicating a deep skin ulcer. This aligns with the exclusion criterion mentioning deep skin ulcers requiring hospitalization and associated complications.	3	excluded
sigir-20146	NCT02512159	exclusion	ERROR	No valid JSON block found in response		ERROR
sigir-20146	NCT02512159	exclusion	Patients who have a history of cutaneous ulcers or cancer tumors within the past year.	The patient note describes a current cutaneous ulcer on the left lower leg, but it does not specify when this condition arose. Without knowing the onset time, we cannot determine if it occurred within the past year, which is necessary for assessing compliance with the exclusion criterion.	3	not enough information
sigir-20146	NCT02512159	exclusion	Patients with cutaneous ulcer with active bleeding.	The patient has a painful skin lesion on the left lower leg that is oozing, which indicates active bleeding. This matches the exclusion criterion of having a cutaneous ulcer with active bleeding.	3	excluded
sigir-20146	NCT02512159	exclusion	patients with cutaneous ulcer necrosis	The patient describes a painful, oozing skin lesion on the left lower leg, which suggests the presence of a serious ulcerative condition potentially leading to necrosis.	3	excluded
sigir-20146	NCT02512159	exclusion	Patients with cutaneous ulcer leishmannia, insect bite.	The patient note does not mention any information regarding cutaneous ulcer leishmannia or insect bites. There is no indication that the patient has these conditions.		not enough information
sigir-20146	NCT02512159	exclusion	Patients with cutaneous ulcer burns.	The patient has a painful skin lesion on the left lower leg that has worsened despite treatment, suggesting a serious underlying condition consistent with cutaneous ulcer burns.	2, 3	excluded
sigir-20146	NCT02512159	exclusion	Patients who do not accept their participation in the study through informed consent.	The patient has provided informed consent and stated she will comply with the trial protocol without any practical issues. This indicates she accepts her participation in the study.	4	not excluded
sigir-20146	NCT00015626	inclusion	Obese patients (wt > 95th percentile for age, for adults increased BMI > 27) greater than 5 years of age	The patient is classified as obese, which meets the BMI threshold for adults (>27). Her age is over 5 years.	0	included
sigir-20146	NCT00015626	inclusion	And/or presence of complications of insulin resistance such as acanthosis nigricans, dyslipidemia, elevated blood pressure, hyperandrogenism	The patient has a skin lesion on the left lower leg, which corresponds to acanthosis nigricans, a known complication of insulin resistance.	3	included
sigir-20146	NCT00015626	inclusion	Siblings and parents of patients with insulin resistance. Siblings and parents will be included only in the case of documented insulin resistance in the index subject.	The patient note indicates the presence of diabetes mellitus and elevated HbA1c, suggesting potential complications. However, there is no explicit documentation of insulin resistance as required by the criterion. Without evidence of insulin resistance through OGTT or IVGTT, the criterion cannot be satisfied.	0	not included
sigir-20146	NCT00015626	inclusion	Family history of type II diabetes.	The patient note does not mention any information about the patient's family history of type II diabetes. Sentence 0 states the patient's current diagnosis of diabetes mellitus, which refers to their personal health rather than familial history.	0	not enough information
sigir-20146	NCT00015626	exclusion	Critically ill patients, patients will congestive heart failure, renal or liver insufficiency	The patient is a 64-year-old with diabetes and poor glycemic control but shows no signs of critical illness, congestive heart failure, renal, or liver insufficiency. The patient note lacks relevant information indicating any of these conditions.	0	not excluded
sigir-20146	NCT00015626	exclusion	Inability to give consent	The patient note indicates that the individual is willing and able to provide informed consent.	4	not excluded
sigir-20146	NCT00015626	exclusion	History of poor compliance with physician's recommendations	The patient note indicates poor compliance with diabetes medication and exercise, meeting the exclusion criterion.	0	excluded
sigir-20147	NCT00845988	inclusion	patients with bipolar disorders (I, II, NOS) diagnosed with DSM-IV criteria	The patient has a history of bipolar disorder, but it is unclear if the diagnosis was made using DSM-IV criteria.	0	not enough information
sigir-20147	NCT00845988	inclusion	age between 18 and 65	The patient is 26 years old, which is between 18 and 65.	0	included
sigir-20147	NCT00845988	inclusion	Decisional capacity is adequate to provide informed consent or has an authorized appropriate surrogate decision maker.	The patient note provides no direct evidence of impaired decisional capacity. The patient is able to provide informed consent and comply with the trial protocol, indicating her capacity is adequate.	6	included
sigir-20147	NCT00845988	inclusion	in a syndromal remission state at least for 2 months : CGI - BP ≤ 3	The patient reports ongoing symptoms including anxiety, depression, and irritability, indicating they are not in syndromal remission. No information suggests a CGI-BP score ≤3.	0, 1, 2, 3, 4	not included
sigir-20147	NCT00845988	inclusion	patients who have exhibited a clinically significant increase in body weight after starting the administration of their current antipsychotic (ie >7% weight gain)	The patient note describes her as being obese, indicating pre-existing weight issues. However, it does not specify whether this obesity occurred after starting her current antipsychotic medications. Additionally, the medications mentioned (lithium carbonate and zolpidem) are not antipsychotics; thus, no conclusive evidence exists regarding weight gain after starting an antipsychotic.	0	not enough information
sigir-20147	NCT00845988	exclusion	diagnosis of eating disorder	The patient notes difficulties with weight and eating causing depression but lacks a formal diagnosis of an eating disorder.	0	not excluded
sigir-20147	NCT00845988	exclusion	history of neurological and medical illnesses	The patient has a documented history of bipolar disorder, which qualifies as a neurological condition. Additionally, she is currently prescribed lithium carbonate, which can lead to metabolic complications.	0, 5	excluded
sigir-20147	NCT00845988	exclusion	pregnant or breast feeding women	The patient note does not provide information regarding the patient's pregnancy or breastfeeding status.		not excluded
sigir-20147	NCT01863628	inclusion	have at least one biological parent diagnosed as bipolar disorder (bipolar I or II)	The patient note does not provide information regarding the mental health history of her biological parents.	0	not enough information
sigir-20147	NCT01863628	inclusion	have at least one of the following syndromes i) two or more DSM-IV defined hypomania/mania symptoms, lasting for at least 4 days; ii) two or more DSM defined major depressive symptoms, lasting for 1 week; iii) at least one of the psychotic symptoms, lasting at least 10 min for each manifestation, and 2-7 manifestations a week for at least 3 months, including: ideas of reference; odd ideas, odd belief, unusual perceptual experiences, bizarre thought or speech, Grandiosity, suspicious ideas, paranoid idea, odd mannerisms, hallucination, disorganized/catatonic behavior; iv)two or more of the DSM-IV defined Attention deficit hyperactivity disorder (ADHD)symptoms; and there must be clear evidence of clinically significant impairment in social, academic, or occupational functioning due to ADHD symptoms	The patient exhibits two or more DSM-defined major depressive symptoms (e.g., depressed mood, difficulty sleeping, excessive anxiety, and suicidal ideation), which have persisted for at least one week.	1, 2	included
sigir-20147	NCT01863628	exclusion	ERROR	No valid JSON block found in response		ERROR
sigir-20147	NCT01863628	exclusion	Serious general medical illness	The patient's note describes symptoms consistent with mental health concerns but does not indicate any serious general medical illnesses.	0, 1	not excluded
sigir-20147	NCT01863628	exclusion	mental retardation	The patient note does not indicate any signs of mental retardation; instead, it describes symptoms consistent with mood disorders.	0	not excluded
sigir-20147	NCT01863628	exclusion	was/is treated with antipsychotic drugs	The patient is taking lithium carbonate and zolpidem. Neither of these medications are antipsychotic drugs.	5	not excluded
sigir-20147	NCT01863628	exclusion	able to complete neuropsychological tests due to physical conditions	The patient is a 26-year-old woman with a history of bipolar disorder and currently reports symptoms including depression, anxiety, and irritability. There is no mention of any physical conditions that would prevent her from completing neuropsychological tests.	0	not excluded
sigir-20147	NCT01863628	exclusion	in pregnancy and lactation	The patient note does not specify whether the patient is pregnant or lactating.		not enough information
sigir-20147	NCT01863628	exclusion	was taking thyroxine therapy in the last three months or is taking hormone therapy	The patient note does not mention any history of thyroxine or hormone therapy usage.		not excluded
sigir-20148	NCT01519271	inclusion	Participants must be experiencing symptoms of mild cognitive impairment; this will be determined by study personnel.	The patient reports memory loss and exhibits severe cognitive deficits and memory dysfunction, indicating cognitive impairment. While the term 'severe' suggests higher severity, the presence of mild cognitive impairment symptoms aligns with the criterion, awaiting confirmation by study personnel.	0, 1	included
sigir-20148	NCT01519271	inclusion	Participants must be on a stable medication regimen for 2 months prior to starting the study (necessary dose adjustments during the study are acceptable).	The patient note does not mention anything about the patient currently being on a stable medication regimen or having been on one for two months prior to the study.		not enough information
sigir-20148	NCT01519271	inclusion	Participants are capable of giving informed consent supported by not meeting Parkinson's disease Dementia criteria; this will be determined by study personnel.	The patient provides informed consent as noted in point 5. However, the patient's condition includes moderate cognitive deficits and memory dysfunction (points 1 and 3). Without explicit assessment of whether these deficits meet PD Dementia criteria, we lack sufficient information to determine eligibility under this criterion.	5	not enough information
sigir-20148	NCT01519271	exclusion	Active suicide ideation.	The patient's note does not mention any signs of active suicide ideation. There is no discussion of suicidal thoughts, intentions, or behaviors.		not excluded
sigir-20148	NCT01519271	exclusion	Weighing less than 100 lbs (45 kgs)	The patient note does not provide any information regarding the patient's weight.		not enough information
sigir-20148	NCT01519271	exclusion	History of Deep Brain Stimulation surgery.	The patient note does not mention anything about having undergone Deep Brain Stimulation surgery. Since the criterion requires a history of such surgery, and none is mentioned, the patient does not meet the exclusion condition.		not excluded
sigir-20148	NCT01519271	exclusion	Diagnosis of Dementia	The patient exhibits symptoms and imaging indicative of cognitive impairment but lacks an official diagnosis of dementia.	0, 1, 4	not excluded
sigir-20148	NCT01519271	exclusion	Taking certain types of medications may be an	The patient note does not explicitly state whether the patient is taking any specific medications mentioned in the exclusion criterion.		not enough information
sigir-20148	NCT01628315	inclusion	Enrolled into the 2-year, double-blind, placebo-controlled ASA study and entered 3 year extension study	The patient note does not mention anything about the patient being enrolled into the specified clinical trial or its extension study.		not included
sigir-20148	NCT01628315	inclusion	MRI was performed on all patients using a 1.5 T magnet	The patient note indicates that neuroimaging studies were conducted, showing cerebral atrophy. However, the specific type of imaging (e.g., MRI) and its parameters (e.g., 1.5 T magnet) are not explicitly stated.	3	not enough information
sigir-20148	NCT01628315	exclusion	MRI images unable to be processed	The patient note does not provide any information regarding the processing of MRI images. Without knowing whether the MRI images can be processed, we cannot determine if this exclusion criterion applies.		not enough information
sigir-20148	NCT01628315	exclusion	All 5 MRI time points not collected	The patient underwent neuroimaging studies showing cerebral atrophy, indicating prior MRI assessments. However, the note lacks details on the completeness of these MRI time points.	3	not enough information
sigir-20149	NCT02615912	inclusion	Healthy Subjects with Fitzpatrick Skin Types I, II or III	The patient note provides limited information regarding the Fitzpatrick skin type; it focuses on the presence of skin lesions rather than describing the overall skin tone.	0	not enough information
sigir-20149	NCT02615912	inclusion	Subjects with visible skin disease, tattoos, skin condition, or abnormal skin color	The patient has visible skin lesions on her neck, indicating a skin disease.	0	included
sigir-20149	NCT02615912	exclusion	Subjects with visible skin disease, tattoos, skin condition, or abnormal skin color	The patient has visible skin lesions on her neck, which meet the criteria of 'visible skin disease' or 'skin condition'. Additionally, the varied pigmentation of the lesions indicates 'abnormal skin color', thus meeting the exclusion criteria.	0, 2	excluded
sigir-20149	NCT01950026	inclusion	belong to ethnic groups requested	The patient note does not specify the patient's ethnicity.	0	not enough information
sigir-20149	NCT01950026	exclusion	suffering any change in skin sensitivity, illness of an infectious nature or previously diagnosed diseases that respond negatively to the use of cold	The patient note does not mention any changes in skin sensitivity, infectious illnesses, or previously diagnosed diseases that would negatively respond to the use of cold.	0, 1	not excluded
sigir-201410	NCT02097186	inclusion	Age greater than 18 years	The patient is 67 years old, which is greater than 18.	0	included
sigir-201410	NCT02097186	inclusion	Patient willing to give full informed consent for participation	The patient note states that the patient will provide informed consent and comply with the trial protocol.	3	included
sigir-201410	NCT02097186	inclusion	Clinical evidence of critical lower limb ischemia (CLI) according to the TASC II classification.	The patient presented with a cool right foot, loss of distal pulses, and a bruit after cardiac catheterization. While these findings suggest possible vascular compromise, they do not specifically confirm the presence of critical lower limb ischemia as defined by the TASC II classification, which typically involves more advanced or severe ischemic manifestations than described here.	0, 1	not included
sigir-201410	NCT02097186	inclusion	Clinical evidence of critical lower limb ischemia	The patient experienced a cool right foot, loss of distal pulses, and a pulsatile mass in the right groin with a bruit. These findings suggest potential complications from the recent cardiac catheterization but do not indicate critical lower limb ischemia, which typically involves more severe symptoms like gangrene or rest pain.	0, 1	not included
sigir-201410	NCT02097186	inclusion	Clinical evidence of critical lower limb ischemia	The patient presented with symptoms indicative of critical lower limb ischemia, including coolness of the right foot, loss of distal pulses, and a bruit suggesting possible arterial obstruction.	0, 1	included
sigir-201410	NCT02097186	inclusion	Surgical lower limb revascularisation (suprainguinal or infrainguinal)	The patient underwent cardiac catheterization, not a surgical revascularization.	0	not included
sigir-201410	NCT02097186	exclusion	Pregnancy	The patient note does not mention anything regarding pregnancy. There is no information indicating that the patient is pregnant.	0, 1, 2	not excluded
sigir-201410	NCT02097186	exclusion	Significant upper limb peripheral arterial disease	The patient's condition involves the femoral artery, not the upper limb arteries. No relevant sentences indicate upper limb peripheral arterial disease.		not excluded
sigir-201410	NCT02097186	exclusion	Previous history of upper limb deep vein thrombosis	The patient note does not mention any history of upper limb deep vein thrombosis.	0	not excluded
sigir-201410	NCT02097186	exclusion	Patients on glibenclamide or nicorandil (these medications may interfere with RIPC)	The patient note does not mention anything about the patient being on glibenclamide or nicorandil.		not enough information
sigir-201410	NCT02097186	exclusion	Patients with an estimated pre-operative glomerular filtration rate < 30mls/min/1.73m²	The patient note does not provide information about the patient's glomerular filtration rate (GFR). There is no mention of blood work, urinalysis, or symptoms indicative of reduced kidney function.	0	not enough information
sigir-201410	NCT02097186	exclusion	Patients with a known history of myocarditis, pericarditis or amyloidosis	The patient note does not mention any history of myocarditis, pericarditis, or amyloidosis.	0, 1	not excluded
sigir-201410	NCT02097186	exclusion	Patients with severe hepatic disease defined as an international normalized ratio (>2) in the absence of systemic anticoagulation.	The patient note does not mention any information regarding the patient's INR levels or systemic anticoagulation status. Without this information, it is impossible to determine if the patient meets the exclusion criterion.		not enough information
sigir-201410	NCT02097186	exclusion	Patients with severe respiratory disease (for the trial, defined as patients requiring home oxygen therapy)	The patient did not exhibit signs of a severe respiratory disease nor require home oxygen therapy.	0, 1	not excluded
sigir-201410	NCT02097186	exclusion	Patients previously enrolled in the trial representing for a further procedure	The patient note does not indicate whether the patient has been previously enrolled in the trial.	3	not enough information
sigir-201410	NCT02097186	exclusion	Patients with previous axillary surgery	The patient note does not mention any history of axillary surgery.	0, 1, 2	not excluded
sigir-201410	NCT02264964	inclusion	Chronic renal failure requiring hemodialysis	The patient note does not indicate that the individual has chronic renal failure requiring hemodialysis.		not included
sigir-201410	NCT02264964	inclusion	Medical history of central venous catheterization.	The patient note describes a cardiac catheterization via the right femoral artery but does not mention a history of central venous catheterization. There is no evidence in the provided sentences suggesting the presence of a central venous catheter.	0	not included
sigir-201410	NCT02264964	inclusion	Maintenance hemodialysis after central vena catheterization.	The patient note describes a 67-year-old woman who underwent cardiac catheterization via the right femoral artery and presented with symptoms indicating possible complications, including a cool right foot and a pulsatile mass with a bruit. However, the note does not explicitly mention that the patient is receiving maintenance hemodialysis after central vena catheterization. Without clear evidence of ongoing dialysis, the criterion cannot be confirmed as met.		not included
sigir-201410	NCT02264964	inclusion	Signed informed consent.	The patient note states that the patient will provide informed consent and comply with the trial protocol without any practical issues. Since the patient has already provided informed consent, this meets the requirement of having signed informed consent.	3	included
sigir-201410	NCT02264964	exclusion	Had been performed central venous puncture or catheterization before.	The patient underwent cardiac catheterization via the right femoral artery, which constitutes central venous catheterization. This matches the exclusion criterion of having undergone central venous puncture or catheterization previously.	0	excluded
sigir-201410	NCT02264964	exclusion	Can not use heparin.	The patient note does not mention anything about the patient's use of heparin or any contraindication to its use. There is insufficient information to determine if the patient meets this exclusion criterion.		not applicable
sigir-201410	NCT02264964	exclusion	Refused to sign the informed consent.	The patient has already provided informed consent, so this criterion does not apply.		not applicable
sigir-201410	NCT02264964	exclusion	Advanced cancer patients.	The patient note does not indicate that the patient has advanced cancer. No relevant information about the patient's cancer status is provided.		not excluded
sigir-201410	NCT02264964	exclusion	With or will take arteriovenous fistula surgery in right arm.	The patient underwent cardiac catheterization via the right femoral artery but did not explicitly mention undergoing or planning to undergo arteriovenous fistula surgery in the right arm. There is no indication in the provided note suggesting she requires or will require such surgery.	0	not enough information
sigir-201410	NCT02264964	exclusion	Other inappropriate situations	The patient is experiencing symptoms and physical exam findings consistent with potential complications from recent cardiac catheterization, including a cool right foot and loss of distal pulses. These observations suggest possible vascular compromise or thrombotic events. While these findings raise concern, they do not directly indicate an 'other inappropriate situation' as defined by the exclusion criterion.	0, 1	not excluded
sigir-201411	NCT01526382	inclusion	Diagnosed with shock, acute respiratory distress syndrome (ards), or both.	The patient note does not mention a diagnosis of shock or acute respiratory distress syndrome (ards). There are no symptoms or test results indicating these conditions.	0	not included
sigir-201411	NCT01526382	inclusion	Heart rate of at least 90/min	The patient exhibits tachycardia, indicating a heart rate greater than 90 beats per minute.	2	included
sigir-201411	NCT01526382	inclusion	A respiratory rate of at least 20/min or a PaCO2 of 32mmHg or lower or the use of mechanical ventilation;	The patient exhibits tachypnea, suggesting a respiratory rate greater than 20/min. However, there is no explicit confirmation of her PaCO2 level or whether she requires mechanical ventilation.	0	not enough information
sigir-201411	NCT01526382	inclusion	The use of vasopressors to maintain a systolic blood pressure of at least 90mmHg despite fluid resuscitation, low dose of dopamine (≤ 5 μg/kg per minute), or dobutamine;	The patient note does not indicate whether the patient is receiving vasopressors such as dopamine or dobutamine.		not included
sigir-201411	NCT01526382	inclusion	at least 1 of 3 signs of hypoperfusion (urine output < 0.5mL/kg of body weight per hour for 1 hour or more; neurologic dysfunction defined by confusion, psychosis, or a Glasgow coma scale score of ≤ 6; plasma lactate higher than the upper limit of the normal value)	The patient exhibits signs consistent with hypoperfusion, including pallor and compensatory tachycardia/tachypnea, but lacks explicit documentation of measurable signs such as urine output, neurological dysfunction (specifically GCS ≤6) or elevated plasma lactate.	0	not enough information
sigir-201411	NCT01526382	inclusion	presence of acute decrease in PaO2/FIO2 to 200mmHg or lower	The patient note does not provide specific information regarding the patient's PaO2/FIO2 levels or indicate an acute decrease.	0	not included
sigir-201411	NCT01526382	inclusion	bilateral pulmonary infiltrates or a chest radiograph consistent with edema	The patient note lacks specific information regarding pulmonary infiltrates or imaging results indicating edema.		not enough information
sigir-201411	NCT01526382	inclusion	no clinical evidence of left atrial hypertension; and requirement for positive pressure ventilation.	The patient note does not provide information regarding whether there is clinical evidence of left atrial hypertension or if the patient requires positive pressure ventilation. Additionally, although the patient exhibits tachypnea, there is no indication of respiratory failure or the necessity for mechanical ventilation.	0	not included
sigir-201411	NCT01526382	exclusion	Patients were moribund.	The patient note describes a 40-year-old woman presenting with acute arm pain and associated symptoms, including pallor, tachypnea, and tachycardia. However, there is no indication that her condition was immediately life-threatening or that she was moribund.	0	not excluded
sigir-201411	NCT01526382	exclusion	signed do-not-resuscitate order	The patient note does not mention anything about a signed do-not-resuscitate order. Without this information, we cannot determine if the criterion applies.	5	not enough information
sigir-201411	NCT01723137	inclusion	Reported pain greater than or equal to 3 out of 10	The patient reports experiencing 'ex cruciating pain,' indicating a severity level significantly exceeding 3 out of 10.	0	included
sigir-201411	NCT01723137	exclusion	Less than 18 years of age	The patient is 40 years old, which is greater than 18.	0	not excluded
sigir-201411	NCT01723137	exclusion	The patient’s level of consciousness needs to be evaluated before inclusion into the trial. If decreased, patients are excluded.	The patient presented to the ER with excruciating pain and was described as pale and in moderate discomfort, tachypneic, and tachycardic. However, her level of consciousness wasn't explicitly noted as decreased. There were no reports of altered mental status or confusion, suggesting her consciousness isn't decreased.	0	not excluded
sigir-201411	NCT01723137	exclusion	Inability to answer questions	The patient note indicates that the participant will provide informed consent and comply with the trial protocol without any practical issues.	5	not excluded
sigir-201411	NCT01723137	exclusion	Prisoner	The patient note does not indicate whether the patient is a prisoner.	0	not excluded
sigir-201412	NCT00271427	inclusion	 Clinically approved AIT patients who do not use any medication other than LT4 to keep TSH in the lower half of normal range.	The patient note lacks explicit confirmation of a diagnosis of AIT or Hashimoto's Thyroiditis and does not detail specific medications beyond potentially mentioning symptomatology. Without definitive diagnostic information and detailed medication history, eligibility cannot be determined.	0, 2	not enough information
sigir-201412	NCT00271427	exclusion	Any kind of drug use other than LT4 or any kind of known pathology which may affect GIS absorption.	The patient note does not specify any drug use other than possibly LT4, nor does it indicate any known pathology affecting GIS absorption. The presence of symptoms suggestive of hypothyroidism aligns with potential LT4 use, but no evidence of other exclusions is provided.	0, 1	not excluded
sigir-201412	NCT01551498	inclusion	adults 18-70 years of age	The patient is 25 years old, which falls within the specified age range.	0	included
sigir-201412	NCT01551498	inclusion	having positive antibodies against thyroid peroxidase	The patient presented with symptoms suggestive of autoimmune thyroid condition, including hair loss, weight gain, and cold intolerance. These symptoms align with potential autoimmune thyroid diseases, which often involve the presence of anti-thyroperoxidase antibodies. However, the patient note does not explicitly state whether these antibodies are present.	0, 1, 2, 3	not enough information
sigir-201412	NCT01551498	inclusion	having sonographic evidence consistent with a diagnosis of Hashimoto's thyroiditis	The patient presented with symptoms suggestive of Hashimoto's thyroiditis but did not undergo imaging to confirm the condition.	0	not included
sigir-201412	NCT01551498	exclusion	having evidence of end-stage thyroiditis	The patient presented with symptoms suggestive of thyroid issues but did not exhibit indicators of end-stage thyroiditis such as severe complications or functional impairment.	4	not excluded
sigir-201412	NCT01551498	exclusion	being a current smoker or smokeless tobacco user	The patient note does not mention anything regarding smoking or smokeless tobacco usage.		not enough information
sigir-201412	NCT01551498	exclusion	be taking systemic glucocorticoids, interferon-alpha, anti-CD20 antibody, or anti-CTLA-4 antibody	The patient note does not indicate that the patient is currently taking any of the listed medications or treatments.		not excluded
sigir-201412	NCT01551498	exclusion	be taking any medication for treatment of autoimmune thyroiditis other than L-thyroxine or equivalent	The patient note does not provide information regarding the medications the patient is currently taking.	5	not enough information
sigir-201413	NCT02264769	inclusion	Elective cesarean delivery under spinal anesthesia	The patient has not undergone an elective cesarean delivery and instead delivered a healthy child via vaginal delivery.	2	not included
sigir-201413	NCT02264769	inclusion	Written informed consent to participate in this study	The patient note explicitly states that the patient will provide informed consent and comply with the trial protocol without any practical issues.	6	included
sigir-201413	NCT02264769	inclusion	Term pregnancy	The patient note states that the patient gave birth to a healthy child three weeks ago, indicating a successful term pregnancy.	0	included
sigir-201413	NCT02264769	exclusion	Refusal to give written informed consent.	The patient note explicitly states that the patient provides informed consent and complies with the trial protocol without any practical issues. There is no indication of refusal to give written informed consent.	6	not excluded
sigir-201413	NCT02264769	exclusion	Allergy or hypersensitivity to carbetocin or oxytocin.	The patient note does not mention any allergies or hypersensitivities to carbetocin or oxytocin. There is no information indicating that the patient has experienced adverse reactions to these drugs in the past.	0, 6	not excluded
sigir-201413	NCT02264769	exclusion	previous history of uterine atony and postpartum bleeding	The patient did not report any history of uterine atony or postpartum bleeding. She had a recent uncomplicated delivery and a history of two natural abortions without complications.	0, 1	not excluded
sigir-201413	NCT02264769	exclusion	Hepatic, renal, and vascular disease.	The patient's note does not mention any diagnosed hepatic, renal, or vascular disease. While she exhibited tachycardia during presentation, it was noted as a current state rather than indicative of a pre-existing condition. Other assessments including physical exam, imaging, and lab results were within normal limits, providing no evidence of underlying disease.	0, 3	not excluded
sigir-201413	NCT00163709	inclusion	all patients presenting to the ED with shortness of breath that are over 40 years old and present with an emergency department triage category of 3 or higher	The patient is a 30-year-old woman, who is below the specified age of 40.	0	not included
sigir-201413	NCT00163709	exclusion	Patients presenting with a traumatic cause of dyspnea	The patient presented with shortness of breath but there was no mention of a traumatic event causing it.	0	not excluded
sigir-201413	NCT00163709	exclusion	patients with severe renal disease (serum creatinine level of more than 250 micro mmol/L)	The patient note does not specify the serum creatinine level; therefore, it is unclear if the criterion applies.	0	not enough information
sigir-201413	NCT00163709	exclusion	patients with cardiogenic shock	The patient presented with shortness of breath and tachycardia but did not exhibit signs of severe hemodynamic instability typical of cardiogenic shock. Her blood pressure was within normal limits, and imaging studies showed no abnormalities.	0, 1	not excluded
sigir-201413	NCT00163709	exclusion	patients who have an early transfer to another hospital (within 24 hrs)	The patient presented directly to this hospital with shortness of breath starting two hours prior to admission; there is no mention of a prior transfer.	0	not excluded
sigir-201414	NCT01624545	inclusion	Newly diagnosed chronic subdural hematoma by CT scan or MRI, operated within the last 48 hours	The patient note indicates that the patient had a normal head CT after a car accident three weeks prior but does not mention any current imaging findings confirming a chronic subdural hematoma or recent surgical intervention.	0, 3	not included
sigir-201414	NCT01624545	inclusion	Age 18 years or older	The patient is 85 years old, meeting the required age criterion.	0	included
sigir-201414	NCT01624545	inclusion	Written informed consent from the patient to participate in the study	The patient note states that the individual will provide informed consent and comply with the trial protocol without any practical issues.	4	included
sigir-201414	NCT01624545	exclusion	Moribund state of health prohibiting surgery	The patient is elderly and shows signs of decreased consciousness and reduced self-care abilities, potentially indicating poor health. However, there is no explicit indication that he requires surgery or is in a moribund state.	0, 1	not excluded
sigir-201414	NCT01624545	exclusion	Foreseeable difficulties in follow-up due to geographic reasons (e.g., patients living abroad)	There is no information in the patient note regarding the patient's geographic location or potential difficulty in follow-up due to distance.	0	not enough information
sigir-201414	NCT01624545	exclusion	Recurrent hematoma if the first surgery was performed before study start	The patient note does not specify details regarding past surgeries or presence of recurrent hematomas.	0	not enough information
sigir-201414	NCT01624545	exclusion	CSH due to spontaneous spinal CSF fistula or meningeosis carcinomatosa	The patient's recent presentation includes decreased activity but lacks specific indicators of underlying causes linked to CSH via spinal CSF fistula or meningeal carcinoma.	0, 3	not excluded
sigir-201414	NCT01624545	exclusion	Pregnancy	The patient note does not mention anything regarding pregnancy.	0, 1, 2, 3	not excluded
sigir-201414	NCT01624545	exclusion	Patient with Metastatic Disease and a high possibility to pass away in the next 6 month	The patient note does not mention anything about metastatic disease or a high possibility of passing away in the next 6 months.		not enough information
sigir-201414	NCT01869855	inclusion	Patient at least 18 years of age presenting with a symptomatic chronic subdural hematoma	The patient is 85 years old, meeting the age criterion. Symptoms including decreased level of consciousness and inability to perform daily activities suggest a symptomatic chronic subdral hematoma.	0, 1	included
sigir-201414	NCT01869855	inclusion	Chronic subdural hematoma verified on cranial CT or MRI	The patient had a normal head CT after a car accident three weeks prior, indicating no chronic subdural hematoma at that time. The patient note lacks information regarding current cranial imaging results to verify the presence of a chronic subdural hematoma.	3	not enough information
sigir-201414	NCT01869855	exclusion	The surgeon decides based on intraoperative conditions to perform a craniotomy (e.g., acute hematoma indicating a craniotomy)	There is no information in the patient note about intraoperative conditions or imaging results suggesting the need for a craniotomy.		not enough information
sigir-201414	NCT01869855	exclusion	Chronic subdural hematoma caused by another underlying illness (e.g., caused by over-drainage of a VP shunt)	The patient note does not indicate the presence of a chronic subdural hematoma caused by another underlying condition such as over-drainage of a VP shunt.	0	not excluded
sigir-201414	NCT01869855	exclusion	no informed consent	The patient note indicates that the individual has provided informed consent and complies with the trial protocol without any practical issues.	4	not excluded
sigir-201415	NCT00277680	inclusion	Menorrhagia and/or bulk symptoms associated with uterine fibroids	The patient presents with symptoms including vaginal spotting, lower abdominal tenderness, and an enlarged uterus, which are consistent with uterine fibroids. These symptoms align with the inclusion criterion.	0, 1	included
sigir-201415	NCT00277680	exclusion	Malignancy	The patient's presentation and diagnostic workup reveal no signs of malignancy; her condition is likely related to fibroid degeneration.	0, 1	not excluded
sigir-201415	NCT00277680	exclusion	Current or planned pregnancy	The patient tested negative for pregnancy using a sensitive beta-HCG test and did not report any signs of current or planned pregnancy.	3	not excluded
sigir-201415	NCT00277680	exclusion	Small submucous fibroids suitable for hysteroscopic resection	The patient's ultrasound indicates an enlarged uterus with multiple cystic areas, suggesting possible fibroids. However, the absence of explicit details about the fibroids' size and accessibility for hysteroscopic resection leaves uncertainty.	4	not enough information
sigir-201415	NCT00277680	exclusion	Postmenopausal women	The patient is 36 years old, indicating she is still of reproductive age and therefore not postmenopausal.	0	not excluded
sigir-201415	NCT00277680	exclusion	Suspected or known adenomyosis	The patient's presentation includes signs of potential early pregnancy complications rather than clear indicators of adenomyosis.	0	not excluded
sigir-201415	NCT00277680	exclusion	Uterus size exceeding the umbilical level	The patient's ultrasound shows an enlarged uterus measuring 12 cm x 9 cm x 7 cm with multiple cystic areas, suggesting significant enlargement.	4	excluded
sigir-201415	NCT00277680	exclusion	Contraintications against laparoscopic surgery	No information in the patient note indicates any contraindications against laparoscopic surgery.	0	not excluded
sigir-201415	NCT00180739	inclusion	ERROR	No valid JSON block found in response		ERROR
sigir-201415	NCT00180739	inclusion	Use or non-use of non-steroidal treatments for excessive vaginal bleeding such as antifibrinolytic agents (e.g., Tranexamic acid) or non-steroidal anti-inflammatory drugs (e.g., Mefanamic Acid) has been maintained for the three months prior to the planned date of the study procedure and the patient has agreed to maintain this use or non-use through the 6-month follow-up period.	The patient note does not mention anything about the use or non-use of specified medications for excessive vaginal bleeding. No relevant sentences were found regarding this criterion.		not enough information
sigir-201415	NCT00180739	inclusion	Clinically normal PAP smear within timing of National Guidelines in the country of the clinical site.	The patient note does not mention any information regarding a PAP smear result. There is no data indicating whether a PAP smear was performed recently or its results.		not enough information
sigir-201415	NCT00180739	inclusion	Able and willing to give consent and able to attend all study visits	The patient explicitly states she will provide informed consent and comply with the trial protocol without practical issues.	6	included
sigir-201415	NCT00180739	inclusion	Able to communicate sensations during the MRgFUS procedure	The patient note does not specify whether the individual can communicate sensations during the MRgFUS procedure.		not enough information
sigir-201415	NCT00180739	inclusion	Having uterine fibroids that are device accessible (i.e., positioned in the uterus such that they can be accessed without being shielded by bowel or bone)	The patient note indicates a differential diagnosis including fibroid degeneration, suggesting the possibility of uterine fibroids. However, there is insufficient detail provided about the fibroids' accessibility.	5	not enough information
sigir-201415	NCT00180739	inclusion	Tumors are clearly visible on non-contrast MRI.	The patient note does not mention undergoing an MRI or providing MRI results. Without this information, it is impossible to determine if the tumors are clearly visible on a non-contrast MRI.	4	not enough information
sigir-201415	NCT00180739	inclusion	Largest fibroid 8 cm in diameter or 12 cm if receiving GnRH	The patient's ultrasound showed an enlarged uterus but did not specify the size of individual fibroids. Additionally, there was no mention of the patient receiving GnRH therapy.	4	not enough information
sigir-201415	NCT00180739	exclusion	Patient is pregnant as confirmed by pregnancy test at time of screening	The patient presented with symptoms suggestive of early pregnancy including amenorrhea and ultrasound findings of an enlarged uterus. However, a negative pregnancy test result with a high sensitivity threshold complicates the assessment. Without clear confirmatory evidence of pregnancy, the exclusion criterion cannot be applied.	3	not excluded
sigir-201415	NCT00180739	exclusion	Uterine size >20 weeks as evaluated by US or MR.	The patient's ultrasound shows an enlarged uterus, but the lack of positive beta-HCG indicates no active pregnancy. This makes the uterine size unlikely to relate to a gestational age beyond 20 weeks. Therefore, the exclusion criterion based on uterine size for pregnancy does not apply.	4	not excluded
sigir-201415	NCT00180739	exclusion	Patients who have had a prior spontaneous abortion or induced abortion within the last year.	The patient note does not mention any history of prior spontaneous or induced abortion within the last year. There is no information provided about the patient's obstetric history, specifically regarding recent reproductive events.	6	not enough information
sigir-201415	NCT00180739	exclusion	Patients with fibroid that is more than 50% sub-mucosal or with hysteroscopically resectable	The patient’s condition involves fibroids; however, the note lacks explicit details regarding the proportion of sub-mucosal involvement or hysteroscopic resectability.	5	not enough information
sigir-201415	NCT00180739	exclusion	Patients with adenomyosis	The patient note does not mention adenomyosis explicitly nor provide sufficient information to diagnose or rule out adenomyosis.		not enough information
sigir-201415	NCT00180739	exclusion	Patient is on dialysis	The patient note does not mention anything about dialysis or kidney function.		not excluded
sigir-201415	NCT00180739	exclusion	Hematocrit is < 25	The patient's complete blood count was noted as normal, but specific details about hematocrit levels were not provided.	2	not enough information
sigir-201415	NCT00180739	exclusion	Patient has hemolytic anemia	The patient's lab results showed a normal complete blood count and biochemical profile, indicating no signs of hemolytic anemia.	2	not excluded
sigir-201415	NCT00180739	exclusion	Patient has unstable cardiac status including: § Unstable angina pectoris on medication§ Documented myocardial infarction within 6 months of protocol entry§ Congestive heart failure requiring medication (other than diuretic)§ Currently taking anti-arrhythmic drugs§ Severe hypertension (diastolic BP>100 on medication)§ Presence of cardiac pacemaker	The patient note does not mention any cardiac-related issues such as unstable angina, recent myocardial infarction, congestive heart failure, anti-arrhythmic drug use, severe hypertension, or presence of a cardiac pacemaker.		not excluded
sigir-201415	NCT00180739	exclusion	Patient has an ASA score of >2	The patient note does not provide information about the ASA score.	0	not enough information
sigir-201415	NCT00180739	exclusion	Patient has severe cerebrovascular disease (multiple CVA or CVA within 6 months)	The patient note does not mention any history of cerebrovascular disease or events such as CVA.	0	not excluded
sigir-201415	NCT00180739	exclusion	Patient is on anti-coagulation therapy or has an underlying bleeding disorder	The patient note does not mention any anti-coagulation therapy or underlying bleeding disorders.	0	not excluded
sigir-201415	NCT00180739	exclusion	Evidence of uterine pathology other than leiomyoma	The patient's ultrasound report indicates an enlarged uterus with multiple cystic areas, suggesting potential uterine pathology beyond leiomyoma.	5	excluded
sigir-201415	NCT00180739	exclusion	Patient has an active pelvic infection or history of pelvic inflammatory disease	The patient's presentation, including symptoms, physical exam, and diagnostic results, does not indicate an active pelvic infection or history of pelvic inflammatory disease.	0, 1	not excluded
sigir-201415	NCT00180739	exclusion	Patient has an undiagnosed pelvic mass outside the uterus.	The patient's ultrasound shows an enlarged uterus with multiple cystic areas internally, which does not indicate a pelvic mass outside the uterus. There is no evidence of an undiagnosed pelvic mass outside the uterus based on the provided information.	5	not excluded
sigir-201415	NCT00180739	exclusion	Patient weight >110 kg	The patient note does not provide specific information about the patient's weight.		not enough information
sigir-201415	NCT00180739	exclusion	Subject with extensive abdominal scarring in an area of the abdomen directly anterior to the treatment area.	The patient note does not mention anything regarding abdominal scarring. Without this information, it is impossible to determine if the patient meets the exclusion criterion.		not enough information
sigir-201415	NCT00180739	exclusion	Subject with standard contraindications for MR imaging such as non-MRI compatible implanted metallic devices.	The patient note does not mention any history of metallic devices or implants. There is no indication of any contraindications for MRI related to metallic devices.	0, 1	not excluded
sigir-201415	NCT00180739	exclusion	Known intolerance to the MRI contrast agent (e.g. Gadolinium or Magnevist).	The patient did not report any history of intolerance to MRI contrast agents.	6	not excluded
sigir-201415	NCT00180739	exclusion	Individuals who are not able or unwilling to tolerate the required prolonged stationary prone position during treatment (approximately 3 hours.)	The patient note does not provide information on the patient's ability to tolerate a prolonged stationary prone position.		not enough information
sigir-201415	NCT00180739	exclusion	Patient with an intrauterine contraceptive device present within the last 30 days prior to randomization.	The patient note does not mention the presence of an intrauterine contraceptive device within the last 30 days prior to randomization. There is insufficient information to determine if this exclusion criterion applies.		not enough information
sigir-201415	NCT00180739	exclusion	Women who are breast feeding.	The patient note does not provide information about the patient's current breastfeeding status. Without this information, we cannot determine if the patient meets this exclusion criterion.		not enough information
sigir-201415	NCT00180739	exclusion	Five or more fibroids, bigger then 3cm diameter, each	The patient note describes an ultrasound finding of multiple cystic areas within the uterus, suggesting the presence of fibroids. However, the exact number of fibroids and their sizes are not specified. Without knowing the number of fibroids and their respective sizes, it is impossible to determine if the exclusion applies.	5	not enough information
sigir-201416	NCT02238756	inclusion	Compliant with protocol procedures and available for clinical F/U until the protocol-defined end of the trial	The patient is compliant with protocol procedures as indicated by her willingness to provide informed consent and adhere to the trial protocol. Additionally, despite current hospitalization, there is no specific information indicating that she would not be available for required clinical follow-ups throughout the trial.	4	included
sigir-201416	NCT02238756	inclusion	Physical examination and laboratory results without clinically significant findings	The patient's physical exam revealed slight tremors and minimal spasticity, with no other notable findings. No clinically significant abnormalities were identified.	0	included
sigir-201416	NCT02238756	inclusion	Body Mass Index (BMI) ≥ 18.0 and ≤ 32.0 kg/m²	The patient's age is mentioned, but there is no information regarding her height or weight to calculate BMI.	0	not enough information
sigir-201416	NCT02238756	inclusion	Subjects must use reliable forms of contraception (barrier method with spermicidal agent or true abstinence) and must refrain from sperm donation during treatment and the 4-week F/U period after the last treatment.	The patient note does not specify any information about her current contraceptive methods or adherence to abstinence periods. Therefore, it is unclear if she meets the requirement of using reliable forms of contraception or refraining from sperm donation.		not enough information
sigir-201416	NCT02238756	exclusion	Use of any investigational or non-registered product (adjuvant, drug) other than CV8102 within 4 weeks preceding the administration of the CV8102, or planned use of any such agent during the trial period	The patient note does not specifically mention the use of any investigational or non-registered products other than CV8102 within the specified timeframe or plan to use such agents during the trial.	0	not enough information
sigir-201416	NCT02238756	exclusion	Subject has received any licensed or non-licensed vaccines within 4 weeks prior to the administration of CV8102 alone or in combination with the licensed rabies vaccine or planned vaccinations during the trial period	The patient did not explicitly state receipt of any rabies vaccine or other relevant vaccination within the required timeframe.	0	not excluded
sigir-201416	NCT02238756	exclusion	Any treatment with immunosuppressants or other immune-modifying drugs within 6 months prior to the administration of CV8102 alone or in combination with the licensed rabies vaccine.	The patient was prescribed NSAIDs, which are immunomodulating drugs. Assuming their use occurred within the past six months, this meets the exclusion criterion.	0	excluded
sigir-201416	NCT02238756	exclusion	Any medically diagnosed or suspected immune deficient condition based on medical history and physical examination	The patient's presenting symptoms and physical findings do not suggest an immune deficient condition. Symptoms included neck and shoulder pain, left-hand/arm paresthesias, spastic movements, sweating, agitation, anxiety, malaise, difficulty swallowing, and hydrophobia. None of these indicate immune deficiency.	0, 1	not excluded
sigir-201416	NCT02238756	exclusion	History of autoimmune disease or suspected autoimmune disease based on medical history and physical examination that cannot be ruled out based on further examinations	The patient's notes do not indicate any history or suspicion of autoimmune disease. Symptoms described are consistent with other conditions and no labs or further tests suggesting autoimmune issues are noted.	0, 1	not excluded
sigir-201416	NCT02238756	exclusion	Administration of immunoglobulins (Igs) and/or any blood products within the 3 months preceding the administration of CV8102 or licensed rabies vaccine	The patient note does not specify whether the patient received immunoglobulins or blood products within the past 3 months.	4	not enough information
sigir-201416	NCT02238756	exclusion	Acute disease at the time of enrolment. Acute disease is defined as the presence of any acute condition including but not limited to non-febrile or febrile common colds, urinary tract infections, inflammatory, allergic or traumatic conditions that may interfere with safety assessment of the investigational products	The patient experienced worsening symptoms over several days, including spastic arm movements, sweating, agitation, anxiety, malaise, difficulty swallowing, and hydrophobia, which suggest an acute condition affecting her ability to safely participate in the trial.	3	excluded
sigir-201416	NCT02238756	exclusion	Presence or evidence of significant acute or chronic disease, in particular heart disease including coronary artery disease and chronic pulmonary diseases (e.g., chronic obstructive pulmonary disease [COPD]); uncontrolled medical or psychiatric illness (subjects with uncomplicated chronic diagnoses stable and treated for ≥ 3 months e.g., mild hypertension well-controlled with medication, may be enrolled - provided the condition and its therapy are known not to be associated with an immunocompromised state or an autoimmune disease)	The patient exhibits symptoms consistent with rabies, which is a significant acute disease.	3	excluded
sigir-201416	NCT02238756	exclusion	Major congenital defects	The patient’s note does not mention anything regarding congenital defects or any relevant medical history that would indicate the presence of major congenital defects.	0	not enough information
sigir-201416	NCT02238756	exclusion	Known allergy to any component (or closely related substance) of the licensed rabies vaccine product	The patient's condition appears to be progressing toward rabies rather than an allergic reaction.	3	not excluded
sigir-201416	NCT02238756	exclusion	Known type I allergy to beta-lactam antibiotics	The patient note does not mention any history of allergies, specifically a type I allergy to beta-lactam antibiotics.	0	not enough information
sigir-201416	NCT02238756	exclusion	Evidence of current alcohol or drug abuse	The patient note does not mention any signs of current alcohol or drug abuse.		not excluded
sigir-201416	NCT02238756	exclusion	History of any neurological disorders or seizures	The patient exhibits symptoms consistent with neurological disorders, including spasticity, tremors, and altered mental state, which meet the exclusion criterion.	0, 3	excluded
sigir-201416	NCT02238756	exclusion	Known seropositivity for human immunodeficiency virus (HIV), hepatitis B virus (HBV) (except in subjects previously vaccinated against HBV) or hepatitis C virus (HCV)	The patient note does not mention any information regarding the patient's serological status for HIV, HBV, or HCV. As a result, there is insufficient information to determine if the patient meets the exclusion criterion.		not enough information
sigir-201416	NCT02238756	exclusion	Foreseeable non-compliance with protocol as judged by the Investigator	The patient note indicates that she will provide informed consent and comply with the trial protocol without any practical issues.	4	not excluded
sigir-201416	NCT02238756	exclusion	History of any life-threatening anaphylactic reactions	The patient note does not mention any history of life-threatening anaphylactic reactions.	0	not excluded
sigir-201416	NCT02238756	exclusion	Subjects with impaired coagulation in whom an IM injection is contraindicated.	The patient's condition includes symptoms suggestive of neurological impairment potentially linked to rabies, but there is no mention of impaired coagulation or reasons why an IM injection would be contraindicated. No relevant information regarding clotting disorders or risks associated with IM injections is provided in the patient note.		not excluded
sigir-201416	NCT02374814	inclusion	Male and non-pregnant females aged ≥ 18 to ≤ 60 years on the day of inclusion	The patient is a 28-year-old female, meeting the age requirement. However, the patient note does not provide information regarding her pregnancy status, which is necessary for determining eligibility.	0	not enough information
sigir-201416	NCT02374814	inclusion	Able to comprehend and give informed consent	The patient note explicitly states that she will provide informed consent and comply with the trial protocol without any practical issues.	4	included
sigir-201416	NCT02374814	inclusion	Able to attend all scheduled visits and to comply with all trial procedures	The patient explicitly states she will provide informed consent and comply with the trial protocol without any practical issues.	4	included
sigir-201416	NCT02374814	inclusion	Subject in good health, based on medical history and physical examination	The patient exhibits symptoms consistent with rabies infection, including neurological deficits and significant distress. Rabies is a severe illness that typically precludes individuals from being classified as being in good health.	3	not included
sigir-201416	NCT02374814	exclusion	Subject is pregnant, or lactifying, or of childbearing potential	The patient note does not provide information about the patient's pregnancy status, lactification, or childbearing potential.		not enough information
sigir-201416	NCT02374814	exclusion	Participation in the 4 weeks preceding the first trial vaccination, or planned participation during the present trial period, in another clinical trial investigating a vaccine, drug, medical device, or medical procedure.	The patient did not indicate participation in another clinical trial within the 4-week period preceding the first vaccination.	0	not excluded
sigir-201416	NCT02374814	exclusion	Previous history of receiving the rabies vaccine.	The patient note does not specify whether the individual received the rabies vaccine. While she attended a campaign involving animals, which could imply potential exposure, there is no direct indication of vaccination.	0	not enough information
sigir-201416	NCT02374814	exclusion	Previous history of receiving rabies immune globulin.	The patient note does not mention any prior receipt of rabies immune globulin. While she experienced symptoms potentially linked to rabies exposure, there is no indication that she received rabies immune globulin beforehand.	0	not excluded
sigir-201416	NCT02374814	exclusion	Any major psychiatric disorder, such as severe depression, severe anxiety disorder, psychosis, schizophrenia, other major psychiatric disorders, or seizures.	The patient's reported symptoms included anxiety and agitation, but these appear to be related to her physical condition rather than indicating a pre-existing psychiatric disorder. There is no indication in the patient note of a history of mild depression or anxiety disorder that is well-controlled. Therefore, the patient does not meet the exclusion criterion based on major psychiatric disorders.	3	not excluded
sigir-201417	NCT01745731	inclusion	Patients of both sexes aged ≥ 18 years.	The patient is a 48-year-old male who meets the age requirement of being ≥ 18 years old. Gender is not specified as excluding, as the criterion allows both sexes.	0	included
sigir-201417	NCT01745731	inclusion	Leukocytes ≥ 3000	The patient note does not provide information regarding leukocyte count.		not enough information
sigir-201417	NCT01745731	inclusion	Patients with liver space occupying lesion (LOE) that require extended hepatic resection.	The patient has a ruptured liver abscess, which is classified as a space occupying lesion (LOE), and underwent surgical intervention, suggesting it requires extended hepatic resection.	3	included
sigir-201417	NCT01745731	inclusion	ERROR	No valid JSON block found in response		ERROR
sigir-201417	NCT01745731	inclusion	Patients give their written informed consent for participation in the study and provide sufficient guarantees adherence to protocol according to the opinion of the investigator in charge of the patient care.	The patient note confirms that they provided informed consent and there are no practical issues with adhering to the protocol. This satisfies the requirement of providing written informed consent and ensuring adherence.	5	included
sigir-201417	NCT01745731	exclusion	Different tumor records current disease or any disease hematologic.	The patient note does not indicate the presence of a different tumor record indicating a current disease or any hematologic disease. The patient has a history of CVID, which is a primary immunodeficiency, not a tumor or hematologic disease. No evidence of a second malignancy or active hematologic condition is mentioned.	0	not excluded
sigir-201417	NCT01745731	exclusion	Patients with uncontrolled hypertension.	The patient note does not mention any information regarding the patient's blood pressure or hypertensive condition. Without this information, it is impossible to determine if the patient meets the exclusion criterion of having uncontrolled hypertension.	0	not enough information
sigir-201417	NCT01745731	exclusion	Severe heart failure (NYHA IV)	The patient's note does not mention anything regarding severe heart failure or New York Heart Association Class IV symptoms.		not excluded
sigir-201417	NCT01745731	exclusion	Patients with malignant ventricular arrhythmias or unstable angina.	The patient note describes a 48-year-old male with a history of common variable immunodeficiency and presents with acute abdominal pain, fever, dehydration, tachycardia, and hypotension. There is no indication of malignant ventricular arrhythmias or unstable angina in the provided notes.	0	not excluded
sigir-201417	NCT01745731	exclusion	Diagnosis of deep vein thrombosis in the previous 3 months.	The patient note does not mention anything regarding a recent diagnosis of deep vein thrombosis. There is no relevant information indicating the presence of deep vein thrombosis in the last three months.		not excluded
sigir-201417	NCT01745731	exclusion	Patients who have received prior treatment with COX-2 inhibitors within 6 months before randomization.	The patient note does not mention any information about prior treatment with COX-2 inhibitors. Without this information, we cannot determine if the patient meets the exclusion criterion.		not enough information
sigir-201417	NCT01745731	exclusion	BMI> 40 kg/m2.	The patient note does not provide information regarding the patient's BMI. Without knowing the patient's BMI, we cannot determine if it meets the exclusion criterion of BMI > 40 kg/m².		not excluded
sigir-201417	NCT01745731	exclusion	Patients with alcoholic with active alcoholism.	The patient note does not mention anything regarding alcohol consumption or active alcoholism. There is no information provided that would indicate whether the patient has active alcoholism.		not enough information
sigir-201417	NCT01745731	exclusion	Proliferative retinopathy.	The patient's note does not indicate any signs or symptoms related to proliferative retinopathy, including any eye-related issues or underlying conditions typically associated with it.	0	not excluded
sigir-201417	NCT01745731	exclusion	Concomitant disease that reduces life expectancy to less than a year.	The patient has a history of common variable immunodeficiency (CVID), which can impact life expectancy, along with several severe complications including a ruptured liver abscess and ICU admission. While these indicate potential comorbidity, the specific impact on life expectancy isn't clearly stated beyond these immediate issues. Without more detailed information on the patient's prognosis, it's difficult to confirm if their life expectancy is reduced to less than a year due to concurrent diseases.	0	not enough information
sigir-201417	NCT01745731	exclusion	Difficulty in monitoring.	No reasoning provided	5	not excluded
sigir-201417	NCT01745731	exclusion	Heart failure or ejection fraction (EF) <30%	The patient note does not provide information regarding heart failure or ejection fraction.		not enough information
sigir-201417	NCT01745731	exclusion	Stroke or myocardial infarction within the last 3 months.	The patient note does not mention any recent stroke or myocardial infarction events. There is no indication of cardiovascular or cerebrovascular incidents in the provided information.	0	not excluded
sigir-201417	NCT01745731	exclusion	Pregnant women or women of childbearing age who do not have adequate contraception.	The patient is a 48-year-old male, thus not a woman of childbearing age. Additionally, the criterion pertains specifically to women, excluding men from consideration.	5	not excluded
sigir-201417	NCT02556359	inclusion	ERROR	No valid JSON block found in response		ERROR
sigir-201417	NCT02556359	inclusion	Common Variable Immunodeficiency (CVID)	The patient has a documented history of Common Variable Immunodeficiency (CVID), meeting the inclusion criterion.	0	included
sigir-201417	NCT02556359	inclusion	Genetic predisposition to immune deficiency	The patient has a diagnosis of Common Variable Immunodeficiency (CVID), which is often associated with genetic mutations affecting immune function.	0	included
sigir-201417	NCT02556359	exclusion	Age <18 years old.	The patient is 48 years old, which is greater than or equal to 18 years old. Since the criterion specifies age younger than 18, the patient does not meet this exclusion criterion.	0	not excluded
sigir-201418	NCT01260883	inclusion	Non-prematurely-born infants admitted to hospital following surgery ages 2-18 months	The patient is a 6-month-old male infant, falling within the specified age range of 6-12 months.	0	included
sigir-201418	NCT01260883	exclusion	Bleeding history in infant or family	The patient note does not explicitly state any history of bleeding in the infant or family members.		not enough information
sigir-201418	NCT01260883	exclusion	Coagulopathy	The patient note describes a 6-month-old male with post-surgery symptoms including low urine output, edema, and mild elevations in blood pressure and blood urea nitrogen. There are no indicators of a bleeding disorder or clotting abnormalities typically associated with coagulopathy.	0	not excluded
sigir-201418	NCT01260883	exclusion	Gastrointestinal bleeding history	There is no mention in the patient note indicating a history of gastrointestinal bleeding.		not excluded
sigir-201418	NCT01260883	exclusion	Renal or hepatic disease assessed by history and by pre-drug blood tests	The patient's urinalysis shows signs of potential renal inflammation or injury, but without prior medical history indicating chronic renal or hepatic disease and with normal creatinine levels, there is insufficient evidence to conclude the presence of such diseases.	5	not excluded
sigir-201418	NCT01260883	exclusion	Premature birth (<36 weeks gestation)	There is insufficient information regarding the patient's gestational age at birth.	0	not enough information
sigir-201418	NCT00557219	inclusion	Cardiothoracic surgeons performing the procedure have experience with extracorporeal membrane oxygenation (ECMO).	The patient note provides information regarding the patient's condition after surgery but does not mention anything about the surgeons' experience or qualifications.		not enough information
sigir-201418	NCT00557219	inclusion	at least one risk factor for acute renal failure: oliguria < 0.5 ml/kg/hour for over 3 hours despite adequate blood volume and furosemide intravenously	The patient exhibited oliguria (<0.2 mL/kg/hr) shortly after surgery, meeting the criterion of <0.5 mL/kg/hr. Although the duration is described as 'shortly,' the persistence of oliguria despite furosemide administration suggests a risk factor.	0, 4	included
sigir-201418	NCT00557219	inclusion	at least 60 mg furosemide/12 hours iv to maintain diuresis > 1 ml/kg/hour	The patient note does not specify whether the patient received furosemide or the dosage administered.	7	not enough information
sigir-201418	NCT00557219	exclusion	Refused or None Consent	The patient note explicitly states that the patient provides informed consent and complies with the trial protocol without any practical issues.	7	not excluded
sigir-201418	NCT00557219	exclusion	chronic renal failure with chronic renal replacement therapy	The patient's condition appears to involve acute kidney issues based on symptoms like reduced urine output, edema, elevated BUN and creatinine, and findings from urinalysis. There is no indication of chronic renal failure requiring chronic renal replacement therapy.	0, 1, 3	not excluded
sigir-201418	NCT00557219	exclusion	chronic increase of serum creatinine > 2 mg/dl	The patient's serum creatinine is noted as 1.3 mg/dL, which is below the threshold of 2 mg/dL mentioned in the exclusion criterion. Additionally, there is no indication of a chronic increase in serum creatinine; instead, the findings suggest an acute elevation possibly related to surgical stress.	3	not excluded
sigir-201419	NCT00256529	inclusion	Patients aged 18-90 presenting with dysphagia or food impaction	The patient is 52 years old, which falls within the age range of 18-90. The patient reports progressive dysphagia beginning several months ago, describing difficulty swallowing various types of food, including meats, solids, soft foods, and ultimately liquids.	0, 1, 2	included
sigir-201419	NCT00256529	inclusion	Ability to undergo esophagogastroduodenoscopy and biopsies	The patient's description includes a history of heavy smoking and drinking, which could potentially affect his ability to undergo EGD and biopsies; however, there is no explicit indication of any current medical condition that would prevent him from doing so.	0	included
sigir-201419	NCT00256529	inclusion	No significant cardiopulmonary disease, or other contraindication to EGD	The patient has a history of heavy smoking and drinking, which increases the risk of cardiopulmonary disease, but there is no specific information indicating the presence of significant cardiopulmonary disease or contraindications to an EGD.	0	not enough information
sigir-201419	NCT00256529	exclusion	Contradiction to EGD and/or biopsies such as Boerhaave's syndrome, or history or bleeding disorder or elevated INR	The patient has no reported history of bleeding disorders or elevated INR, and his primary issue appears to be dysphagia rather than conditions requiring EGD and biopsies.	0, 1, 2, 3	not excluded
sigir-201419	NCT00256529	exclusion	Inability to provide informed consent	The patient note indicates that the individual is capable of providing informed consent.	5	not excluded
sigir-201419	NCT00256529	exclusion	Esophageal varices	The patient has a history of heavy smoking and drinking, which are risk factors for esophageal varices. However, the patient note does not mention anything about current esophageal varices, including signs of active varices or complications.	0	not excluded
sigir-201419	NCT02509286	inclusion	Histologically verified adenocarcinoma of the esophagus according to the UICC definition (TNM7)	The patient note provides details about dysphagia and weight loss but lacks histological confirmation of adenocarcinoma of the esophagus.	0	not included
sigir-201419	NCT02509286	inclusion	Pre-treatment stage cT1N+, M0 or cT2-4a, N0/+, M0	The patient note provides information about the onset and progression of dysphagia but lacks specific details about the tumor's pre-treatment stage, including CT or imaging results needed to classify the stage.	0	not enough information
sigir-201419	NCT02509286	inclusion	Age ≥18 years	The patient is 52 years old, which is greater than 18.	0	included
sigir-201419	NCT02509286	inclusion	No prior abdominal or thoracic radiotherapy	The patient did not report receiving any prior abdominal or thoracic radiotherapy.	0	included
sigir-201419	NCT02509286	inclusion	ECOG Performance status 0-2	The patient note provides information about dysphagia and weight loss but does not specify the patient's current ECOG performance status. No relevant sentences discuss the patient's functional capacity or ability to perform daily activities.		not enough information
sigir-201419	NCT02509286	inclusion	Adequate cardiac function (Patients with a cardiac history (e.g., myocardial infarction, heart failure, coronary artery disease) should have a cardiology review)	The patient note does not mention any specific cardiac history or issues such as myocardial infarction, heart failure, or coronary artery disease.	0	not enough information
sigir-201419	NCT02509286	inclusion	Adequate bone marrow function (WBC > 3x10^9/L; Hb > 9g/dl; platelets > 100x10^9/L)	The patient note does not provide information regarding the patient's bone marrow function, including WBC, Hb, or platelet levels.	0	not enough information
sigir-201419	NCT02509286	inclusion	Adequate respiratory function. Symptomatic Patients should have pulmonary function tests with FEV1 >65% of predicted)	The patient note does not indicate any symptoms of respiratory dysfunction nor provides data on pulmonary function tests.		not included
sigir-201419	NCT02509286	inclusion	Adequate renal function (GFR >60ml/min)	The patient note provides no information about the patient's renal function, including GFR levels or indicators of potential renal issues.		not enough information
sigir-201419	NCT02509286	inclusion	Adequate liver function (serum bilirubin <1.5x Upper level of Normal (ULN); AST <2.5x ULN and ALT <3x ULN (ULN as per institutional standard)	The patient note does not provide any information regarding liver function tests such as serum bilirubin, AST, or ALT levels.	0	not enough information
sigir-201419	NCT02509286	inclusion	written informed consent	The patient has already provided informed consent for participation.		included
sigir-201419	NCT02509286	exclusion	Tumors of squamous or other non-adenocarcinoma histology	The patient has esophageal adenocarcinoma, which is included in the allowed histologies.	0	not excluded
sigir-201419	NCT02509286	exclusion	Patients who have received prior chemotherapy for their current malignancy.	The patient note does not explicitly state whether the individual has undergone prior chemotherapy for their current malignancy. Without this information, we cannot definitively apply the exclusion criterion.	5	not enough information
sigir-201419	NCT02509286	exclusion	Stage cT1N0 and cT4b	The patient's symptoms suggest a more advanced tumor stage, possibly cT4b, which would meet the exclusion criterion. However, the exact tumor stage is unknown.	0	not enough information
sigir-201419	NCT02509286	exclusion	Gastric carcinoma	The patient's description focuses on dysphagia and weight loss, indicative of potential serious health concerns, but there is no explicit confirmation of a diagnosis of Gastric carcinoma.	0	not enough information
sigir-201419	NCT02509286	exclusion	Prior chemotherapy for cancer	The patient has a history of heavy smoking and drinking but no explicit mention of prior chemotherapy for cancer.	0	not enough information
sigir-201419	NCT02509286	exclusion	 Clinically significant (i.e., active) cardiac disease (e.g., symptomatic coronary artery disease or myocardial infarction within last 12 months)	The patient note does not mention any history or presence of clinically significant active cardiac disease.		not excluded
sigir-201419	NCT02509286	exclusion	Clinical significant lung disease (FEV1 <65% of predicted)	The patient note does not provide information regarding the patient's lung function tests or diagnosis of lung disease.		not enough information
sigir-201419	NCT02509286	exclusion	Peripheral neuropathy Grade >1	The patient's condition involves dysphagia, likely caused by esophageal issues rather than peripheral neuropathy. No specific symptoms indicative of peripheral neuropathy (e.g., numbness, tingling) are noted.	0	not excluded
sigir-201420	NCT02255487	inclusion	Is male or female, 18 years of age or older	The patient is a 32-year-old woman, meeting the age criterion of 18 years or older.	0	included
sigir-201420	NCT02255487	inclusion	Has provided written informed consent or has surrogate consent provided by a Legally Authorized Representative (LAR)	The patient note explicitly states that the patient will provide informed consent.	6	included
sigir-201420	NCT02255487	inclusion	Has experienced abdominal trauma, blunt or penetrating, requiring open abdominal laparotomy with primary closure	The patient note describes a car accident causing multiple injuries, including fractures, but does not explicitly state that she experienced abdominal trauma requiring an open laparotomy.	0	not included
sigir-201420	NCT02255487	inclusion	Has experienced acute surgical abdomen requiring open abdominal laparotomy with primary closure	The patient presented with a tender abdomen, guarding, rebound tenderness, and absence of bowel sounds, indicating an acute surgical abdomen.	4	included
sigir-201420	NCT02255487	exclusion	Known allergy to Chlorhexidine Gluconate (CHG)	The patient note does not specify any allergies, particularly to Chlorhexidine Gluconate.	0	not enough information
sigir-201420	NCT02255487	exclusion	Estimated Abbreviated Injury Scale (AIS) score of six (6) at the time of surgery, for all trauma patients	The patient note describes a traumatic injury leading to fractures but does not specify the AIS score at the time of surgery.	0	not enough information
sigir-201420	NCT02255487	exclusion	American Society of Anesthesiologists Physical Status Classification (ASA) score of five (5) or greater	The patient note does not provide information regarding the American Society of Anesthesiologists Physical Status Classification (ASA) score.		not enough information
sigir-201420	NCT02255487	exclusion	Female volunteers who are pregnant and/or breast feeding	The patient note does not indicate that the female volunteer is pregnant or breastfeeding.	0	not excluded
sigir-201420	NCT02255487	exclusion	Patients who have undergone prior major abdominal surgery within the past year.	The patient note does not mention any prior major abdominal surgery within the past year. While she has a tender abdomen with guarding and rebound, this is likely due to her car accident-related injuries rather than previous surgery.	4	not excluded
sigir-201420	NCT02255487	exclusion	Abdominal incision created prior to operating room (i.e., incision made in trauma bay to cross clamp the aorta)	The patient note does not mention any prior abdominal incision or presence in the trauma bay requiring such an intervention.	5	not enough information
sigir-201420	NCT02255487	exclusion	Currently enrolled in an ongoing, interventional, randomized clinical trial	The patient note does not indicate whether the individual is currently enrolled in another interventional, randomized clinical trial. While the presence of such enrollment would lead to exclusion, the absence of relevant information prevents definitive categorization.	6	not enough information
sigir-201420	NCT01594385	inclusion	Trauma patients undergoing DC/OA management for traumatic injury	The patient is a trauma patient with multiple injuries after a car accident. The physical examination suggests she may require DC/OA management due to signs of intra-abdominal injury.	4	included
sigir-201420	NCT01594385	inclusion	Age 18+	The patient is 32 years old, meeting the required age criterion.	0	included
sigir-201420	NCT01594385	inclusion	Life expectancy longer than 48 hours	The patient is recovering from moderate injuries typical in a car accident scenario. Without evidence of critical organ failure or immediate threats to life, her life expectancy exceeds 48 hours.	0	included
sigir-201420	NCT01594385	exclusion	Prisoners	The patient has provided informed consent and complies with the trial protocol without any practical issues.	6	not excluded
sigir-201420	NCT01594385	exclusion	Pregnant patients	There is no information in the patient note indicating whether the patient is pregnant.		not enough information
sigir-201420	NCT01594385	exclusion	Younger than 18 years of age	The patient is 32 years old, which is greater than 18.	0	not excluded
sigir-201421	NCT00997100	inclusion	Age > 18 years at the time of signing the informed consent form	The patient is 21 years old, meeting the required age criterion.	0	included
sigir-201421	NCT00997100	inclusion	Fulfil at least 4 criteria for SLE as defined by the American College of Rheumatology (ACR)	The patient meets multiple ACR criteria for SLE including malar rash, positive ANA, proteinuria, and arthralgias.	0, 1, 2, 3	included
sigir-201421	NCT00997100	inclusion	Present with active SLE disease with at least one of the following symptoms: i) Arthritis - > 2 joints with pain and signs of inflammation (i.e., tenderness, swelling, or effusion) ii) Inflammatory-type skin rash iii) Oral ulcers	The patient presents with a rash, indicating point ii. Additionally, she exhibits symptoms of arthritis in her wrists and ankles, fulfilling condition i.	0, 1	included
sigir-201421	NCT00997100	inclusion	ERROR	No valid JSON block found in response		ERROR
sigir-201421	NCT00997100	inclusion	Ability to take and retain oral medication	The patient note does not explicitly state whether the patient can take and retain oral medication. While she agrees to comply with the trial protocol, this does not directly indicate her ability to take and retain oral medications.	4	not enough information
sigir-201421	NCT00997100	inclusion	Ability to sign and date a written informed consent prior to entering the study	The patient note states that the individual will provide informed consent and comply with the trial protocol without any practical issues.	4	included
sigir-201421	NCT00997100	inclusion	Will the participant be willing and able to comply with the protocol for the duration of the study?	The patient note indicates that the individual will provide informed consent and comply with the trial protocol without any practical issues.	4	included
sigir-201421	NCT00997100	exclusion	Active severe SLE flare with central nervous system (CNS) manifestations	No mention of CNS manifestations.		not excluded
sigir-201421	NCT00997100	exclusion	Severe renal impairment (estimated or measured GFR <50%)	The patient note lacks specific information regarding the patient's renal function, including measures such as GFR.	4	not enough information
sigir-201421	NCT00997100	exclusion	Oral treatment with corticosteroids (>15 mg/day prednisolone or equivalent) or changes in corticosteroid dosing within 30 days prior to the first dose of study medication. This also includes intraarticular steroid injections or topical treatment for SLE symptoms.	The patient note does not specify whether the patient is currently receiving oral corticosteroids or had recent changes in corticosteroid dosing. Additionally, there is no mention of intraarticular steroid injections or topical treatments specifically for SLE symptoms. Without this information, it is unclear if the patient meets the exclusion criterion.		not enough information
sigir-201421	NCT00997100	exclusion	Intravenous corticosteroids within 3 months prior to the first dose of study medication.	The patient note does not mention receipt of intravenous corticosteroids within the last 3 months. Therefore, there is insufficient information to determine if this exclusion applies.	0, 1	not enough information
sigir-201421	NCT00997100	exclusion	Intravenous cyclophosphamide within 6 months prior to the first dose of study medication.	The patient note does not mention any details regarding previous treatment with intravenous cyclophosphamide. There is insufficient information to determine if the patient received this treatment within the specified timeframe.		not enough information
sigir-201421	NCT00997100	exclusion	Treatment with anti-rheumatic/immunosuppressive drugs within 3 months prior to first dose of study medication, other than the following medications at stable doses: methotrexate (≤25 mg/week), azathioprine (≤2.5 mg/kg/day), hydroxychloroquine and mycophenolate mofetil (≤3000 mg/day).	The patient note does not indicate that the participant is currently taking any anti-rheumatic or immunosuppressive drugs within the past 3 months.	4	not excluded
sigir-201421	NCT00997100	exclusion	B-cell depletion therapy (such as treatment with Rituximab) within 12 months prior to the first dose of study medication.	The patient note does not mention any treatment with B-cell depletion therapy, such as Rituximab, within the last 12 months. There is insufficient information to confirm whether this criterion applies to the patient.		not enough information
sigir-201421	NCT00997100	exclusion	Potent inhibitors or inducers of CYP3A4 intravenously or orally within 14 days prior to first dose of study medication.	The patient note does not mention any information about the patient's recent use of potent inhibitors or inducers of CYP3A4, which is required by the exclusion criterion. Without knowing whether the patient received such medications within the specified timeframe, we cannot determine their eligibility under this criterion.		not enough information
sigir-201421	NCT00997100	exclusion	History of myocardial infarction or current uncontrolled angina, severe uncontrolled ventricular arrhythmias, symptomatic congestive heart failure, unstable angina pectoris, or electrocardiographic evidence of acute ischemia.	The patient note does not mention any history of cardiovascular events such as myocardial infarction, angina, or electrocardiographic changes indicative of acute ischemia. There is also no indication of uncontrolled arrhythmias or congestive heart failure.		not excluded
sigir-201421	NCT00997100	exclusion	Marked baseline prolongation of QT/QTc interval (e.g., repeated demonstration of a QTc interval >450 milliseconds)	The patient note does not mention any findings related to the QT/QTc interval. There is insufficient information to determine if the patient meets this exclusion criterion.		not enough information
sigir-201421	NCT00997100	exclusion	History of additional risk factors for torsade de pointes (eg, heart failure, hypokalemia, family history of long QT syndrome)	The patient note does not mention any history of heart failure, hypokalemia, or family history of long QT syndrome.		not excluded
sigir-201421	NCT00997100	exclusion	Treatment with concomitant medications that prolong the QT interval.	The patient note does not provide information about the patient's current medications. Without knowing which medications the patient is taking, it is impossible to determine if any of them prolong the QT interval.		not enough information
sigir-201421	NCT00997100	exclusion	History of, or current, ischemic CNS disease.	The patient note does not indicate any history of or current ischemic CNS disease; it focuses on systemic lupus erythematosus-related symptoms.	0	not excluded
sigir-201421	NCT00997100	exclusion	Current malignancy. A 5-year cancer-free period is required with the exception of skin basal or squamous cell carcinoma or cervical cancer in situ that has been excised.	The patient note does not indicate a current diagnosis of cancer or any past malignancy within the last five years, except for cases explicitly allowed (skin basal/squamous cell carcinoma or cervical cancer in situ). There is no evidence of active cancer or recent treatment for cancer in the provided information.	0	not excluded
sigir-201421	NCT00997100	exclusion	Current severe infection	The patient's notes describe symptoms and lab results suggestive of an autoimmune disorder (e.g., Systemic Lupus Erythematosus), including anemia, thrombocytopenia, and proteinuria. These findings suggest an active condition rather than a current severe infection.	0, 1, 2	not excluded
sigir-201421	NCT00997100	exclusion	Positive result on screening for hepatitis B surface antigen, hepatitis C antibodies or human immunodeficiency virus (HIV) antibodies.	The patient note does not mention any results related to hepatitis B, C, or HIV screenings. There is insufficient information to determine if the patient meets this exclusion criterion.		not enough information
sigir-201421	NCT00997100	exclusion	Drug abuse.	There is no information in the patient note indicating whether the patient has a history of drug abuse. Without this information, it is impossible to determine if the patient meets the exclusion criterion.		not enough information
sigir-201421	NCT00997100	exclusion	Major surgery within 3 weeks prior to study entry.	The patient note does not mention any recent major surgery. There is no information indicating that she underwent major surgery within three weeks prior to the study entry. Based on the absence of information, we can infer that she did not have major surgery during this period.		not excluded
sigir-201421	NCT00997100	exclusion	Known or suspected hypersensitivity to ABR-215757 or excipients.	The patient note does not mention any hypersensitivity reaction to paquinimod or its excipients. There is insufficient information indicating the presence of such a condition.		not excluded
sigir-201421	NCT00997100	exclusion	Female subject of child-bearing potential who is not using a medically accepted safe method of contraception. All female subjects of child-bearing potential must have a negative urine pregnancy test at the Screening and Baseline Visits. As interaction studies between ABR-215757 and oral contraceptives have not yet been performed, women using the contraceptive pill must also use a complementary contraceptive device, i.e. barrier method, during the treatment period and for at least 1 month thereafter.	The patient is a 21-year-old female, potentially of child-bearing potential. However, the patient note does not provide information about her current contraception method or results of pregnancy testing required by the criterion. Therefore, it is unclear if she meets the requirement of having a negative urine pregnancy test and using appropriate precautions.	0	not enough information
sigir-201421	NCT00997100	exclusion	Female subject of child-bearing potential who is pregnant or lactating.	The patient note does not mention anything about the patient's pregnancy or lactation status. Without this information, we cannot determine if the exclusion applies.	4	not excluded
sigir-201421	NCT00997100	exclusion	Simultaneous participation or participation within 4 months or 5 half lives (whichever is longer) prior to study entry in any other study involving investigational drugs or other experimental therapy.	The patient note does not indicate participation in any studies involving investigational drugs or experimental therapies within the specified timeframe.		not enough information
sigir-201421	NCT00997100	exclusion	Other significant, unstable medical disease not related to SLE that in the investigator's opinion would confound the study result or put the patient at risk.	The patient's symptoms and lab results indicate active systemic lupus erythematosus, including positive ANA and anti-dsDNA levels, and urinary changes suggestive of lupus nephritis. These findings do not indicate another significant, unrelated medical disease that would confound the study results or pose a risk.	0, 1, 2	not excluded
sigir-201421	NCT00997100	exclusion	Patients who are likely to receive oral or intravenous steroids or immunosuppressants for other non-SLE conditions during the study duration.	The patient note does not indicate receipt of steroids or immunosuppressants; thus, they meet the exclusion criterion.		included
sigir-201421	NCT00997100	exclusion	Age younger than 18 years old OR older than 75 years old.	The patient is 21 years old, which does not fall into the specified exclusion range of being younger than 18 or older than 75 years old.	0	not excluded
sigir-201421	NCT01520155	inclusion	Patients with systemic Lupus erythematosus	The patient’s lab results show a 4/4 positive ANA and anti-dsDNA, which are indicative of systemic lupus erythematosus.	2	included
sigir-201421	NCT01520155	exclusion	Patients without systemic Lupus erythematosus	The patient demonstrates laboratory evidence of systemic lupus erythematosus through positive ANA and anti-dsDNA levels, along with urinary abnormalities indicative of nephritis.	2	not excluded
sigir-201422	NCT00723788	inclusion	Age 8-18 years	The patient is 15 years old, which falls within the specified age range.	0	included
sigir-201422	NCT00723788	inclusion	referred from emergency department for suspected appendicitis	The patient presented to the emergency department with symptoms indicative of appendicitis and was referred accordingly.	0	included
sigir-201422	NCT00723788	inclusion	receiving either CT scan or ultrasound of the abdomen for diagnosis	The patient underwent an abdominal ultrasound as noted in point 5 of the patient note.	5	included
sigir-201422	NCT00723788	exclusion	Failure to pass MRI metal screening	The patient note does not indicate any presence of metals which would prevent passing an MRI metal screening.		not excluded
sigir-201422	NCT00723788	exclusion	Claustrophobia or need for sedation due to inability to hold still	The patient note does not mention any issues related to claustrophobia or the ability to hold still during an imaging procedure.		not excluded
sigir-201422	NCT00236912	inclusion	Two or more symptoms of acute appendicitis for at least 24 hours or radiologic evidence of complicated appendicitis	The patient's ultrasound showed a markedly edematous appendix, providing radiographic evidence of complicated appendicitis.	5	included
sigir-201422	NCT00236912	inclusion	Able to take medicine orally after recovering from surgery	The patient is a minor who presented with appendicitis and underwent appropriate care. After recovery, she would follow medical advice regarding oral medication intake.	0, 5	included
sigir-201422	NCT00236912	inclusion	If female, using birth control	The patient is a female, meeting the first condition of the criterion. However, the patient note does not specify whether she is using birth control.	3	not enough information
sigir-201422	NCT00236912	exclusion	History of allergy to any study medication	The patient note does not mention any history of allergy to the study medications (levofloxacin or metronidazole). No symptoms indicative of an allergic reaction are reported.	0, 1	not excluded
sigir-201422	NCT00236912	exclusion	Life expectancy < 72 hours	The patient presented with signs of appendicitis, which generally carries a good prognosis when treated promptly. No information indicates her life expectancy is compromised.	0	not excluded
sigir-201422	NCT00236912	exclusion	APACHE II (health) score > 25	The patient is a 15-year-old girl presenting with appendicitis symptoms who does not exhibit signs of critical illness or multi-organ dysfunction typical of an APACHE II score >25.	0, 1	not excluded
sigir-201422	NCT00236912	exclusion	Neutropenic (low white blood cell count)	The patient note does not provide information regarding the patient's white blood cell count or presence of neutropenia.	0, 1	not enough information
sigir-201422	NCT00236912	exclusion	HIV positive with current or past CD4 count < 200/mm^3	The patient note does not mention anything about the patient's HIV status or CD4 count.		not enough information
sigir-201422	NCT00236912	exclusion	Low platelet count (bleeds easily)	The patient note does not provide information regarding the patient's platelet count or bleeding tendency.		not enough information
sigir-201422	NCT00236912	exclusion	Malnourished with low albumin	The patient note lacks specific information regarding malnutrition or low albumin levels.	0, 2	not enough information
sigir-201422	NCT00236912	exclusion	Condition requiring use of major tranquillizers	There is no information in the patient note indicating the presence of a condition requiring the use of major tranquillizers.		not enough information
sigir-201423	NCT02219360	inclusion	Hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease	The patient presented with symptoms consistent with a respiratory issue, including cough and shortness of breath, and was hospitalized. However, there is no explicit confirmation of a diagnosis of acute exacerbation of COPD.	0	not included
sigir-201423	NCT02219360	inclusion	Age≥ 40years old	The patient is 63 years old, which is greater than 40.	0	included
sigir-201423	NCT02219360	exclusion	The first diagnosis which caused hospitalization is not acute exacerbation of chronic obstructive pulmonary disease	The patient's current condition might relate to COPD, but there's insufficient information to confirm if it's an acute exacerbation.	3	not enough information
sigir-201423	NCT02219360	exclusion	Chest radiography shows congestive heart failure	The patient's chest x-ray showed hyperinflation with no consolidation, indicating no sign of congestive heart failure.	6	not excluded
sigir-201423	NCT02219360	exclusion	Chest CT shows lung cancer, active pulmonary tuberculosis, pulmonary trombomobolism or interstitial lung diseases	The patient note does not mention anything regarding a chest CT result. Without knowing the outcome of the chest CT, we cannot assess whether the patient meets the exclusion criterion.		not enough information
sigir-201423	NCT02219360	exclusion	Serious cardiac failure, renal insufficiency or hepatic dysfunction	The patient's medical history does not indicate serious cardiac failure, renal insufficiency, or hepatic dysfunction. There is insufficient information regarding the patient's cardiovascular, renal, or hepatobiliary systems to confirm any of these conditions.	0, 1	not excluded
sigir-201423	NCT00170222	inclusion	Acute exacerbation of COPD type I or II according to GOLD	The patient note does not indicate a diagnosis of COPD; therefore, it cannot be confirmed that the patient has an acute exacerbation of COPD.	0	not included
sigir-201423	NCT00170222	inclusion	Male patients aged ≥18 years who have been diagnosed with Chronic Obstructive Pulmonary Disease (COPD) and able to perform lung function tests.	The patient does not have a documented diagnosis of COPD, so he does not meet the criterion requiring a diagnosis of COPD.	0	not included
sigir-201423	NCT00170222	inclusion	Ability to take oral medication	The patient note does not explicitly state whether the patient is capable of taking oral medication.	7	not enough information
sigir-201423	NCT00170222	exclusion	Pregnant or lactating women, or women of childbearing age not using an acceptable method of contraception.	The patient is a 63-year-old man, which makes the criterion irrelevant as it pertains specifically to women.	0	not excluded
sigir-201423	NCT00170222	exclusion	Pretreatment (> 24 hours) with an antibiotic for the present exacerbation.	The patient note indicates he has been using home oxygen for the past 24 hours but does not specify whether he received antibiotics during that timeframe. There is insufficient information to confirm antibiotic pretreatment beyond 24 hours.	3	not enough information
sigir-201423	NCT00170222	exclusion	Pretreatment with corticosteroids (>30 mg for more than 4 days) for the present exacerbation.	The patient note does not provide information regarding the use of corticosteroids for the present respiratory exacerbation. There is no mention of steroid treatment in the provided data.		not enough information
sigir-201423	NCT00170222	exclusion	Progression or new radiographic abnormalities on the chest X-ray.	The patient's current condition includes a recent exacerbation of COPD, confirmed by chest X-rays showing hyperinflation with no consolidation. This indicates progression or new radiographic abnormalities, meeting the exclusion criterion.	3, 6	excluded
sigir-201423	NCT00170222	exclusion	Severe exacerbation that required mechanical ventilation.	The patient note indicates that the patient used home oxygen for the past 24 hours due to respiratory distress but did not mention anything about being placed on mechanical ventilation. There is no evidence in the provided notes that suggest the patient experienced a severe exacerbation requiring mechanical ventilation.	3	not excluded
sigir-201423	NCT00170222	exclusion	History of bronchiectasis	The patient's past medical history does not indicate a diagnosis of bronchiectasis.	1	not excluded
sigir-201423	NCT00170222	exclusion	Recent or unresolved lung malignancy.	The patient note does not mention any history of lung malignancy or ongoing cancerous condition. There are references to other health issues like diabetes and psoriasis, but none specifically indicating a recent or unresolved lung malignancy.	0, 1	not excluded
sigir-201423	NCT00170222	exclusion	Other disease likely to require antibiotic therapy.	The patient presented with symptoms indicative of a lower respiratory tract infection, potentially requiring antibiotic therapy. However, there is no evidence of another disease that would specifically require antibiotic therapy beyond what is typical for his condition. Additionally, the patient is compliant with the trial protocol.	0, 1	not excluded
sigir-201423	NCT00170222	exclusion	Significant gastrointestinal or other conditions that may affect study drug absorption.	The patient's medical history includes conditions such as diabetes, hypothyroidism, and moderate psoriasis, none of which are known to significantly affect gastrointestinal absorption. Additionally, there is no reported evidence of gastrointestinal symptoms or conditions that would hinder the absorption of doxycycline.	0, 1	not excluded
sigir-201423	NCT00170222	exclusion	Class III or IV congestive heart failure or stroke.	The patient's note does not indicate a history of Class III or IV congestive heart failure or stroke. There is no mention of relevant cardiac or cerebrovascular events.	0	not excluded
sigir-201423	NCT00170222	exclusion	Immunodeficiency disorders such as AIDS, humoral immune defect, ciliary dysfunction etc. and the use of immunosuppressive drugs (>30 mg prednisolone maintenance dose or equivalent for more than 4 weeks).	The patient's medical history does not indicate any immunodeficiency disorders or the use of immunosuppressive drugs.	0	not excluded
sigir-201423	NCT00170222	exclusion	Cystic fibrosis	The patient note does not indicate a confirmed diagnosis of cystic fibrosis; thus, they meet the exclusion criterion.	0	included
sigir-201423	NCT00170222	exclusion	Tuberculosis	The patient note does not indicate a diagnosis of tuberculosis, nor is there any mention of exposure, testing, or history suggesting tuberculosis.	0, 1	not excluded
sigir-201423	NCT00170222	exclusion	Impaired renal function (creatinine clearance < 20 ml/min)	The patient's medical history includes diabetes and hypothyroidism, which can impact renal function, but there is no direct evidence of impaired renal function (creatinine clearance < 20 ml/min) in the provided note.	1	not enough information
sigir-201424	NCT02229695	inclusion	Adults male or female over 18 year old undergoing emergency laparotomy.	The patient is a 33-year-old male, who is over 18, and according to the notes, he required emergency laparotomy due to splenic rupture leading to intraperitoneal hemorrhage.	5	included
sigir-201424	NCT02229695	inclusion	Patients that have their abdominal wall closed at the end of surgery by a temporary closure technique.	The patient note describes the presentation and diagnosis but does not mention anything about the surgical procedure or the method used to close the abdominal wall. Therefore, insufficient information is provided to determine if the criterion was met.	0, 1	not enough information
sigir-201424	NCT02229695	exclusion	Patients that according to the surgeon estimates will not survive 24 hours.	The patient note describes a serious condition involving intraperitoneal hemorrhage and splenic rupture, which is concerning. However, the note does not explicitly state whether the attending surgeon believes the patient will not survive 24 hours. Without this critical information, we cannot determine if the exclusion applies.	5	not enough information
sigir-201424	NCT01771861	inclusion	all patients admitted with the trauma team	The patient note describes the patient presenting to the ER with symptoms related to blunt trauma but does not indicate whether the trauma team was involved in their admission.	0	not enough information
sigir-201424	NCT01771861	inclusion	all patients admitted with Injury Severity Score >15	The patient note describes a case involving blunt trauma and subsequent complications, but it does not explicitly state the Injury Severity Score (ISS). Therefore, we cannot confirm if the ISS is above 15.	0, 1	not enough information
sigir-201424	NCT01771861	exclusion	secondary admittance(transfers)>24 post injury	The patient note describes a single presentation to the ER over a week after the injury, with no indication of subsequent transfers or additional admittances.	0	not enough information
sigir-201425	NCT00282269	inclusion	have a severe traumatic brain injury as defined by either a GCS ≤ 8 and an abnormal CT scan (intracranial hemorrhage, cerebral edema or diffuse axonal injury) or a motor score ≤ 3 and normal CT scan	The patient's GCS is 6/15, which is ≤8, indicating a severe traumatic brain injury. Although a CT scan was deferred due to immediate treatment initiation, the patient exhibited symptoms consistent with a severe TBI, including drowsiness, pallor, vomiting, and impaired motor function.	5	included
sigir-201425	NCT00282269	inclusion	are aged between 1 and 16 years	The patient is 8 years old, which falls within the specified age range.	0	included
sigir-201425	NCT00282269	inclusion	are mechanically ventilated	The patient note does not mention anything about being mechanically ventilated.		not included
sigir-201425	NCT00282269	exclusion	are not randomized by 6 hours after injury	The patient's arrival time relative to the 6-hour window post-injury is unknown. Without knowing how quickly the patient was evaluated and potentially randomized, we cannot assess compliance.	4	not enough information
sigir-201425	NCT00282269	exclusion	have penetrating brain injuries	There is insufficient evidence in the patient note to confirm the presence of a penetrating brain injury. While the patient experienced trauma and subsequent neurological symptoms, these do not specifically indicate a penetrating injury.	0, 5	not excluded
sigir-201425	NCT00282269	exclusion	have fixed dilated pupils and GCS = 3	The patient's GCS is reported as 6/15, which does not equal 3. Additionally, although the pupils were noted to be asymmetrical upon arrival, there is no indication of fixed dilated pupils.	5	not excluded
sigir-201425	NCT00282269	exclusion	have proven cervical spinal cord injury	The patient note does not mention anything about a cervical spinal cord injury. It details a traumatic brain injury incident but lacks evidence of spinal cord involvement.	5	not excluded
sigir-201425	NCT00282269	exclusion	have more than mild neurodevelopmental disability prior to injury	The patient note describes the circumstances surrounding the injury and subsequent physical effects but provides no indication of pre-existing neurodevelopmental disabilities.	0, 1	not excluded
sigir-201425	NCT00282269	exclusion	have an acute isolated epidural hematoma and are expected to recover rapidly after surgical removal	The patient note describes a fall causing potential cranial injury, including altered mental status and pupillary changes. While these could suggest intracranial issues, there's no explicit confirmation of an acute isolated epidural hematoma.	5	not enough information
sigir-201425	NCT00282269	exclusion	have had a post-traumatic seizure with a normal CT scan	The patient note does not indicate the presence of a post-traumatic seizure. Additionally, the CT scan status is unknown as it was deferred.	5	not excluded
sigir-201425	NCT00282269	exclusion	have refractory shock, defined as systolic blood pressure more than 2 standard deviations (SD) below the mean for age despite 80ml/kg intravenous fluid resuscitation	The patient's blood pressure upon arrival was recorded as 155/98 mmHg, which falls within the normal range for children. This indicates that the patient did not exhibit signs of refractory shock.	4	not excluded
sigir-201425	NCT02378311	inclusion	Children 0-15 years inclusive	The patient is 8 years old, which falls within the specified age range.	0	included
sigir-201425	NCT02378311	inclusion	Presenting to either of the study hospitals for assessment or treatment	The patient fell and was brought to the emergency department, indicating they presented for assessment and potential treatment.	4	included
sigir-201425	NCT02378311	inclusion	Sustained an injury or suspected to have sustained an injury (i.e., AIS >=0)	The patient fell from his bike, struck his left temple, exhibited symptoms including drowsiness, pallor, vomiting, and changes in pupil reactivity and motor function indicative of potential head injury.	0, 2	included
sigir-201425	NCT02378311	inclusion	Due to an incident involving any non-motorized bicycle, tricycle or kick scooter	The patient fell from a non-motorized bicycle, meeting the criterion.	0	included
sigir-201425	NCT02378311	exclusion	Incidents where the injured child was involved in a motor vehicle collision	The patient note describes a fall from a bicycle causing injury, not involving a motor vehicle collision.	0	not excluded
sigir-201425	NCT02378311	exclusion	Incidents where the injured child was injured by another rider (e.g., injured child run over by a cyclist)	The patient note indicates the child fell from his bike striking his left temple, not being hit by another rider.	0	not excluded
sigir-201425	NCT02378311	exclusion	Incidents involving a bicycle fitted with 'bull bars'	The patient note describes an incident involving a bicycle fall but does not specify whether the bicycle was fitted with 'bull bars'. Without this information, it cannot be determined if the exclusion criterion is met.	0	not excluded
sigir-201425	NCT02378311	exclusion	Patients for whom neither parent / guardian is fluent in English	The patient note does not provide information about the language abilities of the parents or guardians.		not enough information
sigir-201425	NCT02378311	exclusion	If an eligible patient is dead on arrival the family will not be invited to participate, and they will not subsequently be contacted	The patient note does not indicate whether the patient was deceased upon arrival.	7	not enough information
sigir-201425	NCT02378311	exclusion	If an eligible patient dies during their admission, they will be withdrawn from further involvement in the study and the family will not be contacted	The patient did not die during their admission; there is no mention of death in the provided notes.	0, 1	not excluded
sigir-201426	NCT00373048	inclusion	Permanent residents of the Luanshya district	The patient note does not specify whether the individuals are permanent residents of the Luanshya district.		not enough information
sigir-201426	NCT00373048	inclusion	Males and non pregnant adults between 18 and 50 years old.	The patient note indicates that three women are in different stages of pregnancy, which disqualifies them from participating. However, the gender of the remaining individuals is unknown, preventing confirmation that they are males as required by the criterion.	2	not enough information
sigir-201426	NCT00373048	inclusion	Having a CD4 cell count of least 350 perµL at enrolment	The patient note does not provide information regarding the CD4 cell count.		not enough information
sigir-201426	NCT00373048	inclusion	HIV sero-status determined at the VCT of the health center.	The patient note does not mention anything about the HIV sero-status of the individuals involved. Without this information, it is impossible to determine if the criterion is met.	3	not enough information
sigir-201426	NCT00373048	inclusion	No obvious underlying disease at time of enrolment	The patient note indicates that the individuals involved are healthy and able to undergo travel-related vaccinations and preventive measures. There is no indication of any significant underlying medical conditions.	0, 1	included
sigir-201426	NCT00373048	inclusion	Signed informed consent	The patient note states that the individual will provide informed consent and comply with the trial protocol without any practical issues.	3	included
sigir-201426	NCT00373048	exclusion	HIV stage III or IV following the WHO classification	The patient note does not mention any information regarding the patient's HIV status or stage.		not excluded
sigir-201426	NCT00373048	exclusion	Evidence of underlying chronic diseases (cardiac, renal, hepatic, malnutrition, TB)	The patient note does not mention any of the specified chronic diseases.	0, 1	not excluded
sigir-201426	NCT00373048	exclusion	Intent to move out of the study catchment area during the study period	The patient intends to travel to the Amazon Rainforest region in Brazil, which indicates an intent to move out of the study catchment area.	0	excluded
sigir-201426	NCT00373048	exclusion	History of allergy to MQ (or related drugs) or sulfa drugs	The patient note does not mention any allergies to mefloquine (MQ) or sulfa drugs.	0, 1	not excluded
sigir-201426	NCT00373048	exclusion	Chorionic gonadotrophic hormone in urine or obvious pregnancy	The patient note includes information indicating that three women in the group are in different stages of pregnancy.	2	excluded
sigir-201426	NCT00497471	inclusion	Born in San Francisco Designated District Hospital of Ifakara	The patient note does not provide any information regarding the patient's place of birth.		not enough information
sigir-201426	NCT00497471	exclusion	Obvious severe congenital malformation such as: spina bifida, hydrocephalus or anencepahlus	The patient note does not mention any severe congenital malformations such as spina bifida, hydrocephalus, or anencephalus.		not excluded
sigir-201426	NCT00497471	exclusion	Patients who were born as twins.	The patient note does not mention anything about the individuals having been born as twins. Without this information, it is impossible to determine if the exclusion criterion applies.		not enough information
sigir-201426	NCT00497471	exclusion	Birth weight < 1,5 kg	The patient note does not provide information regarding the birth weight of the patients.	2	not enough information
sigir-201426	NCT00497471	exclusion	ERROR	No valid JSON block found in response		ERROR
sigir-201426	NCT00497471	exclusion	Clinical signs of neonatal or congenital infection	The patient note indicates that three participants are in different stages of pregnancy but does not specify whether they exhibit clinical signs of neonatal or congenital infection.	2	not enough information
sigir-201426	NCT00497471	exclusion	Mother unreliable (deaf, mentally handicapped)	The patient note does not provide information about the mothers' reliability, specifically regarding deafness or mental handicap.	0, 1	not enough information
sigir-201427	NCT01187901	inclusion	Patients who are 18 years or older with a clinical or genetic diagnosis of FAP or attenuated FAP.	The patient is 21 years old, satisfying the age requirement. While he has a family history of FAP in his siblings and presents with multiple polyps, there is no explicit clinical or genetic diagnosis of FAP or attenuated FAP mentioned in the note. Therefore, insufficient information is available to confirm eligibility based on this criterion.	0, 1	not enough information
sigir-201427	NCT01187901	inclusion	Presence of duodenal polyps with a sum of diameters ≥ 5mm.	The patient note describes colon and rectosigmoid polyps but does not mention any duodenal polyps. Therefore, there is insufficient information to confirm the presence of duodenal polyps with a sum of diameters ≥ 5mm.	0, 3	not included
sigir-201427	NCT01187901	inclusion	Minimum of two weeks since any major surgery	The patient note does not mention any recent major surgery. There is insufficient information regarding the patient's surgical history to determine if the required two-week period has elapsed.	0, 1	not enough information
sigir-201427	NCT01187901	inclusion	WHO performance status ≤1	The patient note does not provide information regarding the patient's current physical condition or functional status needed to assess WHO performance status.		not enough information
sigir-201427	NCT01187901	inclusion	Adequate bone marrow function as shown by: normal leukocyte count, platelet count ≥ 120 × 10⁹/L, Hgb > 12 g/dL	The patient note does not provide information regarding the patient's bone marrow function, including leukocyte count, platelet count, or hemoglobin levels.	0, 1, 2, 3, 4	not enough information
sigir-201427	NCT01187901	inclusion	ERROR	Failed to parse JSON: Unterminated string starting at: line 2 column 21 (char 22)		ERROR
sigir-201427	NCT01187901	inclusion	Patient must discontinue taking any Nonsteroidal anti-inflammatory drugs (NSAIDs) within one month of treatment initiation.	The patient note does not indicate that the individual is currently taking NSAIDs or has done so within the required timeframe. Without specific information regarding NSAID use, it cannot be determined if the criterion is met.	0, 1	not enough information
sigir-201427	NCT01187901	inclusion	Patients must be able to provide written informed consent.	The patient has provided informed consent, meeting the criterion of being able to give written consent.	5	included
sigir-201427	NCT01187901	exclusion	Prior treatment with any investigational drug within the preceding 4 weeks.	The patient note does not provide information regarding recent treatment with investigational drugs. There is no indication that the patient has undergone such treatment in the past 4 weeks.	5	not enough information
sigir-201427	NCT01187901	exclusion	Malignancies within the past 3 years except for adequately treated carcinoma of the cervix or basal or squamous cell carcinomas of the skin.	The patient has been diagnosed with numerous small colonic polyps, all of which are benign adenomas upon biopsy. There is no evidence of malignancy in the past three years. Therefore, the patient does not meet the exclusion criterion regarding recent malignancies.	3	not excluded
sigir-201427	NCT01187901	exclusion	Any active (acute or chronic) or uncontrolled infections/disorders.	The patient note indicates that the individual does not have any active or uncontrolled infections or disorders. No relevant sentences in the note suggest otherwise.		not excluded
sigir-201427	NCT01187901	exclusion	Screening clinical laboratory values that indicate any of the following: anemia thrombocytopenia leucopenia elevations of transaminases greater than 2X ULN elevation of bilirubin > 1.5 X ULN alkaline phosphatase elevation > 1.5 X ULN increased creatinine, urinary protein, or urinary casts outside the clinically normal range.	The patient note does not provide information regarding the relevant clinical laboratory values needed to assess this criterion. Specifically, details about anemia, thrombocytopenia, leucopenia, transaminases, bilirubin, alkaline phosphatase, creatinine, urinary protein, or urinary casts are absent. Without this information, it is impossible to determine if the patient meets the exclusion criterion.		not enough information
sigir-201427	NCT01187901	exclusion	Clinical assessment needed to rule out gastrointestinal bleeding.	The patient note indicates the individual is asymptomatic and has been diagnosed with only benign polyps. There is no indication of gastrointestinal bleeding or its associated symptoms.	3	not excluded
sigir-201427	NCT01187901	exclusion	Patient who is currently taking any anti-coagulation medication.	The patient note does not mention that the individual is currently taking any anti-coagulation medication. Since the note lacks information about anti-coagulation usage, we cannot confirm exclusion under this criterion.		not excluded
sigir-201427	NCT01187901	exclusion	Women who are pregnant or breast feeding.	The patient is a 21-year-old male; there is no mention of pregnancy or breastfeeding in the provided note.	0	not excluded
sigir-201427	NCT01187901	exclusion	Patients with a known hypersensitivity to sulindac or erlotinib or to their excipients	The patient note does not mention any hypersensitivity reaction to sulindac or erlotinib.		not excluded
sigir-201427	NCT01713881	inclusion	Any adenoma found on screening/surveillance colonoscopy	The patient underwent a sigmoidoscopy and was found to have dozens of small colonic polyps, several of which were biopsied and identified as benign adenomas.	3	included
sigir-201427	NCT01713881	inclusion	Greater than 18 years old	The patient is 21 years old, which is greater than 18.	0	included
sigir-201427	NCT01713881	exclusion	Less than 18 years old	The patient is 21 years old, which is greater than or equal to 18.	0	not excluded
sigir-201427	NCT01713881	exclusion	Diagnosis of IBD	The patient does not have a diagnosis of IBD as indicated by the absence of symptoms, imaging, or biopsy results suggesting inflammatory bowel disease.	0, 1	not excluded
sigir-201429	NCT01978834	inclusion	Female sex	The patient is identified as a 51-year-old woman, meeting the inclusion criterion of female sex.	0	included
sigir-201429	NCT01978834	inclusion	Age 50 to 89 years	The patient is 51 years old, which falls within the specified age range.	0	included
sigir-201429	NCT01978834	exclusion	Those who have opted out of being contacted for research on their general Park Nicollet clinic consent will not be recruited by mail	The patient note does not mention anything about the patient opting out of being contacted for research or having declined general Park Nicollet clinic consent.	5	not enough information
sigir-201429	NCT01978834	exclusion	Inability to sign consent form due to cognitive impairment. Those with dementia (ICD-9 diagnosis codes 331.0, 294.1, 294.10, 294.11, or 294.8) will be excluded from mailed recruitment	The patient note does not mention anything about cognitive impairment or dementia. There is no indication that the patient lacks the ability to sign a consent form.		not enough information
sigir-201429	NCT01978834	exclusion	Measurement of hip BMD is not feasible (for example, those who have had bilateral hip replacement surgeries or who cannot have central DXA because of their body weight)	The patient note does not mention any history of bilateral hip replacement surgeries or inability to perform central DXA due to body weight.	0	not excluded
sigir-201429	NCT01978834	exclusion	Open leg or arm wounds at sites where ultrasound measurements are supposed to be taken, precluding such measurements	The patient note does not provide information about open leg or arm wounds that would preclude ultrasound measurements.	0, 1	not enough information
sigir-201429	NCT00703417	inclusion	Postmenopausal female, 55-75 years old	The patient is a 51-year-old woman who has been diagnosed as postmenopausal within the last year but does not meet the age criterion of 55-75 years.	3	not included
sigir-201429	NCT00703417	inclusion	History of Type II diabetes, as defined by the American Diabetes Association for more than 5 years that is either insulin requiring or treated with oral therapies such as sulfonylureas and metformin	The patient has a history of diet-controlled diabetes mellitus, but it is unclear if this condition has been diagnosed for more than 5 years or if it is currently treated with insulin or oral therapies.	1	not enough information
sigir-201429	NCT00703417	inclusion	Body mass index (BMI) of 19-35	The patient note does not provide information about the patient's BMI.		not enough information
sigir-201429	NCT00703417	inclusion	Able to move without walkers and without a history of long periods (>3 months) of inactivity	The patient did not indicate needing a walker or cane and appears to have normal mobility. Additionally, there is no reported history of long-term inactivity exceeding three months.	0	included
sigir-201429	NCT00703417	inclusion	Fractures of the proximal humerus and femur as well as the ankle and foot should have occurred after the onset of diabetes and should have been caused by a low energy trauma such as falling from standing height. All fractures will be verified by radiographs.	The patient note does not mention any fractures of the specified locations or their relation to diabetes or low-energy trauma. There is insufficient information to verify if such fractures exist.		not included
sigir-201429	NCT00703417	exclusion	Severe neuropathic disease such as neurogenic osteoarthropathies (i.e., Charcot joints) of the foot	The patient note does not indicate the presence of severe neuropathic disease or Charcot joints.	0	not excluded
sigir-201429	NCT00703417	exclusion	Steroid users or have disease conditions that could play a significant role in the development of osteoporosis such as idiopathic osteoporosis, immobilization, hyperparathyroidism, or hyperthyroidism	The patient does not report current use of steroids nor does the medical history indicate presence of idiopathic osteoporosis, immobilization, hyperparathyroidism, or hyperthyroidism.	0	not excluded
sigir-201429	NCT00703417	exclusion	Diseases that may affect bone metabolism: alcoholism, chronic drug use, chronic gastrointestinal disease, renal or hepatic impairment	The patient does not have a documented history of alcoholism, chronic drug use, chronic gastrointestinal disease, renal or hepatic impairment according to the provided note.	1	not excluded
sigir-201429	NCT00703417	exclusion	Chronic treatment with antacids, estrogen, adrenal or anabolic steroids, anticonvulsants, anticoagulants, or pharmacologic doses of Vitamin A supplements 6 months prior	The patient note does not mention any current use of the specified medications or supplements. There is insufficient information to determine if the patient has been chronically treated with these agents.	1	not enough information
sigir-201429	NCT00703417	exclusion	Diabetic patients on rosiglitazone or pioglitazone medications	The patient has a diagnosis of diabetes mellitus; however, she is managing her condition with diet alone rather than using rosiglitazone or pioglitazone.	1	not excluded
sigir-201429	NCT00703417	exclusion	high energy trauma, e.g., due to motor vehicle accidents	The patient note does not mention any history of high energy trauma or involvement in a motor vehicle accident.	0	not excluded
sigir-201429	NCT00703417	exclusion	Pathological fractures of other origin, i.e., tumor, tumor-like lesions as well as focal demineralization visualized on radiographs	The patient does not have a diagnosis of cancer or evidence of tumors, tumor-like lesions, or focal demineralization visible on imaging.	0	not excluded
sigir-201429	NCT00703417	exclusion	History of fluoride, bisphosphonate, calcitonin or tamoxifen use	The patient note does not mention anything regarding the use of fluoride, bisphosphonate, calcitonin, or tamoxifen.	0	not enough information
sigir-201429	NCT00703417	exclusion	History of unstable cardiovascular disease or uncontrolled hypertension	The patient has a past medical history of significant hypertension, which meets the exclusion criterion.	1	excluded
sigir-201429	NCT00703417	exclusion	MRI contraindications	The patient note does not mention any contraindications related to MRI.		not excluded
sigir-201429	NCT00703417	exclusion	Body mass index greater than 35	The patient note does not provide information about the patient's body mass index.	0	not enough information
sigir-201430	NCT02273232	inclusion	Known moderate PVD	The patient reports calf pain upon exertion, has experienced worsening symptoms over three months, and exhibits signs of reduced perfusion in the lower extremities (coolness and diminished pulses). These findings align with the presentation of moderate peripheral arterial disease.	0, 1, 7	included
sigir-201430	NCT02273232	inclusion	New claudication patient with Rutherford stage 2 and Fontaine stage 2a symptoms	The patient describes calf pain upon exertion, indicative of claudication. Given his history of prior cardiovascular events and current symptoms meeting Rutherford stage 2 and Fontaine stage 2a, he qualifies.	0, 1	included
sigir-201430	NCT02273232	exclusion	Known upper limb PVD	The patient's note discusses calf pain and lower extremity issues but lacks specific documentation regarding upper limb peripheral artery disease.	0	not enough information
sigir-201430	NCT02273232	exclusion	Severe cardiac condition	The patient has a history of myocardial infarction and transient ischemic attack, both indicative of a severe cardiac condition.	2	excluded
sigir-201430	NCT02273232	exclusion	Risk classification for exercise training: class C and above	The patient has a history of myocardial infarction and transient ischemic attack, along with current symptoms suggesting potential peripheral arterial disease. These factors indicate a high-risk profile consistent with a risk classification beyond class C.	0, 2	excluded
sigir-201430	NCT02273232	exclusion	Severe respiratory condition	There is no indication in the patient note suggesting the presence of a severe respiratory condition.		not excluded
sigir-201430	NCT02273232	exclusion	Previous history of upper limb deep vein thrombosis	The patient note does not mention a history of deep vein thrombosis.		not excluded
sigir-201430	NCT02273232	exclusion	Patients on glibenclamide or nicorandil - May affect RIPC	The patient is not currently taking glibenclamide or nicorandil according to the provided note.	4	not excluded
sigir-201430	NCT02273232	exclusion	Raynaud\'s Disease	The patient note does not indicate a diagnosis of Raynaud's Disease. Symptoms described, such as calf pain and high blood pressure, are not specific to Raynaud's Disease.	0, 1	not excluded
sigir-201430	NCT02273232	exclusion	Patient has a contraindication to MRI	The patient note does not mention any contraindications to MRI.		not excluded
sigir-201430	NCT02273232	exclusion	Pregnancy	The patient is a male and there is no mention of pregnancy in the provided notes.		not excluded
sigir-201430	NCT02273232	exclusion	Previous major limb amputation affect ability to exercise	The patient note does not mention any history of major limb amputation. While it discusses calf pain and peripheral artery disease signs, there is no indication of a previous amputation affecting exercise ability.	0, 5, 6, 7	not excluded
sigir-201430	NCT00721006	inclusion	Males or females older than 18 years of age.	The patient is a 72-year-old man, who is older than 18 years of age.	0	included
sigir-201430	NCT00721006	inclusion	Limb ischemia with ABI of < 0.7 in the index lower extremity in two consecutive examinations done at least 1 week apart.	The patient note describes symptoms consistent with possible peripheral artery disease, such as coolness and diminished pulses, but does not explicitly document two consecutive ABI measurements below 0.7. Without this information, the criterion cannot be confirmed as met.	7	not included
sigir-201430	NCT00721006	inclusion	Limb ischemia with resting ischemic pain and/or claudication at 100 meters and/or non-healing ulcers.	The patient reports calf pain when walking uphill, indicating possible activity-related discomfort. Physical exam shows signs of peripheral artery disease, suggesting limb ischemia. However, there is no direct indication of resting ischemic pain or non-healing ulcers required by the criterion.	0	not included
sigir-201430	NCT00721006	inclusion	Claudication due to peripheral artery disease.	The patient reports calf pain upon walking uphill, indicative of claudication. This aligns with the condition described in the inclusion criterion.	0	included
sigir-201430	NCT00721006	inclusion	Patients not considered candidates for surgical or percutaneous revascularization, due to poor target vessels, inability to cross total occlusions, or a morbidity which precludes general anesthesia.	The patient did not indicate any issues related to poor target vessels, inability to cross total occlusions, or mobility/morbidity that prevents general anesthesia. Therefore, the patient may still qualify for consideration under this criterion.	0, 1	included
sigir-201430	NCT00721006	exclusion	Inability to provide informed consent.	The patient note states that the individual will provide informed consent and comply with the trial protocol without any practical issues. This indicates that the patient is capable of providing informed consent, thereby meeting the requirement and thus not meeting the exclusion criterion.	8	not excluded
sigir-201430	NCT00721006	exclusion	Previous angiogenic therapy.	The patient note does not mention any history of previous angiogenic therapy. No relevant sentences indicate receipt of such therapy.		not excluded
sigir-201430	NCT00721006	exclusion	Known sensitivity to gentamycin and/or amphotericin B.	The patient note does not mention any information regarding sensitivity to gentamycin or amphotericin B. Without this information, we cannot determine if the patient meets the exclusion criterion.		not enough information
sigir-201430	NCT00721006	exclusion	Use or expected use of antineoplastic drugs.	The patient's medication includes isosorbide dinitrate, hydrochlorothiazide, and aspirin, none of which are antineoplastic drugs. No information indicates the use or expectation of such drugs.		not excluded
sigir-201430	NCT00721006	exclusion	Any illness, which might affect the patient's survival after enrollment in the protocol.	The patient has multiple comorbidities, including hypertension, a transient ischemic attack, and potential peripheral artery disease. However, these conditions do not actively threaten the patient's immediate survival or fall within the scope of critical limb ischemia or severe leg ischemia mentioned in the trial context. Therefore, the patient's illnesses do not meet the exclusion criterion regarding survival.	0, 1, 2, 3, 5, 6, 7	not excluded
sigir-201430	NCT00721006	exclusion	Any illness or significant laboratory abnormality, which in the investigator's judgment will interfere with the patient's ability to comply with the protocol, compromise the patient's safety, or interfere with the interpretation of the study results.	The patient has a history of severe cardiovascular events (myocardial infarction and transient ischemic attack) and current signs of poor peripheral circulation (diminished pedal pulses), along with uncontrolled hypertension. These conditions suggest significant health risks that could interfere with protocol adherence and patient safety.	0, 2, 5, 6, 7	excluded
sigir-201430	NCT00721006	exclusion	No evidence of acute infection	The patient's medical history includes cardiovascular events but shows no signs of acute infection.	0, 1, 2	not excluded
sigir-201430	NCT00721006	exclusion	WBC > 15000.	There is no information in the patient note regarding the white blood cell count. Without knowing the actual value, we cannot determine if the patient meets this criterion.		not enough information
sigir-201430	NCT00721006	exclusion	WBC < 4000	The patient note does not provide information about the white blood cell (WBC) count. Without specific data, we cannot confirm if the WBC is below 4000. Following the guidance, if a fact is not mentioned, it is assumed not to be present. Hence, the WBC is likely ≥4000.		not excluded
sigir-201430	NCT00721006	exclusion	Serum Creatinine > 3.0 mg/dL in patients who are not in hemodialysis.	The patient note provides no information regarding the patient's serum creatinine levels. Without this data, it is impossible to determine if the exclusion criterion applies.	0, 1, 2, 3, 4, 5, 6, 7	not enough information
sigir-201430	NCT00721006	exclusion	Pregnant women or women planning to become pregnant or unwilling to use appropriate birth control methods before and 2 months after cell infusion.	The patient note does not mention anything about pregnancy, birth control, or plans related to pregnancy. Therefore, insufficient information is available to determine if the patient meets this exclusion criterion.		not enough information
sigir-201430	NCT00721006	exclusion	Recent myocardial infarction within 3 months prior to screening.	The patient had a transient ischemic attack 6 months ago but did not report a recent myocardial infarction within the past 3 months. Without evidence of a recent myocardial infarction, the exclusion criterion is not met.	2	not excluded
sigir-20151	NCT01142245	inclusion	Age ≥ 18	The patient is 44 years old, which is greater than or equal to 18.	0	included
sigir-20151	NCT01142245	inclusion	Confirmed ulcer bleeding with Forrest Ia, Ib, IIa, IIb	The patient presented with symptoms indicative of upper GI bleeding, including coffee-ground vomit. However, there is no confirmation of Forrest category classification.	0	not included
sigir-20151	NCT01142245	inclusion	Endoscopic hemostasis achieved	The patient note describes symptoms of gastrointestinal bleeding but does not indicate that an endoscopic hemostasis procedure was actually performed.	0, 1	not included
sigir-20151	NCT01142245	inclusion	Informed consent obtained	The patient note states that the patient will provide informed consent and comply with the trial protocol without any practical issues.	4	included
sigir-20151	NCT01142245	exclusion	No consent	The patient has already provided informed consent, which fulfills the requirement.	4	not excluded
sigir-20151	NCT01142245	exclusion	Forrest II c, III (clear ulcer base/flat spot and no active bleeding, i.e., minimal risk for rebleeding)	The patient note describes symptoms of upper gastrointestinal bleeding but does not mention undergoing an endoscopy or providing endoscopic findings.	0	not enough information
sigir-20151	NCT01142245	exclusion	Unsuccessful endoscopic treatment (i.e., injection and/or thermal coagulation for the initial bleeding) or severe bleeding that immediate surgery is indicated	The patient note describes symptoms consistent with upper gastrointestinal bleeding but does not specify whether endoscopic treatment was attempted or successful. Additionally, although the patient required treatment for active bleeding, it did not necessitate immediate surgery.	0, 1, 2	not excluded
sigir-20151	NCT01142245	exclusion	Moribund patients in whom active treatment of any form is not considered.	The patient received active treatment including fluid resuscitation and blood transfusion, indicating that active treatment is being considered. This contradicts the exclusion criterion which applies to patients where no active treatment is considered.	0	not excluded
sigir-20151	NCT01142245	exclusion	Polytrauma, severe injury, unconsciousness, burns, or need for continuous artificial ventilation	The patient presented with gastrointestinal symptoms including vomiting and coffee-ground stools, indicative of potential bleeding. His vitals showed tachycardia and hypotension, suggesting volume depletion or significant blood loss. Physical examination noted decreased mental status and cool extremities, consistent with hypoperfusion. However, there were no mentions of polytrauma, severe injury, unconsciousness, burns, or requirement for continuous artificial ventilation.	0, 1	not excluded
sigir-20151	NCT01142245	exclusion	Upper GI malignancy or disseminated malignant disease	The patient presented with symptoms suggesting gastrointestinal bleeding but did not have a confirmed diagnosis of Upper GI malignancy or disseminated malignant disease.	0	not excluded
sigir-20151	NCT01142245	exclusion	Esophageal varices	The patient presented with symptoms indicative of active gastrointestinal bleeding, including coffee-ground vomit and hypotension, potentially linked to esophageal varices.	0, 1	excluded
sigir-20151	NCT01142245	exclusion	A Mallory-Weiss lesion	The patient presented with symptoms including coffee-ground vomit, which is indicative of a Mallory-Weiss lesion. Additionally, he was treated with crystalloid and packed red blood cells, suggesting significant blood loss.	0	excluded
sigir-20151	NCT01142245	exclusion	Phenytoin or theophylline treatment	The patient did not receive Phenyltoin or Theophylline treatment according to the provided notes.	0	not excluded
sigir-20151	NCT01142245	exclusion	Uses of PPI or H2RAs within 3 days of admission, including uses at Emergency Department	The patient note does not mention anything about the use of proton pump inhibitors (PPI) or histamine-2 receptor antagonists (H2RAs). Without this information, it is impossible to determine if the patient meets the exclusion criterion.	0	not enough information
sigir-20151	NCT00843063	inclusion	upper GIB or dyspepsia due to peptic ulcers / erosions while receiving low-dose aspirin with a daily dose ranging from 80 mg to 320 mg	The patient experienced symptoms indicative of gastrointestinal bleeding, suggesting potential upper GIB. However, the patient note does not indicate whether the patient is currently receiving low-dose aspirin therapy, which is a requirement for this criterion.	0	not enough information
sigir-20151	NCT00843063	inclusion	Endoscopy revealed a gastric or duodenal ulcers of 3 mm or more in diameter with unequivocal depth, or more than 5 erosions in the stomach or duodenum	The patient note describes symptoms indicative of gastrointestinal bleeding but does not mention the results of an endoscopy. Since the inclusion criterion requires documented findings from an endoscopy, insufficient information is available to determine eligibility.	0	not enough information
sigir-20151	NCT00843063	inclusion	they required continuous low-dose aspirin for the secondary prevention of coronary heart disease, peripheral vascular disease, and ischemic stroke or transient ischemic attacks	The patient note does not mention anything about the patient's use of aspirin for the specified conditions.		not enough information
sigir-20151	NCT00843063	inclusion	18 years old or older.	The patient is described as a 44-year-old male, which meets the age requirement of 18 years or older.	0	included
sigir-20151	NCT00843063	exclusion	concurrent erosive or ulcerative esophagitis	The patient note describes symptoms consistent with upper gastrointestinal bleeding, potentially from a peptic ulcer or gastritis, but does not specify or diagnose concurrent erosive or ulcerative esophagitis.	0	not excluded
sigir-20151	NCT00843063	exclusion	Pyloric stenosis	The patient note does not mention anything about pyloric stenosis, which suggests the condition is not relevant to the patient.		not excluded
sigir-20151	NCT00843063	exclusion	previous gastric or duodenal surgery other than oversewing of a perforation	The patient note does not mention any history of previous gastric or duodenal surgery.	0	not excluded
sigir-20151	NCT00843063	exclusion	thrombocytopenia	The patient note does not mention anything about thrombocytopenia, so there is insufficient information to determine if this exclusion criterion applies.		not enough information
sigir-20151	NCT00843063	exclusion	renal failure with estimated creatinine clearance less than 10 ml / min	The patient note does not provide information regarding the patient's renal function, specifically the estimated creatinine clearance.	0	not enough information
sigir-20151	NCT00843063	exclusion	active cancer	There is no mention in the patient note indicating the presence of active cancer.		not excluded
sigir-20151	NCT00843063	exclusion	known allergic to aspirin, famotidine or pantoprazole	The patient note does not mention any allergies, specifically regarding aspirin, famotidine, or pantoprazole.	0	not enough information
sigir-20151	NCT00843063	exclusion	Pregnancy, lactation, or being of child-bearing potential in the absence of contraception	The patient note does not provide information about the patient's pregnancy status, lactation, or child-bearing potential.	0	not enough information
sigir-20151	NCT00843063	exclusion	Psychosomatic disorder	There is insufficient information in the patient note to determine if the patient has a psychosomatic disorder. The note focuses on his acute physical symptoms and treatment but does not provide details regarding any potential psychological causes.	0	not applicable
sigir-20151	NCT00843063	exclusion	planned co-prescription of nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or anticoagulants	The patient note indicates that he will comply with the trial protocol without any practical issues, suggesting he will undergo the planned co-prescription.	4	excluded
sigir-20151	NCT00843063	exclusion	c) Age <18 or >65 years	The patient is 44 years old, which falls within the age range of 18 to 65 years.	0	not excluded
sigir-20152	NCT02532452	inclusion	Immunocompromised patient with evidence of viral infection or reactivation	The patient is on immunosuppressive medications (prednisone), indicating immunocompromise. Additionally, symptoms of non-productive cough and fever along with findings from BAL showing owl's eye inclusion bodies suggest a viral infection.	0, 1, 3	included
sigir-20152	NCT02532452	inclusion	Age >1 day	The patient is 62 years old, which is greater than 1 day.	0	included
sigir-20152	NCT02532452	inclusion	Recipients who have had a stem cell transplant must be at least 21 days after stem cell infusion	The patient note does not mention whether the recipient has undergone a stem cell transplant or the duration post-transplant.		not enough information
sigir-20152	NCT02532452	inclusion	Clinical status must allow tapering of steroids to < 0.5mg/kg prednisone or other steroid equivalent	The patient is on immunosuppressive medications, including prednisone. However, there is no information indicating whether his clinical status allows for the required tapering of steroids.	1	not enough information
sigir-20152	NCT02532452	inclusion	Must be able to receive CTL infusion in Cincinnati	The patient note does not provide information regarding the patient's ability to receive the CTL infusion in Cincinnati.		not enough information
sigir-20152	NCT02532452	inclusion	Informed consent obtained by PI or sub-investigator either in person or by phone	The patient note indicates that the participant will provide informed consent.	4	included
sigir-20152	NCT02532452	exclusion	Active acute GVHD grades II-IV	The patient is not undergoing a bone marrow transplant and does not exhibit symptoms commonly associated with active acute GVHD, such as skin, liver, or gastrointestinal issues.	0	not excluded
sigir-20152	NCT02532452	exclusion	Uncontrolled bacterial or fungal infection	The patient presented with symptoms suggestive of a viral infection (non-productive cough and fever), confirmed by BAL showing viral inclusion bodies. While he is immunosuppressed, the infection appears to be viral rather than bacterial or fungal.	0, 2	not excluded
sigir-20152	NCT02532452	exclusion	Uncontrolled relapse of malignancy	The patient note does not mention anything regarding a relapse of malignancy or any active cancer.	0, 1	not excluded
sigir-20152	NCT02532452	exclusion	Infusion of ATG or alemtuzumab within 2 weeks of VST infusion	The patient is on immunosuppressive medications (prednisone), but there is no explicit mention of recent infusions of ATG or alemtuzumab.	1	not excluded
sigir-20152	NCT00034437	inclusion	Age 18-65	The patient is 62 years old, which falls within the specified age range.	0	included
sigir-20152	NCT00034437	inclusion	CMV seropositive	While the patient presented with symptoms and findings suggestive of CMV infection (owl's eye inclusion bodies), there is no specific information provided regarding CMV serostatus (e.g., positive CMV IgG). Therefore, insufficient information is available to confirm CMV seropositivity.	0	not enough information
sigir-20152	NCT00034437	inclusion	Informed consent given	The patient note indicates that the patient will provide informed consent and comply with the trial protocol without any practical issues.	4	included
sigir-20152	NCT00034437	exclusion	CMV seronegative	The patient has been diagnosed with cytomegalovirus infection based on the presence of owl's eye inclusion bodies in the BAL. This indicates that the patient is CMV seropositive, contradicting the exclusion criterion of CMV seronegativity.	3	not excluded
sigir-20152	NCT00034437	exclusion	Abnormal blood counts (hemoglobin less than 12 g/dl, platelets less than 150,000/ul, absolute neutrophil count less than 1,500/ul, absolute lymphocyte count less than 1,000/ul)	The patient's blood counts are not mentioned in the provided note, so we lack necessary information to assess them against the exclusion criterion.	0, 1	not enough information
sigir-20152	NCT00034437	exclusion	Known history of heart, lung, kidney, liver, or bleeding disorder	The patient note does not specify any history of heart, lung, kidney, liver, or bleeding disorders. While the patient currently has a cytomegaloviral infection, which can cause pulmonary involvement, there is no indication of a prior existing condition.	0	not excluded
sigir-20152	NCT00034437	exclusion	Diagnosis of HIV infection	The patient note does not indicate a confirmed diagnosis of HIV infection. While cytomegalovirus inclusion bodies were found in the BAL, there is no specific mention of an HIV diagnosis.	0	not excluded
sigir-20152	NCT00034437	exclusion	Diagnosis or suspicion of immunodeficiency state	The patient is on immunosuppressive medications (prednisone), which indicates a potential immunodeficiency state. Additionally, the presence of owl's eye inclusion bodies in the BAL supports a cytomegaloviral infection, commonly seen in immunocompromised patients.	1	excluded
sigir-20152	NCT00034437	exclusion	History of intravenous drug use	The patient note does not mention anything regarding a history of intravenous drug use.		not enough information
sigir-20152	NCT00034437	exclusion	Currently pregnant	The patient is a 62-year-old male presenting with respiratory symptoms and undergoing diagnostic procedures. There is no indication of pregnancy in the provided notes.		not excluded
sigir-20153	NCT01326507	inclusion	patients with acute pulmonary embolism diagnosed in the emergency department	The patient presented with symptoms suggestive of pulmonary embolism, including shortness of breath, tachypnea, and chest pain worsening with inspiration. However, the patient note does not explicitly state that a diagnosis of acute pulmonary embolism was made in the emergency department.	.	not included
sigir-20153	NCT01326507	exclusion	patient under guardianship	The patient note does not indicate that the individual is under guardianship.		not excluded
sigir-20153	NCT01326507	exclusion	patient without social insurance	The patient note does not provide any information about the patient's social insurance status.		not enough information
sigir-20153	NCT01326507	exclusion	pregnant women	The patient is a 65-year-old male, who cannot be pregnant.		not excluded
sigir-20153	NCT01326507	exclusion	refusal to sign the consent	The patient has already provided informed consent, meeting the requirement.		not excluded
sigir-20153	NCT01326507	exclusion	myocardial infarction in the 10 days before pulmonary embolism	The patient presented with acute onset of respiratory symptoms potentially indicative of pulmonary embolism but did not report any symptoms or evidence of a recent myocardial infarction within the specified timeframe.	0	not excluded
sigir-20153	NCT01139632	inclusion	Candidates who have been admitted to the hospital with a primary diagnosis of chest pain or undergoing elective CT angiography due to suspicion of coronary artery disease.	The patient presented with chest pain but the note does not explicitly state that his primary diagnosis was chest pain or that he underwent elective CT angiography. Without this specific information, we cannot confirm eligibility based on this criterion.	0	not enough information
sigir-20153	NCT01139632	inclusion	Male and female 18 years or older.	The patient is a 65-year-old male, who is above 18 years old.	0	included
sigir-20153	NCT01139632	inclusion	Able to provide written informed consent.	The patient note indicates that the individual will provide informed consent without any practical issues. This aligns with the requirement of being able to provide written informed consent.	3	included
sigir-20153	NCT01139632	inclusion	Intermediate Risk patients for having significant CAD defined as: chest pain or dyspnea in the presence of negative stress tests; the absence of chest pain but positive stress tests; the absence of chest pain and of positive stress tests but intermittent arrhythmias	The patient presented with chest pain and dyspnea but lacks information regarding the results of a stress test needed to assess intermediate risk for CAD.	0	not enough information
sigir-20153	NCT01139632	exclusion	Acute coronary syndrome presentation: ST segment deviation on ECG and/or Cardiac troponin elevation.	The patient presented with symptoms suggestive of acute coronary syndrome, including shortness of breath, tachycardia, and chest pain worsening with inspiration. However, the patient note lacks explicit documentation of ST segment deviations on ECG or cardiac troponin elevation, both of which are required components of the exclusion criterion. Without these findings, the criterion cannot be applied to exclude the patient.	0	not excluded
sigir-20153	NCT01139632	exclusion	Chest pain in combination with positive tests for myocardial ischemia	The patient presented with chest pain, but there is insufficient information regarding whether he had positive tests for myocardial ischemia.	0	not enough information
sigir-20153	NCT01139632	exclusion	Hemodynamic instability on presentation.	The patient presented with acute symptoms including shortness of breath and tachypnea, which could suggest physiological stress. However, there were no specific reports of hemodynamic instability such as hypotension or shock. Therefore, the criterion is not clearly met.	0	not excluded
sigir-20153	NCT01139632	exclusion	Inability to write inform consent.	The patient note states that the individual will provide informed consent and comply with the trial protocol without any practical issues. This indicates that the patient is capable of providing written informed consent.	3	not excluded
sigir-20153	NCT01139632	exclusion	Age <18 years.	The patient is 65 years old, which is greater than 18 years, so they do not meet the exclusion criterion.	0	not excluded
sigir-20153	NCT01139632	exclusion	Participation in an investigational study within the previous 30 days.	The patient note does not indicate participation in any clinical trial within the past 30 days. No relevant sentences support this criterion.		not excluded
sigir-20154	NCT01243255	inclusion	Patients on lipid lowering drug treatment	The patient has hypercholesterolemia, which may require lipid-lowering drugs, but the note does not state that she is currently receiving such treatment.	1	not enough information
sigir-20154	NCT01243255	inclusion	Lipid lowering drug treatment lasting at least 3 months	The patient note does not mention any lipid-lowering drug treatment. While she has hypercholesterolemia, there is no indication that she is currently undergoing lipid-lowering treatment.		not enough information
sigir-20154	NCT01243255	inclusion	No lipid lowering drug/dose change for a minimum of 6 weeks prior to enrolment to the study	The patient has hypercholesterolemia, suggesting she may be on lipid-lowering medications. However, the patient note lacks detailed information about the duration of her current lipid-lowering therapy or any recent changes. Without this information, it is impossible to determine if she has adhered to the required 6-week stability period.	1	not enough information
sigir-20154	NCT01243255	exclusion	Lack of patient's signed informed consent form	The patient has provided informed consent as noted in sentence 11.	11	not excluded
sigir-20154	NCT01243255	exclusion	Lack of the blood sample taken for lipid profile and glucose within 10 days before or after assessment of the patient	The patient note does not provide information regarding the timing of blood samples for lipid profile and glucose testing relative to the assessment.	1	not enough information
sigir-20154	NCT00844987	inclusion	typical chest pain	The patient experienced substernal chest pain radiating to the left shoulder and jaw, accompanied by elevated troponin levels and ST-segment elevation, indicating potential acute coronary syndrome.	0	included
sigir-20154	NCT00844987	inclusion	ST segment elevation or depression in ECG	The patient's EKG showed ST-segment elevations, meeting the criterion.	5	included
sigir-20154	NCT00844987	inclusion	indication for coronary angiography	The patient presented with chest pain and electrocardiographic changes suggestive of acute coronary syndrome. Elevated troponin levels support this diagnosis. She underwent coronary angiography, which did not reveal stenosis but indicated ischemic damage.	0, 4	included
sigir-20154	NCT00844987	inclusion	signed informed consent	The patient has already provided informed consent for participation.	11	included
sigir-20154	NCT00844987	exclusion	known past history of a myocardial infarction	The patient presents with chest pain, shortness of breath, and EKG showing ST-segment elevations indicative of ischemia. Elevated troponin and CK levels suggest possible acute coronary syndrome, which relates to a myocardial infarction.	0, 4	excluded
sigir-20154	NCT00844987	exclusion	not signed informed consent	The patient note states that the individual has already provided informed consent and complies with the trial protocol.	11	not excluded
sigir-20155	NCT02407106	inclusion	Rheumatic heart disease with recommended strep prophylaxis	The patient does not exhibit signs or symptoms indicative of rheumatic heart disease, nor is there a documented history suggesting such a condition.	2, 3	not included
sigir-20155	NCT02407106	exclusion	less than one year from first diagnosis	The patient reported a two-week history of symptoms, indicating she has not yet reached the required one-year period following her first diagnosis.	0	not enough information
sigir-20155	NCT02407106	exclusion	refusal to take the tablets	The patient note indicates that she provides informed consent and complies with the trial protocol without any practical issues.	4	not excluded
sigir-20155	NCT02118818	inclusion	Clinical and echocardiographic signs of RHD using WHF criteria	The patient's presentation includes joint pain, fatigue, and chest pain, but there is no indication of heart-related symptoms or echocardiographic evidence of RHD.	0	not included
sigir-20155	NCT02118818	exclusion	Congenital heart disease	The patient does not have a reported history of congenital heart disease.	0	not excluded
sigir-20156	NCT02375451	inclusion	Patients who have been treated with radioiodine therapy	The patient’s note describes symptoms consistent with hyperthyroidism but does not mention any treatment with radioiodine.	0	not included
sigir-20156	NCT02375451	inclusion	Never received radioiodine therapy	The patient note does not mention any history of radioiodine therapy.	0	not enough information
sigir-20156	NCT02375451	exclusion	Non-English speaking subjects will be excluded due to our lack of translation support resources at this time.	The patient note does not provide any information about the patient's language proficiency. Without knowing if the patient is a non-English speaker, we cannot definitively apply this exclusion criterion.		not enough information
sigir-20156	NCT01717352	inclusion	age 21 to 65	The patient is 46 years old, which falls within the specified age range.	0	included
sigir-20156	NCT01717352	inclusion	BMI 25 to 45	The patient's weight loss suggests she may be underweight or have experienced significant changes, but without her actual weight and height, BMI cannot be accurately determined.	0	not enough information
sigir-20156	NCT01717352	inclusion	sleep 7 hours or less most nights	The patient note does not provide information regarding the patient's sleep duration.	0, 1, 2	not enough information
sigir-20156	NCT01717352	exclusion	use of medications affecting sleep	The patient note does not mention any specific medications the patient is using, particularly those that affect sleep.	0	not enough information
sigir-20156	NCT01717352	exclusion	sleep apnea	The patient exhibits symptoms such as weight loss, sweating, insomnia, increased eating, and an irregular heartbeat. These symptoms could be indicative of various conditions, including sleep apnea. However, the absence of explicit documentation regarding a formal diagnosis of sleep apnea suggests that the condition has not been confirmed.	0	not excluded
sigir-20156	NCT01717352	exclusion	shift work	The patient note indicates the individual works as a nurse, which typically involves shift work. This aligns with the exclusion criterion.	0	excluded
sigir-20157	NCT01632319	inclusion	Currently enrolled in college as an undergraduate student.	The patient is described as a 20 yo female college student, indicating she is currently enrolled in college as an undergraduate student. This aligns with the inclusion criterion.	0	included
sigir-20157	NCT01632319	inclusion	Ages 18-24 years (inclusive).	The patient is 20 years old, which falls within the specified age range.	0	included
sigir-20157	NCT01632319	inclusion	Presence of two binge drinking episodes in the past month (defined as consumption of 5 or more drinks in 2 hours for males and 4 for females; NIAAA, 2004).	The patient note does not mention any details about alcohol consumption or binge drinking episodes.		not enough information
sigir-20157	NCT01632319	inclusion	BDI-II 12 (12 is often used to indicate the presence of at least mild depressive symptoms)	The patient note does not provide specific information about the BDI-II score.		not enough information
sigir-20157	NCT01632319	exclusion	Meeting criteria for substance dependence or abuse (any substance) in the past six months	The patient note does not indicate any history of substance dependence or abuse in the past six months.	0	not excluded
sigir-20157	NCT01632319	exclusion	Diagnosis of bulimia, psychosis, or bipolar disorder	The patient note does not indicate a current diagnosis of bulimia, psychosis, or bipolar disorder.	0	not excluded
sigir-20157	NCT01632319	exclusion	Having received any psychosocial treatment for depression or substance abuse in the past month	The patient note does not indicate receipt of psychosocial treatment for depression or substance abuse in the past month.	0	not excluded
sigir-20157	NCT01632319	exclusion	Having received CBT for depression and/or alcohol use in the previous 6 months	The patient note does not mention any recent cognitive behavioral therapy (CBT) sessions for depression or alcohol abuse.	0, 1	not excluded
sigir-20157	NCT01632319	exclusion	If receiving pharmacological treatment for depression or substance abuse, has not been on a stable dose for at least 4 weeks	The patient note does not mention whether the patient is currently receiving pharmacological treatment for depression or substance abuse, nor does it provide information regarding the stability of any such treatment.	0	not enough information
sigir-20157	NCT01632319	exclusion	Discontinued an antidepressant medication less than 1 month ago	There is insufficient information in the patient note to determine if the patient discontinued an antidepressant medication less than 1 month ago.		not enough information
sigir-20157	NCT01632319	exclusion	Meeting criteria for severe depression or posing a serious suicide or homicide risk	The patient exhibits symptoms consistent with mild to moderate depression, including fatigue, changes in sleep and eating habits, and social withdrawal. However, there is no indication of severe depression or a serious suicide risk.	0, 1	not excluded
sigir-20157	NCT02633449	inclusion	unipolar major depressive disorder	The patient presented with symptoms consistent with major depressive disorder, including fatigue, changes in sleep and appetite, and difficulty concentrating. However, there is no explicit mention of a formal diagnosis of unipolar major depressive disorder.	0, 1	not included
sigir-20157	NCT02633449	exclusion	neurological diseases or relevant psychiatric diseases other than major depressive disorder	The patient report indicates no evidence of neurological diseases or other relevant psychiatric diseases beyond potentially major depressive disorder. The absence of explicit diagnoses for other conditions and normal lab results support this conclusion.	0, 1	not excluded
sigir-20157	NCT02633449	exclusion	current medication other than SSRI or Mirtazapine	The patient note does not indicate that the participant is currently taking any medications, specifically excluding SSRIs or Mirtazapine.	0	not excluded
sigir-20157	NCT02633449	exclusion	history of manic episodes (lifetime)	The patient report does not mention any history of manic episodes. Symptoms described, such as fatigue, increased sleep, and appetite changes, align more with depressive symptoms rather than manic behavior.	0	not enough information
sigir-20157	NCT02633449	exclusion	psychotic symptoms (lifetime)	The patient report does not mention any history of psychotic symptoms. Therefore, this criterion cannot be evaluated against the provided information.		not applicable
sigir-20157	NCT02633449	exclusion	Treatment with psychotherapy within the past 2 years	The patient report does not indicate receipt of psychotherapy within the past 2 years.	0	not excluded
sigir-20157	NCT02633449	exclusion	treatment with electroconvulsive therapy (lifetime)	The patient note does not indicate any history of treatment with electroconvulsive therapy.	0	not excluded
sigir-20158	NCT02562040	inclusion	"Diagnosis of mild sleep-disordered breathing (MSDB). Defined as meeting ALL of the following:
- Caregiver reports of HABITUAL SNOURING that occurs MOST OF THE NIGHT on AT LEAST THREE NIGHTS PER WEEK, and HAS BEEN PRESENT FOR AT LEAST THREE MONTHS.
- Daytime HYPERACTIVITY OR HYPERVENTILATION DUE TO SLEEP FRAGMENTATION."	The patient note indicates the child snores nightly, fulfilling the first part of the diagnosis. Additionally, the teacher noted excessive sleepiness, indicating potential daytime effects, thus satisfying the second requirement.	0, 2	included
sigir-20158	NCT02562040	inclusion	Centrally-scored polysomnogram (PSG) confirming an obstructive apnea index (OAI) <1/hour and apnea-hypopnea index (AHI) ≤3/hour and no oxygen saturation (SpO2) desaturation < 90% in conjunction with obstructive events, confirmed on PSG.	The patient note describes symptoms consistent with sleep-disordered breathing but lacks explicit documentation of PSG-measured OAI, AHI, and SpO2 values required by the criterion. Without these data, the criterion cannot be verified.	0, 2	not included
sigir-20158	NCT02562040	inclusion	Tonsillar hypertrophy ≥2 based on a standardized scale of 0-4.	The patient note describes symptoms like nighttime snoring and restlessness but does not provide specific information regarding the degree of tonsillar hypertrophy using the mentioned scale. Without this information, it is impossible to determine if the criterion is met.	0, 2	not enough information
sigir-20158	NCT02562040	inclusion	Deemed to be a candidate for AT by otolaryngologist (ENT) evaluation (i.e., no technical issues that would be a contraindication for surgery such as submucous cleft palate.)	The patient note describes symptoms consistent with sleep-disordered breathing but does not indicate that an ENT evaluation has deemed the patient a candidate for adenotonsillectomy.	0	not included
sigir-20158	NCT02562040	inclusion	Primary indication for AT is nocturnal obstructive symptoms (i.e., not recurrent infections or other indications).	The patient exhibits symptoms indicative of obstructive sleep apnea, including nighttime snoring and pauses in breathing, which align with the criterion focusing on nocturnal obstructive symptoms.	0	included
sigir-20158	NCT02562040	exclusion	Previous tonsillectomy, including partial tonsillectomy	There is no mention in the patient note indicating that the child has undergone a tonsillectomy.	0	not excluded
sigir-20158	NCT02562040	exclusion	Recurrent tonsillitis that merits prompt adenotonsillectomy (AT) per the American Academy of Otolaryngology-Head and Neck Surgery Clinical Practice Guidelines (i.e., ≥7 episodes/yr in the past year; ≥5 episodes/year over the past 2 years or ≥3 episodes/yr over the past 3 years.)	The patient note describes nighttime snoring, pauses in breathing, and restlessness, suggesting sleep-related issues rather than recurrent tonsillitis.	0	not excluded
sigir-20158	NCT02562040	exclusion	Severe obesity (body mass index (BMI) z-score ≥3).	The patient note does not provide information regarding the patient's body mass index (BMI), specifically whether it meets the threshold for severe obesity.	0, 1, 2	not enough information
sigir-20158	NCT02562040	exclusion	Failure to thrive, defined as either height or weight being below the 5th percentile for age and gender.	The patient note provides the age of the boy but does not include information regarding his height or weight status relative to the 5th percentile. Without this data, it is impossible to determine if the patient meets the failure to thrive criterion.	0	not enough information
sigir-20158	NCT02562040	exclusion	severe bleeding disorders	The patient note does not mention any history of severe bleeding disorders.	0	not excluded
sigir-20158	NCT02562040	exclusion	Children/caregivers planning to move out of the area within the year.	The patient note does not specify any plans regarding moving out of the area within the year. There is insufficient information to determine if this criterion applies to the patient.	3	not enough information
sigir-20158	NCT02562040	exclusion	Children in foster care.	The patient note does not indicate anything about the child being in foster care. It discusses his symptoms, school performance, and ability to provide informed consent. Without evidence of foster care placement, this criterion cannot apply.	3	not applicable
sigir-20158	NCT02562040	exclusion	Children/caregivers who do not speak English or Spanish well enough to complete the neurobehavioral measures.	The patient note does not provide information regarding the language proficiency of the child or caregiver in English or Spanish. Without this information, it is impossible to determine if the exclusion applies.	0, 1	not enough information
sigir-20158	NCT00393913	inclusion	Experiences symptoms of OSA, including snoring and sleepiness	The patient shows signs of snoring and sleepiness, which aligns with the described symptoms of OSA.	0, 2	included
sigir-20158	NCT00393913	inclusion	Stable medical history with no change in medications that could affect sleepiness	The patient note does not provide specific information about current medications or changes in medications that could affect sleepiness.	0	not enough information
sigir-20158	NCT00393913	exclusion	Suspected diagnosis of a sleep disorder other than OSA	The patient exhibits symptoms indicative of OSA (e.g., snoring, pauses in breathing). Since the exclusion applies to sleep disorders other than OSA, the patient does not meet this criterion.	0	not excluded
sigir-20158	NCT00393913	exclusion	Medically unstable health conditions (e.g., heart attack, congestive heart failure)	The patient note describes symptoms associated with potential sleep issues, including snoring, pauses in breathing, and restlessness, but does not indicate any medically unstable conditions such as heart attack or congestive heart failure.	0	not excluded
sigir-20158	NCT00393913	exclusion	Use of psychotropic medications that cause sedation in the 3 months prior to study entry	The patient note does not mention the use of psychotropic medications that cause sedation in the 3 months prior to study entry.	0, 1, 2	not enough information
sigir-20158	NCT00393913	exclusion	Recent or confirmed history of recreational drug use or alcohol abuse	There is no mention in the patient note indicating a recent or confirmed history of recreational drug use or alcohol abuse.	0, 1, 2	not excluded
sigir-20158	NCT00393913	exclusion	Pregnant	The patient is a 10-year-old boy, indicating he is male and therefore cannot be pregnant.	0	not excluded
sigir-20158	NCT00393913	exclusion	Inability to communicate verbally, write, or read	The patient note provides no specific information regarding the patient's ability to communicate verbally, write, or read. However, since the patient is able to provide informed consent and comply with the trial protocol, it implies they possess the necessary cognitive and communicative capabilities.	3	not excluded
sigir-20158	NCT00393913	exclusion	Visual, hearing, or cognitive impairment	There is no mention in the patient note indicating any form of visual, hearing, or cognitive impairment.	0, 1, 2	not excluded
sigir-20159	NCT01766830	inclusion	fever for ≥ 1 week	The patient's current temperature is elevated (~39.5°C), indicating a fever; however, the duration of this fever isn't clearly established. While there was a low-grade fever reported two weeks ago, it's unclear if this current fever has persisted for at least one week.	0	not enough information
sigir-20159	NCT01766830	inclusion	≥ 5 years old (18 years onward in Cambodia)	The patient is described as a 10-year-old child, which is greater than 5 years old.	0	included
sigir-20159	NCT01766830	exclusion	unwilling or unable to give written informed consent	The patient note states that the individual will provide informed consent and comply with the trial protocol without any practical issues.	6	not excluded
sigir-20159	NCT01766830	exclusion	unable in the study physician’s opinion to comply with the study requirements	The patient note indicates that the patient will provide informed consent and comply with the trial protocol without any practical issues.	6	not excluded
sigir-20159	NCT01766830	exclusion	existing laboratory confirmed diagnosis	The patient's lab results show elevated white blood cell count with eosinophils, but no specific confirmed diagnosis is indicated. There is no mention of a laboratory-confirmed diagnosis of any condition listed in the trial's exclusion criteria.	5	not excluded
sigir-20159	NCT01766830	exclusion	need of immediate intensive care due to shock or respiratory distress	The patient’s condition includes mild fever, elevated heart rate, cyanosis, and periorbital edema, along with an elevated white blood cell count. These signs suggest potential underlying health issues requiring attention but do not specifically indicate the need for immediate intensive care.	0, 3	not excluded
sigir-201510	NCT02340533	inclusion	females complaining of pelvic congestion: dysmenorrhea, dyspareunia, chronic pelvic pain, menorrhagia, metrorrhagia	The patient reports experiencing dysmenorrhea and menorrhagia, both of which match the mentioned symptoms.	0	included
sigir-201510	NCT02340533	exclusion	refusal of the patient to get enrolled in the study	The patient note indicates that the individual provided informed consent and complied with the trial protocol without any practical issues.	2	not excluded
sigir-201510	NCT01377519	inclusion	Age>18 years	The patient is 38 years old, which is greater than 18.	0	included
sigir-201510	NCT01377519	inclusion	Premenopausal	The patient is a woman aged 38, reporting symptoms consistent with perimenopause, such as irregular periods and premenstrual pain. These symptoms suggest she is transitioning through the premenopausal phase.	0	included
sigir-201510	NCT01377519	inclusion	Symptomatic fibroids	The patient experiences symptoms commonly associated with uterine fibroids including severe premenstrual and menstrual pelvic pain, heavy, irregular periods, and occasional spotting.	0	included
sigir-201510	NCT01377519	inclusion	Fibroids accessible for focused ultrasound treatment	The patient's symptoms suggest potential uterine fibroids, but there is insufficient information regarding their accessibility for focused ultrasound treatment.	0	not enough information
sigir-201510	NCT01377519	exclusion	Desires future fertility	The patient's past experience with infertility treatments indicates potential concerns about fertility, but there is no direct indication of a specific desire for future fertility.	0	not excluded
sigir-201510	NCT01377519	exclusion	Current pregnancy	The patient note does not specify whether the patient is currently pregnant.	0	not enough information
sigir-201510	NCT01377519	exclusion	Hematocrit <30%	The patient's note does not provide information regarding her hematocrit level.		not enough information
sigir-201510	NCT01377519	exclusion	Emergency room visit in last 3 months for fibroid symptoms	The patient's note does not mention any emergency room visits, particularly for fibroid symptoms, within the last three months.	0	not excluded
sigir-201510	NCT01377519	exclusion	History of venous thromboembolism	The patient has a history of an ectopic pregnancy, which is associated with an increased risk of venous thromboembolism.	1	excluded
sigir-201510	NCT01377519	exclusion	Fibroids that are: >10cm, non-enhancing with contrast	The patient's note describes symptoms consistent with uterine fibroids but does not provide specific information regarding the size (>10cm) or enhancement status.	0	not enough information
sigir-201510	NCT01377519	exclusion	Adenomyosis	The patient did not report a diagnosis of adenomyosis; her symptoms could be related to other conditions.	0	not excluded
sigir-201510	NCT01377519	exclusion	Contraintications to undergoing MRI	The patient's medical history includes an ectopic pregnancy but does not indicate any known contraindications to undergoing MRI.	0	not excluded
sigir-201510	NCT01377519	exclusion	Unexplained menstrual irregularity	The patient reports having irregular periods along with associated symptoms like pelvic pain and heavy bleeding. Her medical history includes infertility treatments and an ectopic pregnancy, both of which can contribute to menstrual irregularities.	0	not excluded
sigir-201511	NCT01862510	inclusion	Patients with the diagnosis of hypothyroidism that require thyroid replacement therapy.	The patient exhibits symptoms consistent with hypothyroidism (e.g., hyporeflexia, slowed movement), but there is no explicit documentation of a confirmed diagnosis of hypothyroidism requiring thyroid replacement therapy.	0, 2	not enough information
sigir-201511	NCT01862510	exclusion	Surgical resection of thyroid tissue	The patient did not report undergoing thyroid surgery or having a condition necessitating it.	0	not excluded
sigir-201511	NCT01862510	exclusion	neck irradiation	The patient did not report undergoing neck irradiation.	0	not excluded
sigir-201511	NCT01862510	exclusion	radioactive iodine therapy	The patient note does not mention anything about radioactive iodine therapy, including past treatments or current suitability.		not enough information
sigir-201511	NCT01862510	exclusion	prior medical treatment with lithium, methimazole, propylthiouracil, ethionamide, amiodarone, or sunitinib	The patient did not report having undergone previous medical treatment with any of the listed medications.	0	not excluded
sigir-201511	NCT01862510	exclusion	prior serologic testing for celiac disease	There is no mention in the patient note indicating prior serologic testing for celiac disease.	0	not enough information
sigir-201511	NCT01197183	inclusion	Recently diagnosed hypothyroid subject (either during the inclusion period, or within the 6 previous months) for whom, data related to the diagnosis is available if the diagnosis was not carried out initially by the investigating doctor	The patient exhibits symptoms and physical exam findings suggestive of hypothyroidism, including hyporeflexia, slow movement, and dry skin. However, there is no explicit confirmation of a recent diagnosis of hypothyroidism within the required timeframe.	0, 1	not included
sigir-201511	NCT01197183	inclusion	Subject, who has given his/her oral consent for participation	The patient note confirms that the individual will provide informed consent and comply with the trial protocol.	4	included
sigir-201511	NCT01197183	exclusion	Subject included in clinical trial or having participated in a clinical trial during the last 3 months	The patient note indicates she will provide informed consent and comply with the trial protocol without any practical issues, suggesting she has not participated in a clinical trial during the last 3 months.	4	not excluded
sigir-201511	NCT01197183	exclusion	Subject presenting a major and objectifiable risk of not being able to follow up until the next TSH level (moving, problems encountered during another study, pathology affecting the vital prognosis in the short term)	The patient note does not specify any issues related to follow-up care, movements, previous study problems, or short-term health issues that would prevent her from attending scheduled visits.	0, 1	not enough information
sigir-201511	NCT01197183	exclusion	ERROR	No valid JSON block found in response		ERROR
sigir-201512	NCT02467309	inclusion	Clinical manifestation (Any person with sudden onset of fever (> 38.5 °C rectal or 38.0 °C axillary) and one of the following signs: neck stiffness, altered consciousness or other meningeal sign) with cerebrospinal fluid examination showing at least one of the following: A. turbid appearance; B.leukocytosis (> 100 cells/mm3); C.leukocytosis (10-100 cells/ mm3) AND either an elevated protein (> 100 mg/dL) or decreased glucose (< 40 mg/dL)	The patient experienced a sudden onset of fever and exhibited neck stiffness, meeting two parts of the clinical manifestation requirement. However, there is no information provided about the cerebrospinal fluid examination results needed to fully assess eligibility.	3	not enough information
sigir-201512	NCT02467309	inclusion	Confirmed bacterial meningitis patients: A case that is laboratory-confirmed by growing (i.e., culturing) or identifying (i.e., by Gram stain or antigen detection methods) a bacterial pathogen (Hib, pneumococcus or meningococcus) in the cerebrospinal fluid or from the blood in a child with a clinical syndrome consistent with bacterial meningitis.	The patient presented with symptoms like severe headache, fever, and nuchal rigidity, which are indicative of bacterial meningitis. However, the patient note does not provide evidence of laboratory confirmation required by the criterion, such as positive culture or antigen test results.	2, 3	not included
sigir-201512	NCT02467309	exclusion	Congenital immunodeficiency patients	The patient note does not mention any history of congenital immunodeficiency.	0	not excluded
sigir-201512	NCT02467309	exclusion	HIV patients	The patient note does not indicate that the individual is HIV-positive.		not excluded
sigir-201512	NCT02467309	exclusion	Patients with corticosteroid treatment for long time	The patient note does not mention any information about corticosteroid treatment.		not enough information
sigir-201512	NCT02467309	exclusion	Patients with disorders in adrenal gland and pituitary gland and hypothalamus	The patient note does not mention any disorders involving the adrenal gland, pituitary gland, or hypothalamus. There is no indication of such conditions.	0	not excluded
sigir-201512	NCT02467309	exclusion	Patients with tuberculosis	The patient note does not mention any indication of having tuberculosis. The patient presented with symptoms consistent with bacterial meningitis following a traumatic brain injury, including a skull fracture and cerebrospinal fluid leakage.	0, 1	not excluded
sigir-201512	NCT02418169	inclusion	Severe traumatic brain injury, GCS 8 or less and/or Craniofacial fracture	The patient note confirms the presence of a Skull Fracture, satisfying the 'Craniofacial fracture' part of the criterion.	0	included
sigir-201512	NCT02418169	exclusion	Died before admitted to hospital	The patient note indicates the individual survived after the accident and sought treatment, showing they were alive upon admission.	0	not excluded
sigir-201513	NCT01255670	inclusion	The referring doctor suspects peritonsillar abscess	The patient’s presenting symptoms (progressively worsening dysphagia, drooling, fever, and vocal changes) align with those typically associated with a peritonsillar abscess. This suggests that the referring doctor would suspect this condition.	0	included
sigir-201513	NCT01255670	inclusion	The patient is voluntary.	The patient note indicates that the child will provide informed consent and comply with the trial protocol without any practical issues, indicating willingness to participate voluntarily.	4	included
sigir-201513	NCT01255670	inclusion	patient has daily access to his/her e-mail	The patient note does not provide any information regarding the patient's ability to access their email.		not enough information
sigir-201513	NCT01255670	inclusion	patient speaks and understands Finnish or Swedish	The patient note does not provide any information about the patient's ability to speak or understand Finnish or Swedish.		not enough information
sigir-201513	NCT01255670	inclusion	female patients have adequate birth-control method	The patient is a 5-year-old boy, hence not a female. Inclusion criteria requiring adequate birth-control methods typically apply to female participants.		not included
sigir-201513	NCT01255670	inclusion	patient has peritonsillar abscess	The patient note describes symptoms including drooling, dysphagia, and fever, which are indicative of a peritonsillar abscess. However, the note does not explicitly state that the patient has been diagnosed with a peritonsillar abscess.	0	not included
sigir-201513	NCT01255670	exclusion	allergy to penicillin	The patient note does not specify any allergic reaction to penicillin; it only mentions delayed vaccinations.	3	not enough information
sigir-201513	NCT01255670	exclusion	allergy to metronidazole	The patient note does not mention any information regarding allergies, specifically to metronidazole.		not enough information
sigir-201513	NCT01255670	exclusion	use of metronidazole in preceding one month	The patient note does not mention anything regarding the use of metronidazole in the preceding one month.		not enough information
sigir-201513	NCT01255670	exclusion	pregnancy	The patient note does not specify whether the patient is pregnant or not.	3	not enough information
sigir-201513	NCT01255670	exclusion	Breast-feeding	The patient note does not provide information about whether the patient is breastfeeding.		not enough information
sigir-201513	NCT01255670	exclusion	renal insufficiency	The patient note does not provide any information regarding renal function or potential indicators of renal insufficiency.	0, 1, 2	not enough information
sigir-201513	NCT01255670	exclusion	liver insufficiency	The patient note provides no information regarding liver function or symptoms associated with liver insufficiency.		not excluded
sigir-201513	NCT01255670	exclusion	alcoholism (drunk at least once a week)	The patient note does not provide information regarding the patient's alcohol consumption habits.		not enough information
sigir-201513	NCT01255670	exclusion	participant in another clinical trial at the moment	The patient note does not mention anything about the child being involved in another clinical trial.	0, 1, 2, 3	not excluded
sigir-201513	NCT01255670	exclusion	Treatment of peritonsillar abscess requires in-patient care	The patient's presenting symptoms suggest a severe condition requiring in-patient care; however, the note does not confirm that in-patient care is specifically required.	0	not enough information
sigir-201513	NCT01255670	exclusion	tonsillectomy during the next 30 days	The patient note describes current symptoms suggesting a potential need for a tonsillectomy, but there is no explicit indication that a tonsillectomy is planned or scheduled within the next 30 days.	0, 1	not enough information
sigir-201513	NCT01255670	exclusion	certain medical conditions including but not limited to, asthma, hayfever, high blood pressure, heart valve problems, hernias, kidney stones, liver cirrhosis, multiple sclerosis, peptic ulcers, psoriasis, sleep apnea, spinal cord injuries, substance abuse, and vision impairments.	The patient note describes symptoms such as dysphagia, drooling, fever, and vocal changes, potentially indicative of a bacterial infection. However, none of these symptoms nor any other information provided indicate a history of the medical conditions listed in the exclusion criterion. Therefore, the patient does not meet the exclusion condition.	0	not excluded
sigir-201513	NCT00315042	inclusion	Age 6 months to less than 13 years of age (<13)	The patient is a 5-year-old boy, who is within the specified age range.	0	included
sigir-201513	NCT00315042	inclusion	c) Clinical judgment: Based on signs and symptoms consistent with group A strep throat.	The patient exhibits symptoms including dysphagia, drooling, fever, and vocal changes which are indicative of group A strep throat. Although specific tests like RADT or throat culture results are not provided, the clinical presentation aligns with the necessary signs and symptoms for this criterion.	0, 1	included
sigir-201513	NCT00315042	inclusion	A positive result from a rapid detection throat swab test for Group A strepococcal antigen and submission of a throat swab specimen for bacterial culture, identification, and antibiotic-susceptibility testing; and	The patient note does not mention any results from a rapid detection throat swab test for Group A strepococcal antigen.	0	not enough information
sigir-201513	NCT00315042	inclusion	"A sore and scratchy throat and/or pain on swallowing (odynophagia) together with at least 2 of the following clinical signs:

a) Swollen tonsils,
b) Reddish discoloration of the pharynx,
c) Exudative tonsil stones,
d) Enlarged cervical lymph nodes."	The patient exhibits dysphagia (point 0), drooling (point 1), and a muffled voice (point 2). These indicate odynophagia and suggest the presence of exudative tonsil stones or inflamed tonsils, fulfilling at least two of the required signs.	0, 1, 2	included
sigir-201513	NCT00315042	inclusion	Tonsil and/or pharyngeal erythema and/or exudate	The patient presented with dysphagia, drooling, fever, and vocal changes but did not explicitly mention erythema or exudate in the tonsil or pharyngeal areas.	0	not included
sigir-201513	NCT00315042	inclusion	Cervical adenopathy	The patient note describes symptoms consistent with a throat infection (e.g., dysphagia, droeling) but does not explicitly mention cervical adenopathy.	0	not included
sigir-201513	NCT00315042	inclusion	Uvular edema	The patient note does not explicitly mention anything regarding uvular edema.		not included
sigir-201513	NCT00315042	inclusion	Fever	The patient note indicates the presence of a fever.	0	included
sigir-201513	NCT00315042	exclusion	Symptoms that collectively suggest nonstreptococcal T/P (eg, laryngitis, coryza, conjunctivitis, diarrhea, cough)	The patient exhibits symptoms consistent with non-streptococcal T/P including drooling, dysphagia, and fever. However, without confirmation via testing or further details indicating the etiology, it cannot definitively exclude him.	0, 1	not enough information
sigir-201513	NCT00315042	exclusion	History of positive throat culture for Streptococcus pyogenes in the absence of clinical signs and symptoms of T/P	The patient note describes symptoms consistent with T/P (e.g., drooling, muffled speech), suggesting current illness. However, there is no mention of a prior positive throat culture result for S. pyogenes.	0, 1, 2	not excluded
sigir-201513	NCT00315042	exclusion	Infection of the deep tissues of the upper respiratory tract (eg, epiglottitis, retropharyngeal or buccal cellulitis, or abscess of the retropharynx, tonsil, or peritonsillar area) or of the suprapharyngeal respiratory tract and its connecting structures (eg, sinusitis, otitis media, or orbital/periorbital cellulitis)	The patient presented with symptoms like dysphagia, drooling, fever, and vocal changes, which could relate to upper respiratory tract infections. However, the specific details of the infection location were not clearly stated.	0	not excluded
sigir-201513	NCT00315042	exclusion	History of rheumatic heart disease	There is no indication in the patient note that the child has a history of rheumatic heart disease.	0	not excluded
sigir-201513	NCT00315042	exclusion	Females of childbearing potential (ie, have reached menarche)	The patient is identified as a 5-year-old boy, indicating he is male and below the age of puberty.	0	not excluded
sigir-201513	NCT00315042	exclusion	Known congenital prolonged QT syndrome	The patient note does not mention any signs or symptoms indicative of known congenital prolonged QT syndrome, nor does it provide information regarding a confirmed diagnosis or family history of this condition.	0, 1	not excluded
sigir-201513	NCT00315042	exclusion	Known or suspected uncorrected hypokalemia (≤3 mmol/L [mEq/L])	The patient note does not mention anything about hypokalemia, including serum potassium levels.	0	not excluded
sigir-201513	NCT00315042	exclusion	History of myasthenia gravis	The patient note does not mention anything indicating a history of myasthenia gravis. The presented symptoms could be associated with various conditions, including infections or other neurological disorders.	0	not excluded
sigir-201513	NCT00315042	exclusion	Known impaired renal function, as shown by creatinine clearance ≤25 mL/min	The patient note does not mention any indication of impaired renal function or relevant lab values.	0	not excluded
sigir-201513	NCT00315042	exclusion	Is being treated with drugs not permitted by the study protocol ie, cisapride, pimozide, astemizole, terfenadine, ergotamine, dihydroergotamine, Class IA (eg, quinidine and procainamide) or Class III (eg, dofetilide) antiarrhythmic agents, simvastatin, lovastatin and atorvastatin	The patient note does not explicitly state that the patient is currently receiving any of the prohibited medications mentioned in the exclusion criterion.	3	not excluded
sigir-201513	NCT00315042	exclusion	Is currently being treated with systemic antibacterials or has been treated with systemic antibacterials within 14 days prior to enrollment	The patient note does not specify whether the child is currently being treated with systemic antibacterials or has recently received such treatment.	0	not enough information
sigir-201513	NCT00315042	exclusion	Has been treated with any investigational medication within the last 30 days	The patient note does not mention any receipt of investigational medication within the last 30 days.	0, 1	not excluded
sigir-201513	NCT00315042	exclusion	Has been treated with rifampicin, phenytoin, carbamazepine, or St. John's wort within the last 2 weeks	The patient note does not mention any recent treatment with the specified medications.	0, 1, 2, 3	not enough information
sigir-201513	NCT00315042	exclusion	History of hypersensitivity or intolerance to macrolides, penicillins, or cephalosporins	There is no mention in the patient note of any history of hypersensitivity or intolerance to macrolides, penicillins, or cephalosporins.		not excluded
sigir-201513	NCT00315042	exclusion	Previous enrollment in this study or previous treatment with telithromycin	The patient note does not mention anything about being enrolled in this study or having received treatment with telithromycin.	0, 1, 3	not excluded
sigir-201513	NCT00315042	exclusion	Children of the investigator or subinvestigator, research assistant, pharmacist, study coordinator, other staff, or relative thereof directly involved in the conduct of the protocol	The patient is described as a 5-year-old boy with specific symptoms, but there is no indication in the provided note that he is a child of the investigational staff or related to them.	0	not enough information
sigir-201514	NCT01308112	inclusion	Women aged 15-45 years resident in the predefined study area	The patient is a 27-year-old woman who fits within the age requirement. While her residency status isn't explicitly stated, her participation in previous trials suggests she likely resides within the defined area.	0	included
sigir-201514	NCT01308112	inclusion	Pregnant, with gestational age <23 weeks	The patient is described as being 11 weeks gestation in her second pregnancy, which falls well below the threshold of 23 weeks.	0	included
sigir-201514	NCT01308112	exclusion	Failure to provide a blood sample	The patient note indicates that the patient underwent multiple blood tests and provided samples as needed. Additionally, point 9 states that she will provide informed consent and comply with the trial protocol without any practical issues.	0, 1, 2, 3, 4, 9	not excluded
sigir-201514	NCT01308112	exclusion	Initial haemoglobin concentration <90 g/L	The patient's initial hemoglobin level is 9.0 g/dL, which converts to 90 g/L. This is not less than 90 g/L, therefore she does not meet the exclusion criterion.	0	not excluded
sigir-201514	NCT01308112	exclusion	Reported medical history suggestive of sickle cell anaemia	No information in the patient note suggests a history of sickle cell anaemia.		not excluded
sigir-201514	NCT01308112	exclusion	Obstetric history suggestive of eclampsia or pre-eclampsia	The patient's records indicate no history of eclampsia or pre-eclampsia. There are no reported symptoms associated with these conditions.	0	not excluded
sigir-201514	NCT01308112	exclusion	Obvious mental retardation or metabolic disorder	The patient is a 27-year-old woman with mild iron deficiency anemia and reports difficulty swallowing. Lab results show elevated reticulocytes and LDH, indicating possible compensatory mechanisms. No evidence of hemolysis, organ dysfunction, or metabolic disturbances beyond iron deficiency is present. Mental retardation or metabolic disorders require specific indicators absent here.	0, 1	not excluded
sigir-201514	NCT01308112	exclusion	No written consent	The patient note indicates that the participant has provided informed consent, meeting the requirement.	9	not applicable
sigir-201514	NCT01308112	exclusion	Carrying multiples	The patient note states she is 11 weeks gestation in her second pregnancy but does not explicitly mention carrying multiples.	0	not enough information
sigir-201514	NCT01308112	exclusion	Woman planning to leave the homestead or to be absent for prolonged periods in the course of the pregnancy or within a 1-month period thereafter	The patient note does not provide information about the patient's plans regarding leaving home or being absent for prolonged periods during pregnancy.		not excluded
sigir-201514	NCT01308112	exclusion	Woman planning to deliver outside the research clinic	The patient note does not mention anything about her delivery plans or intentions.		not enough information
sigir-201514	NCT00827463	inclusion	Every patient followed at the HME at the beginning of the pregnancy	The patient is followed at the HME at the beginning of her pregnancy and has been diagnosed with anemia, which aligns with the trial's focus.	0	included
sigir-201514	NCT00827463	exclusion	pregnancy women who don't speak french	The patient is identified as a pregnant woman. However, there is no information indicating whether she speaks French or not. Since the criterion requires excluding pregnant women who don't speak French, and the patient's language proficiency is unknown, we cannot confirm she meets the exclusion criterion.		not excluded
sigir-201514	NCT00827463	exclusion	Pregnancy women affected by β-thalassemia	The patient note indicates the presence of anemia through low hemoglobin levels and iron deficiency, but there is no explicit diagnosis of β-thalassemia.	0	not excluded
sigir-201514	NCT00827463	exclusion	Pregnant women receiving periconceptional treatment for anemia.	No reasoning provided		unknown
sigir-201515	NCT00932425	inclusion	Age > 18 years	The patient is 72 years old, which is greater than 18.	0	included
sigir-201515	NCT00932425	inclusion	Seen at UCSF Medical Center for cryptogenic stroke or high-risk TIA	The patient note indicates that Karen was hospitalized for a cryptogenic stroke at UCSF Medical Center.	0	included
sigir-201515	NCT00932425	inclusion	Onset of stroke or TIA symptoms within the previous 60 days	The patient note indicates that Karen experienced a cryptogenic stroke two weeks ago, which falls within the 60-day window.	0	included
sigir-201515	NCT00932425	exclusion	Definite small-vessel etiology by history or imaging	The patient experienced a cryptogenic stroke, which is often linked to small-vessel disease. Her history includes hypertension and type 2 diabetes, both risk factors for small-vessel cerebrovascular disease.	0	excluded
sigir-201515	NCT00932425	exclusion	If the patient had a recent stroke or TIA within the past 6 months, they cannot participate in this trial.	The patient note indicates that Karen experienced a cryptogenic stroke two weeks ago, which falls within the past six months. This satisfies the exclusion criterion regarding a recent stroke.	0	excluded
sigir-201515	NCT00932425	exclusion	Source found by echocardiography (TEE not required)	The patient underwent a transesophageal echocardiogram (TEE), which is listed as acceptable for identifying the source.	2	not excluded
sigir-201515	NCT00932425	exclusion	History of atrial fibrillation	The patient reported a history of occasional palpitations, shortness of breath, and chest pain, which suggests potential cardiac-related issues but did not specify atrial fibrillation.	4	not excluded
sigir-201515	NCT00932425	exclusion	Atrial fibrillation on admission ECG	The patient note does not indicate that an ECG performed upon admission showed atrial fibrillation.	3	not excluded
sigir-201515	NCT00932425	exclusion	Atrial fibrillation detected by inpatient cardiac telemetry (at least 24 hours required)	The patient's ECG showed a normal sinus rhythm, indicating no presence of atrial fibrillation. There is no indication of atrial fibrillation detected via inpatient cardiac telemetry.	3	not excluded
sigir-201515	NCT00932425	exclusion	Obvious culpable systemic illness such as endocarditis	The patient reported occasional palpitations, shortness of breath, and chest pain, which might suggest potential cardiac issues. However, these symptoms alone do not confirm endocarditis, and imaging studies did not reveal any abnormalities indicative of the condition.	4	not excluded
sigir-201515	NCT00932425	exclusion	Patient unable to provide written, informed consent	Karen is reported to provide informed consent without any mentioned issues preventing her from doing so.	5	not excluded
sigir-201515	NCT01550588	inclusion	Subjects who have had a cryptogenic stroke within the previous 3 months, radiologically verified	The patient note confirms a recent cryptogenic stroke within the past two weeks, meeting the temporal requirement.	0	included
sigir-201515	NCT01550588	inclusion	Subjects who have been diagnosed with a high-risk* Patent Foramen Ovale (PFO), echocardiographically verified (*)	The patient note does not mention any diagnosis of Patent Foramen Ovale (PFO) or any findings from an echocardiogram confirming a high-risk PFO.	0	not included
sigir-201515	NCT01550588	inclusion	Subjects willing to participate in follow-up visits	The patient note states that the subject will provide informed consent and comply with the trial protocol without any practical issues.	5	included
sigir-201515	NCT01550588	inclusion	Absence of other potential causes of stroke	The patient experienced a cryptogenic stroke, meaning no identifiable cause was found after thorough investigation. Imaging studies did not reveal any abnormalities indicative of other stroke causes.	0	included
sigir-201515	NCT01550588	exclusion	Any identifiable cause of thromboembolic cause other than PFO	The patient experienced a cryptogenic stroke, which implies an unidentified cause. Without additional information pointing to another cause, this falls under 'other causes,' meeting the exclusion criterion.	0	included
sigir-201515	NCT01550588	exclusion	Subjects with intracardiac thrombus or tumor, dilated cardiomyopathy, prosthetic heart valve or mitral stenosis, endocarditis	The patient note does not indicate the presence of any of the listed exclusion criteria.		not excluded
sigir-201515	NCT01550588	exclusion	Subjects with significant atherosclerosis or dissection of the aorta, collagen vascular disease, arteritis, vasculitis and coagulopathy	The patient note does not indicate presence of significant atherosclerosis, aortic dissection, collagen vascular disease, arteritis, vasculitis, or coagulopathy.	0	not excluded
sigir-201515	NCT01550588	exclusion	Subjects who have an acute or recent (within 6 months) myocardial infarction or unstable angina	The patient experienced a cryptogenic stroke two weeks prior, which is within six months, but there is no specific mention of a recent myocardial infarction or unstable angina.	0	not excluded
sigir-201515	NCT01550588	exclusion	Subjects who have a non-vascular origin of the neurological symptoms after brain imaging (CT scan or MRI)	The patient experienced a cryptogenic stroke, which suggests an uncertain or less common cause. While the stroke was treated with thrombolytic therapy, indicative of an ischemic event, the term 'cryptogenic' implies that the specific cause remains unidentified. Without definitive evidence pointing to a non-vascular origin, the exclusion criterion cannot be applied.	0	not excluded
sigir-201515	NCT01550588	exclusion	History of intracranial bleeding, confirmed arterio-venous malformation, aneurysm or uncontrolled coagulopathy	The patient did not report a history of intracranial bleeding, arterio-venous malformation, aneurysm, or uncontrolled coagulopathy. Imaging studies also did not reveal any evidence of these conditions.	0, 1	not excluded
sigir-201515	NCT01550588	exclusion	Pre-existing neurological disorders or intracranial disease, e.g. multiple sclerosis	The patient does not have a documented history of pre-existing neurological disorders or intracranial disease. Imaging studies did not reveal any abnormalities.	0	not excluded
sigir-201515	NCT01550588	exclusion	Subjects with left ventricular aneurysm or akinesis	The patient's notes indicate no evidence of left ventricular aneurysm or akinesis during current evaluations.	0	not excluded
sigir-201515	NCT01550588	exclusion	Subjects with atrial fibrillation/atrial flutter (chronic or intermittent)	The patient note does not indicate a diagnosis of atrial fibrillation or atrial flutter.	0	not enough information
sigir-201515	NCT01550588	exclusion	Subjects with another source of right to left shunt identified at baseline, including an atrial septal defect and/or fenestrated septum	The patient note does not mention any other sources of right-to-left shunt, such as atrial septal defects or fenestrated septums.	0, 4	not excluded
sigir-201515	NCT01550588	exclusion	Subjects who could not undergo the TEE examination	The patient had a transesophageal echocardiogram (TEE) conducted during their hospitalization.	2	not excluded
sigir-201515	NCT01550588	exclusion	Subjects with contraindication to aspirin or Clopidogrel therapy	The patient note indicates no known contraindications to aspirin or clopidogrel therapy.	0	not excluded
sigir-201515	NCT01550588	exclusion	Pregnant or desire to become pregnant within the next year	The patient note does not mention anything regarding pregnancy or the desire to become pregnant. Given the patient's age (72), it is highly unlikely she fits this criterion.	0	not excluded
sigir-201515	NCT01550588	exclusion	Subjects who have a underlying malignancy	The patient note does not indicate any diagnosis of cancer or malignancy.	0	not excluded
sigir-201516	NCT00930826	inclusion	Clinical diagnosis of bronchial asthma	The patient presented with wheezing, which is often associated with bronchial asthma, but there is no explicit mention of a clinical diagnosis of bronchial asthma in the provided note.	0	not included
sigir-201516	NCT00930826	inclusion	Must be able to swallow tablets	The patient note does not provide information regarding the patient's ability to swallow tablets.		not enough information
sigir-201516	NCT00930826	exclusion	Steroid inhalation or ingestion	The patient note does not mention anything about the use of steroids, either by inhalation or ingestion.		not excluded
sigir-201516	NCT00839124	inclusion	Normal lung function, defined as (Knudson 1976/1984 predicted set): FVC of > 80 % of that predicted for gender, ethnicity, age and height FEV1 of > 80 % of that predicted for gender, ethnicity, age and height FEV1/FVC ratio of > .75	The patient presented with wheezing and a recent onset of symptoms, suggesting potential respiratory issues. However, there is no information regarding specific spirometric measurements (FVC, FEV1, FEV1/FVC ratio) required to assess compliance with the inclusion criterion.	0, 2, 6	not enough information
sigir-201516	NCT00839124	inclusion	Oxygen saturation of > 94 % and normal blood pressure (Systolic between 150 - 90, Diastolic between 90-60 mm Hg)	The patient's oxygen saturation is reported as 100%, meeting the required criterion. However, there is no information provided regarding the patient's blood pressure values.	7	not enough information
sigir-201516	NCT00839124	inclusion	Symptom Score no greater than 6 (out of a possible 24) for total symptom score with a value no greater than 2 for any one score.	The patient presented with wheezing but there is no information regarding symptom severity or individual symptom scores needed to evaluate the total symptom score against the criterion.	0, 1	not enough information
sigir-201516	NCT00839124	inclusion	Negative methacholine inhalation challenge as performed in the screening protocol. (Less than a 20% decrease in FEV1 at a maximum methacholine concentration of 10 mg/ml)	The patient note does not mention any information regarding a methacholine inhalation challenge or its results.		not enough information
sigir-201516	NCT00839124	inclusion	--Negative pregnancy test for females	The criterion requires a negative pregnancy test for females. The patient is a 4-year-old boy, so this criterion does not apply to him.		included
sigir-201516	NCT00839124	inclusion	Negative allergy skin test (AST)	The patient note does not mention anything about allergy skin tests or their results.		not enough information
sigir-201516	NCT00839124	inclusion	History of episodic wheezing, chest tightness, or shortness of breath after age of 6 years consistent with asthma, or physician diagnosed asthma after age of 6 years.	The patient is 4 years old, which is below the required age of 6 years mentioned in the inclusion criterion. Additionally, although the patient presented with wheezing, there is no indication of experiencing such symptoms consistently after the age of 6 years or being diagnosed with asthma by a physician after that age.	0	not included
sigir-201516	NCT00839124	inclusion	Positive methacholine test.	The patient presented with wheezing, which is often associated with a positive methacholine test indicating bronchial hyperresponsiveness. Although the specific test wasn't performed, the clinical signs are consistent with this criterion.	0, 6	included
sigir-201516	NCT00839124	inclusion	FEV1 of at least 80% of predicted and FEV1/FVC ratio of at least .70 (without use of bronchodilating medications for 12 hours)	The patient note lacks specific spirometric values for FEV1 and FEV1/FVC ratio, which are necessary to evaluate the criterion.	0	not enough information
sigir-201516	NCT00839124	inclusion	Allergic sensitization to at least one of the following allergen preparations: (House Dust Mite f, House dust mite p, Cockroach, Tree mix, Grass Mix, Weed Mix, Mold Mix 1, Mold Mix 2, Rat, Mouse, Guinea Pig, Rabbit, Cat or Dog) confirmed by positive AST.	The patient has a history of allergic rhinitis, indicating potential allergic sensitization; however, the note lacks specific details confirming sensitization to the listed allergen preparations or results of AST testing. Therefore, the criterion is not fully satisfied.	0	not included
sigir-201516	NCT00839124	inclusion	Negative allergy skin test as performed in the screening protocol.	The patient has a history of allergic rhinitis, suggesting previous positive responses to allergen exposure. Without evidence of recent negative allergy skin test results, the criterion cannot be confirmed.	1	not included
sigir-201516	NCT00839124	exclusion	Any chronic medical condition considered by the PI as a contraindication to the exposure study including significant cardiovascular disease, diabetes requiring medication, chronic renal disease, or chronic thyroid disease.	There is no mention in the patient note indicating the presence of any chronic medical conditions such as significant cardiovascular disease, diabetes, chronic renal disease, or chronic thyroid disease. Without this information, we cannot assess whether the patient meets the exclusion criterion.		not enough information
sigir-201516	NCT00839124	exclusion	Physician directed emergency treatment for an asthma exacerbation within the preceding 12 months.	The patient presented with wheezing, possibly indicative of an asthma exacerbation. However, the note does not specify that a physician directed emergency treatment for this condition within the previous 12 months. No specific reference to emergency treatment is mentioned.	0, 1	not excluded
sigir-201516	NCT00839124	exclusion	Use of systemic steroid therapy within the preceding 12 months for an asthma exacerbation.	The patient presented with wheezing but did not explicitly state the use of systemic steroid therapy in the preceding 12 months for an asthma exacerbation. There is insufficient information indicating such use.	0, 1	not excluded
sigir-201516	NCT00839124	exclusion	Use of inhaled steroids, cromolyn or leukotriene inhibitors (montelukast or zafirlukast) except for use of cromolyn exclusively prior to exercise.	The patient note does not mention anything regarding the use of inhaled steroids, cromolyn, or leukotriene inhibitors. There is also no information indicating whether cromolyn was used exclusively prior to exercise.		not enough information
sigir-201516	NCT00839124	exclusion	Use of daily theophylline within the past month.	The patient note does not mention anything regarding the use of theophylline. Without this information, we cannot determine if the patient meets the exclusion criterion.		not enough information
sigir-201516	NCT00839124	exclusion	Use of tricyclics and MAO inhibitors	The patient note does not mention anything about the use of tricyclics or MAO inhibitors.		not excluded
sigir-201516	NCT00839124	exclusion	Pregnancy or nursing a baby.	The patient is a 4-year-old boy; there is no mention of pregnancy or nursing a baby in the patient note.	0	not excluded
sigir-201516	NCT00839124	exclusion	Cigarette smoking > 1 pack per month.	The patient note does not mention anything about the patient's smoking habits or frequency. Without specific information about the patient's smoking status, we cannot definitively determine if he meets the exclusion criterion. However, typically, unless indicated, patients are assumed not to smoke heavily. Given the lack of information, it is inferred that the patient does not exceed the smoking limit specified in the criterion.		not excluded
sigir-201516	NCT00839124	exclusion	Nighttime symptoms of cough or wheeze greater than 1x/week at baseline (not during a clearly recognized viral induced asthma exacerbation) which would be characteristic of a person of moderate or severe persistent asthma as outlined in the current NHLBI guidelines for diagnosis and management of asthma.	The patient note describes an acute onset of wheezing triggered by outdoor activity, with no prior history of wheezing. No information regarding baseline nighttime symptoms or persistent asthma is provided. Thus, insufficient data to confirm the presence of required symptoms.	0, 1	not enough information
sigir-201516	NCT00839124	exclusion	Exacerbation of asthma more than 2x/week which would be characteristic of a person of moderate or severe persistent asthma as outlined in the current NHLBI guidelines for diagnosis and management of asthma.	The patient presented with wheezing, likely due to new-onset asthma, as indicated by no prior wheezing history. However, there is insufficient information regarding the frequency of these episodes or their persistence to classify them as moderate or severe persistent asthma as per NHLBI guidelines.	0, 1	not enough information
sigir-201516	NCT00839124	exclusion	Daily requirement for albuterol due to asthma symptoms (cough, wheeze, chest tightness) which would be characteristic of a person of moderate or severe persistent asthma as outlined in the current NHLBI guidelines for diagnosis and management of asthma. (Not to include prophylactic use of albuterol prior to exercise)	The patient presented with wheezing but did not report requiring albuterol for asthma symptoms. There is insufficient information about regular albuterol usage for asthma.	0, 1	not excluded
sigir-201516	NCT00839124	exclusion	Viral upper respiratory tract infection within 2 weeks of challenge.	There is no mention in the patient note indicating a viral upper respiratory tract infection (URI) within the past 2 weeks. The primary concern noted is wheezing, which could be associated with asthma rather than a URI.	0, 1	not excluded
sigir-201516	NCT00839124	exclusion	Any acute infection requiring antibiotics within 2 weeks of challenge	The patient presented with wheezing, possibly indicative of an infection, but there is no indication in the note that he required antibiotics within the past two weeks.	0, 1	not excluded
sigir-201516	NCT00839124	exclusion	Receipt of LAIV (Live Attenuated Influenza Vaccine), also known as FluMist®, within the prior 14 days	The patient note does not mention any information regarding the administration of the Live Attenuated Influenza Vaccine (LAIV). As such, there is no indication that the patient received the vaccine within the specified timeframe.		not excluded
sigir-201517	NCT01231945	inclusion	have not been previously diagnosed with cervical cancer	The patient report states she has no previous medical history and her latest pap smear results indicate cytology negative and HPV positive. There is no indication of a previous diagnosis of cervical cancer.	0, 2	included
sigir-201517	NCT01231945	inclusion	have a cervix	The patient is a female, and assuming no medical history indicates removal of the cervix, she likely has one.	0	included
sigir-201517	NCT01231945	inclusion	are not pregnant	The patient note does not provide information regarding her pregnancy status.	0	not enough information
sigir-201517	NCT01231945	inclusion	are physically able to undergo routine cervical cancer screening	The patient is a 32-year-old female with no previous medical history who presented for discussion of her Pap smear results. There is no indication of any physical inability to undergo routine cervical cancer screening.	0	included
sigir-201517	NCT01231945	inclusion	are able to provide informed consent	The patient note explicitly states that she will provide informed consent and comply with the trial protocol without any practical issues.	3	included
sigir-201517	NCT01231945	exclusion	are not married AND report never having had sexual intercourse	The patient note does not provide information about the patient's marital status or sexual history.	0, 1	not enough information
sigir-201517	NCT01231945	exclusion	have had a total hysterectomy	The patient note does not mention anything about the patient undergoing a total hysterectomy.		not excluded
sigir-201517	NCT01231945	exclusion	have a history of cervical cancer	The patient report states no previous medical history, indicating no prior diagnosis of cervical cancer.	0	not excluded
sigir-201517	NCT01231945	exclusion	are physically or mentally unable to undergo routine cervical cancer screening or unable to provide informed consent	The patient is a 32-year-old female with no previous medical history, reporting good overall health. She is able to provide informed consent without any reported issues.	0, 3	not excluded
sigir-201517	NCT01231945	exclusion	are pregnant or have been pregnant in the last month	The patient did not report being pregnant or having been pregnant in the last month.	0	not excluded
sigir-201517	NCT01231945	exclusion	Women who are currently menstruating at the time of enrollment will be deferred from participating, and will become eligible to participate 7-14 days after menstruation has ended.	The patient note does not specify whether she is currently menstruating. Without this information, we cannot determine if she meets the exclusion criterion.	0	not enough information
sigir-201517	NCT01446198	inclusion	sample had an aliquot with a valid positive or negative APTIMA HPV Assay TIGRIS System result	The patient note indicates she tested positive for HPV, but it does not specify the use of the APTIMA HPV Assay TIGRIS System. This lack of detail makes it unclear if the criterion is satisfied.	2	not enough information
sigir-201517	NCT01446198	inclusion	an aliquot is available and suitable for testing	The patient note does not mention anything about having an aliquot available or suitable for testing.		not enough information
sigir-201517	NCT01446198	inclusion	ERROR	No valid JSON block found in response		ERROR
sigir-201517	NCT01446198	exclusion	sample integrity was compromised (e.g., stored under unacceptable conditions)	The patient note does not provide any information regarding the storage conditions of the samples or potential compromise of sample integrity.		not enough information
sigir-201518	NCT00344513	inclusion	Hospitalized for episode of worsening heart failure as primary cause of admission or significant heart failure symptoms that develop during the hospitalization when the initial reason for admission was not heart failure.	The patient presented with symptoms and physical exam findings indicative of heart failure. However, the note does not explicitly state that he was hospitalized for worsening heart failure or that he developed significant heart failure symptoms during the hospitalization. Therefore, there is insufficient information to confirm eligibility under this criterion.	0, 1, 2	not enough information
sigir-201518	NCT00344513	inclusion	Systolic dysfunction (LVEF < 40%) or heart failure symptoms in the setting of preserved systolic function (diastolic dysfunction)	The patient exhibits heart failure symptoms (shortness of breath) and has physical examination findings suggestive of heart failure (bibasilar crackles, jugular venous distension), indicating potential diastolic dysfunction.	0, 1	included
sigir-201518	NCT00344513	exclusion		The eligibility criteria state that the study has no relevant exclusions, meaning the patient is eligible.		not excluded
sigir-201518	NCT00534066	inclusion	age 18 or older	The patient is 65 years old, which is greater than 18.	0	included
sigir-201518	NCT00534066	inclusion	primary diagnosis of CHF in the Emergency Department	The patient’s note describes symptoms and physical exam findings suggestive of CHF, including bibasilar crackles, pitting edema, and jugular venous distension. However, there is no indication that the patient received a primary diagnosis of CHF during an Emergency Department visit.	0	not included
sigir-201518	NCT00534066	inclusion	admission to the hospital or transfer to the Observation Unit	The patient note mentions that the individual experienced worsening shortness of breath over three weeks and used additional pillows, indicating potential respiratory issues. However, there is no explicit information regarding their current status in a hospital or Observation Unit.	0	not enough information
sigir-201518	NCT00534066	exclusion	ERROR	Failed to parse JSON: Expecting ',' delimiter: line 8 column 10 (char 259)		ERROR
sigir-201518	NCT00534066	exclusion	unstable angina or acute myocardial infarction in the ED	The patient presented with symptoms suggestive of a respiratory issue, including shortness of breath and difficulty breathing when lying flat. There were no reports of chest pain, ECG abnormalities, or signs consistent with an acute myocardial infarction.	0, 1	not excluded
sigir-201518	NCT00534066	exclusion	dialysis dependent patients	The patient note does not mention anything about dialysis dependence or chronic kidney disease requiring dialysis.		not excluded
sigir-201518	NCT00534066	exclusion	use of nesiritide as a therapy in the ED	The patient note does not mention any information regarding the use of nesiritide as a therapy in the emergency department.		not excluded
sigir-201519	NCT02213809	inclusion	>10.000 patients listed. >70% permanent employed general practitioners	The patient note does not provide any information about the number of patients listed at the primary health care centers or the percentage of permanently employed general practitioners.		not enough information
sigir-201519	NCT02213809	inclusion	Diagnosis of COPD	The patient has a history of smoking and chronic cough, along with symptoms of shortness of breath, suggesting potential COPD. However, the patient note lacks specific diagnostic confirmation for COPD.	0	not enough information
sigir-201519	NCT02213809	inclusion	Grade of COPD 2-3 (GOLD) at the latest spirometry completed since 2008.	The patient note does not mention any spirometry results or GOLD grading, which is required by the inclusion criterion.		not enough information
sigir-201519	NCT02213809	exclusion		No specific exclusion criterion was provided to evaluate.		not applicable
sigir-201519	NCT00806091	inclusion	COPD, smoker	The patient has a significant smoking history (1-2 packs/day for 47 years) which places them at high risk for COPD.	3	included
sigir-201519	NCT00806091	inclusion	COPD, non smoker	The patient has a significant smoking history (1-2 packs/day for 47 years), which contradicts the non-smoker requirement.	3	not included
sigir-201519	NCT00806091	exclusion		Since no exclusion criteria were provided, the patient is not excluded.		not excluded
sigir-201520	NCT00182832	inclusion	65 years of age or older	The patient is 89 years old, which is greater than 65.	0	included
sigir-201520	NCT00182832	inclusion	Hospitalized in a medical ward	The patient was brought to the emergency department by his family due to cognitive changes, suggesting prior hospitalization. However, the patient note does not indicate whether he is currently hospitalized in a medical ward.	0	not enough information
sigir-201520	NCT00182832	inclusion	Able to speak English	The patient note indicates the individual is providing informed consent and complying with the trial protocol, suggesting they can understand and communicate effectively.	13	included
sigir-201520	NCT00182832	inclusion	Cognitive impairment based on screening at time of hospital admission	The patient exhibits several indicators of cognitive impairment, including memory loss, difficulty with tasks requiring attention and concentration, and behavioral changes consistent with cognitive dysfunction.	0, 1, 2, 4, 7	included
sigir-201520	NCT00182832	exclusion	Previously enrolled in the study during prior hospitalization (for multiple admissions; only data from the first admission will be used)	The patient note indicates no prior enrollment in the study, as it specifically notes that the patient will provide informed consent and comply with the trial protocol without any practical issues.	13	not excluded
sigir-201520	NCT00182832	exclusion	Enrolled in another clinical trial	The patient note indicates that the individual is providing informed consent and complying with the trial protocol without any practical issues, suggesting they are not enrolled in another clinical trial.	13	not excluded
sigir-201520	NCT00182832	exclusion	Does not have cognitive impairment based on screening at time of hospital admission	The patient exhibits several indicators of cognitive impairment, including memory loss, difficulties with daily functions, and inability to perform complex mental tasks.	0, 1, 2, 4, 7	excluded
sigir-201520	NCT00880347	inclusion	Male or female patient, aged ≥ 40 years old included at entry.	The patient is 89 years old, which is greater than or equal to 40 years old. No additional criteria regarding age are present in the inclusion criteria. Therefore, the patient meets the age requirement.	0	included
sigir-201520	NCT00880347	inclusion	Patients having a clinical diagnosis of probable AD according to DSM-IV TR [F00.xx] and National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria.	The patient exhibits symptoms and neurological findings consistent with Alzheimer's Disease, including cognitive decline, behavioral changes, and motor abnormalities. However, the patient note lacks explicit documentation of a formal clinical diagnosis meeting the DSM-IV TR and NINCDS-ADRDA criteria for probable AD. Therefore, insufficient information is available to confirm the presence of a clinical diagnosis of probable AD.	0, 1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12	not enough information
sigir-201520	NCT00880347	inclusion	Written informed consent obtained from the patient or, if appropriate, from legal representative according to local laws and regulations.	The patient note confirms that written informed consent has been obtained from the patient, meeting this inclusion criterion.	13	included
sigir-201520	NCT00880347	inclusion	Evidence that brain imaging (either cerebral CT-scan or cerebral MRI) was performed to settle the AD diagnosis, and that the results are compatible with AD diagnosis.	The patient note describes several symptoms indicative of Alzheimer's Disease, including cognitive decline and behavioral changes. However, there is no mention of brain imaging studies (such as CT scans or MRIs) having been performed to diagnose AD. Without this information, we cannot confirm compliance with the criterion.		not enough information
sigir-201520	NCT00880347	inclusion	Neurological exam without any particularities or without any specific focal signs likely to be related to other conditions than AD.	The patient displays several signs consistent with Alzheimer's Disease (AD) during the neurological exam, such as cognitive impairments, behavioral changes, and motor signs like paratonic rigidity and myoclonic jerks. While some findings may relate to other conditions, the majority support a diagnosis of AD.	4, 7, 8, 10, 11	included
sigir-201520	NCT00880347	inclusion	Patient compliant with study procedures.	The patient note explicitly states that the individual will provide informed consent and comply with the trial protocol without any practical issues. This aligns with the inclusion criterion requiring compliance with study procedures.	13	included
sigir-201520	NCT00880347	exclusion	Any pathology, medical condition or symptoms that may lead to reconsider the initial diagnosis of probable AD, or that may render the initial diagnosis of probable AD doubtful at entry, according to the opinion of the investigator.	The patient's presentation includes cognitive decline, behavioral changes, and functional impairment, all of which are consistent with probable AD. However, without explicit evidence suggesting an alternate diagnosis or reversible causes, the initial diagnosis remains probable. Thus, there is insufficient information to reconsider or doubt the initial diagnosis of probable AD.	0, 1, 2, 4, 7	not excluded
sigir-201520	NCT00880347	exclusion	Current or recent history of drug or alcohol abuse or dependence.	The patient note does not mention any history of drug or alcohol abuse or dependence. There is no indication of substance-related issues affecting the patient's health or ability to participate in the trial.		not excluded
sigir-201520	NCT00880347	exclusion	Diagnostic of Mild Cognitive Impairment	The patient exhibits signs of mild cognitive impairment, including memory loss, trouble with tasks like dressing, and inability to follow multi-step commands. However, due to severe functional impairments and associated motor symptoms, the patient's condition exceeds mild cognitive impairment.	0, 1, 2, 4, 5, 7, 8, 9	excluded
sigir-201520	NCT00880347	exclusion	Current diagnosis of brain tumour	The patient note does not indicate a current diagnosis of a brain tumor.		not excluded
sigir-201520	NCT00880347	exclusion	Any current pathology or medical condition, for which blood sampling may involve a risk for the patient's health, according to the patient’s attending physician.	The patient exhibits signs of cognitive decline, difficulty with daily tasks, and neurological abnormalities. While these conditions suggest potential comorbidities, they do not specifically address the risk associated with blood sampling. There is no indication in the patient note of any condition that would increase the risk of blood sampling beyond standard procedures.	0, 1, 2, 4	not excluded
sigir-201520	NCT00880347	exclusion	Pregnancy.	The patient note does not provide any information regarding the patient's pregnancy status. Without knowing whether the patient is pregnant or not, we cannot determine their eligibility based on this criterion.		not enough information
sigir-201520	NCT00880347	exclusion	Patient who is not registered at Sécurité Sociale.	The patient note does not provide any information regarding the patient's registration status with Sécurité Sociale. Without this information, it is impossible to determine if the patient meets the exclusion criterion.		not enough information
sigir-201520	NCT00880347	exclusion	Current participation in another study using an investigational non-marketed product.	The patient note does not mention participation in another study or receipt of investigational products; thus, they are not eligible under this exclusion.		not excluded
sigir-201521	NCT02105714	inclusion	Individuals aged ≥1 year presenting with persistent diarrhoea (≥3 loose stools per day for ≥2 weeks; symptomatic group)	The patient is 32 years old, meeting the age criterion. Symptoms include diarrhea, which aligns with the condition. However, the exact number of stools per day and duration aren't specified, leaving uncertainty.	0, 1	not enough information
sigir-201521	NCT02105714	inclusion	Individuals with written informed consent provided.	The patient note states that the individual will provide informed consent and comply with the trial protocol without any practical issues.	5	included
sigir-201521	NCT02105714	exclusion	Individuals in need of immediate intensive or surgical care.	The patient presented with diarrhea, greasy stools, and mild symptoms including loss of appetite and malaise. There is no indication in the patient note that the individual requires immediate intensive or surgical care. The presence of parasites in the stool is noted but typically does not necessitate such care.	0, 1	not excluded
sigir-201521	NCT02105714	exclusion	Individuals who are unable or unwilling to give written informed consent.	The patient has already provided informed consent and complies with the trial protocol without any practical issues. There is no indication that the patient is unable or unwilling to give written informed consent.	5	not excluded
sigir-201521	NCT02105714	exclusion	Individuals who have been diagnosed with soil-transmitted helminthiasis, schistosomiasis, strongyloidiasis, shigellosis, intestinal salmonellosis, campylobacteriosis, aeromonas spp infections, giardiasis, amoebiasis, dientamoebiasis, cryptosporidium spp infections, or protozoan parasites.	The patient's stool sample revealed ellipsoidal cysts indicative of Giardiasis, matching one of the specified exclusion criteria.	4	excluded
sigir-201521	NCT02105714	exclusion	Individuals with clinical jaundice (assessed by direct observation of the conjunctivae)	The patient presented with gastrointestinal symptoms including diarrhea, abdominal cramping, and flatulence, along with greasy and foul-smelling stools. However, there was no mention of jaundice, which involves yellowing of the skin or eyes.	0	not excluded
sigir-201521	NCT02105714	exclusion	Individuals who are unable, in the study physician's opinion, to comply with the study requirements.	The patient states he will provide informed consent and comply with the trial protocol without any practical issues. There is no evidence indicating inability to comply with study requirements.	5	not excluded
sigir-201521	NCT02105714	exclusion	Individuals who are already participating in other ongoing diagnostic studies and/or clinical trials.	The patient note does not specify whether the individual is currently enrolled in other ongoing diagnostic studies or clinical trials. There is no indication that the patient is involved in another study or trial.		not enough information
sigir-201521	NCT01959048	inclusion	Both genders are eligible for study	The patient is a 32-year-old male, which falls under the category of both genders being eligible.	0	included
sigir-201521	NCT01959048	inclusion	Age 18 years and older	The patient is 32 years old, which is greater than 18.	0	included
sigir-201521	NCT01959048	inclusion	Able to provide written, informed consent	The patient note confirms that the individual will provide informed consent and comply with the trial protocol.	5	included
sigir-201521	NCT01959048	inclusion	Confirmed diagnosis of severe CDAD as defined above	The patient's stool sample showed ellipsoidal cysts consistent with Clostridium difficile, suggesting a confirmed diagnosis of CDAD.	4	included
sigir-201521	NCT01959048	exclusion	Pregnant or lactating women	The patient is a 32-year-old male who is not reported to be pregnant or lactating.	0	not excluded
sigir-201521	NCT01959048	exclusion	Need for prolonged antibiotics for other cause	The patient’s symptoms and diagnostic results indicate a potential Giardia infection rather than Clostridium difficile. Since the antibiotic requirement is specific to another condition, the exclusion criterion does not apply.	0, 1	not excluded
sigir-201521	NCT01959048	exclusion	Other known etiology for diarrhea, or clinical infection with other known enteric pathogens	The patient presented with diarrhea after drinking untreated water during a hiking trip, which increases the risk of contracting enteric pathogens. The stool examination showed features consistent with parasitic infection, potentially indicating Giardia.	0, 1	excluded
sigir-201521	NCT01959048	exclusion	Active, chronic conditions such as: Inflammatory bowel disease, Crohn's disease, Short bowel syndrome, Ulcerative or ischemic colitis	The patient presented with symptoms suggestive of an acute gastrointestinal infection, potentially due to a parasitic infection acquired during travel. There is no indication of a chronic condition such as inflammatory bowel disease, Crohn's disease, short bowel syndrome, ulcerative or ischemic colitis.	0, 1	not excluded
sigir-201521	NCT01959048	exclusion	Laxatives or motility-altering drugs within 12 hours of enrolment	The patient note does not specify whether the individual has taken laxatives or motility-altering drugs within the past 12 hours.	0	not excluded
sigir-201521	NCT01959048	exclusion	 Clinically unstable. Hemodynamic instability defined as hypotension (MAP <60) not responsive to fluids.	The patient presented with gastrointestinal symptoms including diarrhea, abdominal cramping, and flatulence. There was no indication of clinically unstable condition or hemodynamic instability such as hypotension. The patient is described as compliant with the trial protocol, suggesting stability.	0, 1	not excluded
sigir-201521	NCT01959048	exclusion	Any condition that, in the opinion of the investigator, would preclude safe participation in the trial or compromise the quality of the data obtained.	The patient exhibits several concerning symptoms including diarrhea, greasy and foul-smelling stools, loss of appetite, and malaise. His recent exposure to untreated water from natural sources increases the likelihood of gastrointestinal contaminants. These factors collectively raise safety concerns and may impact the integrity of the trial data.	0, 1, 2, 3	excluded
sigir-201521	NCT01959048	exclusion	Immune suppression, HIV, hematological or solid malignancy (chemotherapy in the past 3 months)	The patient note does not mention any history of immune suppression, HIV, hematological or solid malignancies, or recent chemotherapy.	0	not excluded
sigir-201521	NCT01959048	exclusion	Prior colon surgery	The patient's note does not mention having undergone prior colon surgery.	0, 1	not excluded
sigir-201522	NCT02534727	inclusion	At least 18 years of age	The patient is 65 years old, meeting the required age criterion.	0	included
sigir-201522	NCT02534727	inclusion	Diagnosis of TB (and/or NTM for NIH clinical center subjects)	The patient has a history of TB but lacks current confirmed diagnosis of TB or NTM.	0, 3	not included
sigir-201522	NCT02534727	inclusion	Ongoing signs and/or symptoms of pulmonary TB (and/or NTM at the NIH CC)	The patient reports a productive cough with tinges of blood, consistent with respiratory symptoms potentially indicative of pulmonary TB or NTM.	0	included
sigir-201522	NCT02534727	inclusion	Suspected drug resistance (drug susceptible allowed at the NIH CC)	The patient's note describes findings consistent with a potential fungal infection (based on the organism's morphological characteristics), but there is no information regarding drug resistance or susceptibility testing.	3	not included
sigir-201522	NCT02534727	inclusion	Available to provide at least 3 sputa over 2 or more days	The patient note does not explicitly state whether the patient is able to provide at least 3 sputa over 2 or more days.		not enough information
sigir-201522	NCT02534727	inclusion	Taking anti-tuberculosis medicines (or NTM meds at NIH CC) during the time sputa are provided	The patient note does not explicitly state that the patient is currently taking anti-tuberculosis or NTM medications. While the presence of organisms suggests a potential diagnosis, there is no indication of ongoing treatment.	4	not included
sigir-201522	NCT02534727	inclusion	Thought likely to be Mycobacterium culture positive (including NTM infected for the NIH CC) by enrolling physician	The patient's sputum culture showed organisms consistent with Non-Tuberculosis Mycobacteria (NTM), meeting the criterion.	3	included
sigir-201522	NCT02534727	inclusion	GeneXpert MTB/RIF sputum TBpositive (China subjects only)	The patient's note does not specify the patient's country of residence, which is required by the inclusion criterion 'China subjects only'. Additionally, the patient's sputum culture confirms TB positivity.	3	not enough information
sigir-201522	NCT02534727	inclusion	Likely able to produce sputum samples while on study	The patient currently complains of a productive cough with tinges of blood (sentence 0), indicating active sputum production.	0	included
sigir-201522	NCT02534727	inclusion	Willing to provide blood samples	The patient note does not specify whether the individual is willing to provide blood samples.		not enough information
sigir-201522	NCT02534727	inclusion	Willing to have samples stored	The patient agrees to provide informed consent and comply with the trial protocol, including the collection of samples.	4	included
sigir-201522	NCT02534727	exclusion	Acute liver or kidney disease	There is insufficient information in the patient note regarding the presence of acute liver or kidney disease.		not enough information
sigir-201522	NCT02534727	exclusion	c) Subjects who have received prior treatment for Tuberculosis (TB) or Non-Tuberculosis Mycobacteria (NTM) within the last year.	The patient note does not indicate that the individual has received prior treatment for TB or NTM within the last year. There is no mention of current or recent treatment for these conditions.	4	not excluded
sigir-201522	NCT01207128	inclusion	The patient or legally authorized representative has signed an informed consent/assent.	The patient note explicitly states that the patient will provide informed consent and comply with the trial protocol without any practical issues.	4	included
sigir-201522	NCT01207128	inclusion	The patient has a diagnosis of proven or probable invasive aspergillosis and with positive Aspergillus GM index (≥0.5 ng/ml).	The patient note indicates a potential diagnosis of aspergillosis based on the description of the organisms found in the sputum culture. However, the term 'proven or probable invasive aspergillosis' suggests a more definitive diagnosis than what is described. Additionally, there is no information provided regarding the Aspergillus GM index.	3	not included
sigir-201522	NCT01207128	inclusion	The patient is 18 years of age or older.	The patient is 65 years old, meeting the age requirement of being 18 or older.	0	included
sigir-201522	NCT01207128	exclusion	The patient is being treated with an unlicensed investigational drug for aspergillosis.	The patient is currently treated with Voriconazole and Micafungin, which are licensed drugs for aspergillosis. Since these are not unlicensed investigational drugs, the exclusion criterion does not apply.	4	not excluded
sigir-201522	NCT01207128	exclusion	The patient has been administered an antifungal agent (voriconazole, itraconazole, posaconazole, caspofungin, micafungin, anidulafungin, amphotericin B, or lipid formulation of amphotericin B) for > 7 days immediately prior to randomization for treatment of the Probable, or Proven invasive aspergillosis for which the patient is being enrolled.	The patient note does not specify whether the patient has been administered any antifungal agents mentioned in the criterion for more than 7 days prior to randomization.	4	not enough information
sigir-201522	NCT01207128	exclusion	Patient has invasive aspergillosis but with negative Aspergillus GM index.	The patient’s condition matches the description of having invasive aspergillosis despite a negative Aspergillus GM index. This aligns with the exclusion criterion provided.	0, 1	excluded
sigir-201522	NCT01207128	exclusion	The patient is pregnant or lactating. If the patient is female and of childbearing potential, the patient must have a negative pregnancy test and avoid becoming pregnant while receiving study drug. A pregnancy test should be performed within 14 days prior to the first dose of study drug.	The patient note does not mention anything about the patient being pregnant or lactating, nor provides information about pregnancy tests or avoidance of pregnancy.		not enough information
sigir-201522	NCT01207128	exclusion	The patient has a history of being treated for Aspergillus infection.	The patient note does not mention any history of treatment for Aspergillus infection. There is no reference to Aspergillus treatment in the provided information.		not excluded
sigir-201522	NCT01207128	exclusion	The patient has hepatic cirrhosis.	The patient note does not mention any information about hepatic cirrhosis, so it is unclear if the criterion applies.		not enough information
sigir-201522	NCT01207128	exclusion	Previous receipt of azole antifungal therapy	The patient note does not indicate that the individual has received prior azole antifungal therapy.	0	not excluded
sigir-201522	NCT01207128	exclusion	The patient is on artificial ventilation, and unlikely to be extubated within 24 hours of study entry.	The patient note does not mention anything about artificial ventilation or the likelihood of being extubated within 24 hours of study entry.		not enough information
sigir-201522	NCT01207128	exclusion	The patient has a history of allergy, hypersensitivity, or any serious reaction to the azole or echinocandin class of antifungal agents.	The patient note does not mention any history of allergy, hypersensitivity, or adverse reactions to azole or echinocandin antifungal agents. There is no indication of such a history in the provided information.	0	not enough information
sigir-201522	NCT01207128	exclusion	The patient has previously enrolled into this study.	The patient note indicates that the individual will provide informed consent and comply with the trial protocol without any practical issues, implying that they have not been enrolled in the study prior to this point. There is no indication that the patient has been previously enrolled.	4	not excluded
sigir-201522	NCT01207128	exclusion	The patient has a concomitant medical condition, which in the opinion of the Investigator may create an unacceptable additional risk.	The patient has a history of tuberculosis and currently reports a productive cough with tinges of blood. While the chest X-ray indicates a mass and the culture suggests a fungal infection, there is no explicit statement indicating that the Investigator considers these conditions to create an unacceptable additional risk. Additionally, the patient is willing and able to comply with the trial protocol.	0, 1	not excluded
sigir-201522	NCT01207128	exclusion	The patient has an active microbiologically-documented deep infection due to a non-Aspergillus mold.	The patient's sputum culture showed septated, low-angle branching hyphae with straight, parallel walls, indicating a non-Aspergillus mold infection. This matches the exclusion criterion for an active infection due to such organisms.	3	excluded
sigir-201522	NCT01207128	exclusion	The patient has a life expectancy of less than seven days.	The patient note does not provide specific information regarding the patient's life expectancy. There is no indication that the patient's life expectancy is less than seven days.	0, 4	not enough information
sigir-201523	NCT00084240	inclusion	Females and males >=18 years of age with uncomplicated, symptomatic malaria as indicated by the presence of both of the following: a.) Blood smears positive for Plasmodium falciparum asexual parasitemia between 1000 -100,000 parasites/mL b.) Fever or history of fever (>= 38.5 C/101.2 F rectal or tympanic; >= 37.5 C/99.5 F axillary or >= 38 C/100.4 F oral) within the prior 24 hours	The patient is 18 years old and male, meeting the age requirement. He presented with symptoms consistent with malaria, including fever. However, the patient note lacks direct evidence of a positive blood smear confirming Plasmodium falciparum asexual parasitemia within the required parasite count range.	0	not included
sigir-201523	NCT00084240	inclusion	Serum glucose >= 60 mg/dL (by fingerstick or peripheral blood collection)	The patient note does not mention any information regarding serum glucose levels.		not enough information
sigir-201523	NCT00084240	inclusion	Positive rapid diagnostic test (Binax NOW ICT) for P. falciparum	The patient note does not specify the result of the rapid diagnostic test for P. falciparum.		not enough information
sigir-201523	NCT00084240	inclusion	Women of childbearing potential must have a negative urine gonadotropin prior to entry into the study and must agree to use adequate contraception during the entire study	The patient note does not provide information about the patient's reproductive status or their ability to use contraception.		not enough information
sigir-201523	NCT00084240	exclusion	Impaired consciousness, seizures or abnormal neurologic exam	The patient note does not mention any evidence of impaired consciousness, seizures, or abnormal neurological examination.	0	not excluded
sigir-201523	NCT00084240	exclusion	Pregnant or breast-feeding women	The patient is an 18-year-old male; there is no indication of pregnancy or breastfeeding.	0	not excluded
sigir-201523	NCT00084240	exclusion	History of allergy to or hypersensitivity to azithromycin or any macrolide, sulfonamides, pyrimethamine, or chloroquine	The patient did not report any history of allergy or hypersensitivity to the specified medications.	0	not excluded
sigir-201523	NCT00084240	exclusion	Known history of blood dyscrasias (e.g., megaloblastic anemia, agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia, neutropenia, hemolytic anemia)	The patient's current presentation includes leukopenia and thrombocytopenia, which are forms of blood dyscrasias. However, the criterion specifies a 'known history,' implying a prior diagnosis or incident. The patient note does not mention any prior history of these conditions.	0	not excluded
sigir-201523	NCT00084240	exclusion	History of epilepsy or psoriasis	The patient note does not mention any history of epilepsy or psoriasis.	0	not excluded
sigir-201523	NCT00084240	exclusion	History of treatment with any antimalarial drug (chloroquine, quinine, mefloquine, Malarone, SP, artemisinin compounds) or antibacterial with known antimalarial activity (macrolides, doxycycline, clindamycin) within 2 weeks prior to enrollment into the study	The patient did not report receiving any of the specified antimalarial or antibacterial medications within the last two weeks.	0	not enough information
sigir-201523	NCT00084240	exclusion	Known or suspected cardiovascular, hepatic or renal abnormality that in the opinion of the Investigator would place the subject at increased risk to participate in the study. The following findings are specific exclusions: a.) serum creatinine > 2.0 x ULN b.) ALT and/or AST > 3 x ULN	The patient note does not specify any laboratory results regarding serum creatinine, ALT, or AST levels. Without this information, we cannot determine if the patient meets the exclusion criteria.	1	not enough information
sigir-201523	NCT00084240	exclusion	Inability to swallow oral medication in tablet form	The patient note does not mention any issues related to swallowing oral medication. Therefore, there is insufficient information to determine if the patient meets this exclusion criterion.		not enough information
sigir-201523	NCT00084240	exclusion	Treatment with other investigational drugs within 30 Days prior to enrollment into the study	The patient did not report receiving any investigational drugs within the last 30 days.	0	not excluded
sigir-201523	NCT00084240	exclusion	Alcohol and/or any other drug abuse	The patient note does not mention any history of alcohol or drug abuse.	0	not excluded
sigir-201523	NCT00084240	exclusion	Requirement to use medication during the study that might interfere with the evaluation of the study drug (nelfinavir, digoxin, ergot alkaloids, terfenadine, cyclosporine, hexobarbital and phenytoin)	The patient note does not explicitly mention the use of any medications that would interfere with the study drug.	0	not enough information
sigir-201523	NCT00084240	exclusion	Specific systemic diseases or other medical conditions that would interfere with the evaluation of the therapeutic response or safety of the study drug	The patient presented with symptoms suggestive of malaria, including high fever, chills, and joint pain, potentially relevant to the study drugs. However, the patient note lacks a definitive diagnosis confirming a systemic disease that would interfere with the study.	0	not excluded
sigir-201523	NCT00084240	exclusion	Inability to comprehend and/or unwillingness follow the study protocol	The patient explicitly states they will provide informed consent and comply with the trial protocol without any practical issues.	2	not excluded
sigir-201523	NCT00084240	exclusion	Intentional movement outside the clinic catchment area within 42 days	The patient did not express any intent to leave the vicinity of the trial site within the next 42 days.	0	not excluded
sigir-201523	NCT00084240	exclusion	Prior participation in this study	The patient note does not mention any prior participation in this specific study.	2	not excluded
sigir-201523	NCT02334514	inclusion	clinical presentation that suggests influenza virus infection, including sudden onset of high fever, cough, headache, muscle and joint pain, severe malaise, sore throat and runny nose	The patient exhibits several symptoms associated with influenza, such as sudden onset, high fever, chills, facial flushing, severe headache, and joint pain. However, the absence of a reported cough and sore throat may limit full alignment with the criterion.	0	not included
sigir-201523	NCT02334514	inclusion	positive to influenza virus by PCR test	The patient presented with symptoms consistent with an infection, including high fever, but no specific evidence of a positive PCR test for influenza was mentioned.	0	not included
sigir-201523	NCT02334514	inclusion	Anti viral treatment was indicated	The patient’s presentation includes symptoms suggestive of infection, but there is no indication in the provided notes that anti viral treatment was specifically indicated or administered.	0	not included
sigir-201523	NCT02334514	exclusion	patients after solid organ transplant, post bone marrow transplantation, with inherited or acquired immune deficiency, or patients treated chronologically with immunosuppressive drugs.	The patient note does not mention any history of solid organ transplant, bone marrow transplantation, inherited or acquired immune deficiency, or treatment with immunosuppressive drugs. There is insufficient information to determine if the patient meets the exclusion criterion.	0	not excluded
sigir-201523	NCT02334514	exclusion	Pregnant women.	The patient is an 18-year-old male; there is no indication of pregnancy in the provided notes.	0	not applicable
sigir-201523	NCT02334514	exclusion	Patients who were treated with oseltamivir in the previous 6 months	The patient did not explicitly state that they were treated with oseltamivir in the previous 6 months.	0	not excluded
sigir-201524	NCT00711399	inclusion	ERROR	No valid JSON block found in response		ERROR
sigir-201524	NCT00711399	inclusion	Patients with cough or shortness of breath	The patient report includes a productive cough (sentence 0), satisfying the 'cough' part of the criterion.	0	included
sigir-201524	NCT00711399	exclusion	Chest tubes	The patient does not require a chest tube as per the presented information.	0	not excluded
sigir-201524	NCT00711399	exclusion	Skin lesions precluding attachment of sensors	The patient note does not mention any skin lesions or issues that would prevent the attachment of sensors.		not excluded
sigir-201524	NCT00711399	exclusion	Respiratory distress	The patient presented with mild respiratory symptoms including a productive cough, fever, and chest pain. Vital signs showed a low-grade fever and elevated respiratory rate, consistent with an acute respiratory infection rather than severe respiratory distress.	0, 1	not excluded
sigir-201524	NCT00711399	exclusion	Pregnant women	The patient is a 31-year-old male, indicating he is not pregnant.	0	not excluded
sigir-201524	NCT00540072	inclusion	Provide signed and dated informed consent.	The patient has already provided informed consent, which makes this criterion automatically satisfied.		included
sigir-201524	NCT00540072	inclusion	Adults, 18 years of age or older of either gender and of any race weighing up to 150 kg.	The patient is 31 years old, satisfying the age requirement. However, the patient's weight is not mentioned in the note, preventing confirmation against the 150 kg limit.	0	not enough information
sigir-201524	NCT00540072	inclusion	Have a new pulmonary infiltrate on chest radiograph.	The patient presented with symptoms consistent with pneumonia, including fever, chills, and worsening cough. However, there is no explicit mention of a chest radiograph being performed or showing a new pulmonary infiltrate. Therefore, the criterion requiring a new pulmonary infiltrate on chest radiography is not met.	0, 1	not included
sigir-201524	NCT00540072	inclusion	Documented fever, defined as body temperature >38.0 ºC (100.4 ºF) taken orally; >38.5 ºC (101.2 F) tympanically; or >39.0 ºC (102.2 F) rectally or hypothermia, defined as core body temperature of <35.0 ºC (95.0 F)	The patient's temperature recorded as 103.4°F meets the criterion for documented fever (>38.0°C). This falls within the oral threshold.	4	included
sigir-201524	NCT00540072	inclusion	Elevated total peripheral white blood cell count (WBC >10,000/mm^3); or >15% immature neutrophils (bands), regardless of total peripheral white count; or leukopenia with total WBC <4500/mm^3.	The patient note does not provide information about the patient's white blood cell count or immature neutrophil percentage. Therefore, it is unclear whether the patient meets the criterion of having an elevated WBC, >15% immature neutrophils, or leukopenia.	0, 1, 2, 3, 4	not enough information
sigir-201524	NCT00540072	inclusion	Hypoxemia with a PO2 < 60 mmHg (on room air) or O2 saturation <90% on room air	The patient note does not provide specific information about the patient's oxygen levels (PO2 or O2 saturation). Therefore, it is unclear if the patient meets the criterion.	4	not enough information
sigir-201524	NCT00540072	inclusion	Pneumonia which requires hospitalization and intravenous therapy for at least 5 days.	The patient exhibits symptoms and findings indicative of pneumonia. While he required intravenous therapy, the duration of therapy is unclear, and hospitalization status is not specified. Insufficient information exists regarding the necessary criteria.	0, 1	not enough information
sigir-201524	NCT00540072	inclusion	Willingness to participate in this study and to complete all follow-up assessments.	The patient explicitly states they will provide informed consent and comply with the trial protocol without any practical issues. This indicates their willingness to participate and complete follow-up assessments.	6	included
sigir-201524	NCT00540072	exclusion	Patients with Grade V pneumonia (based on Fine Score)	The patient's presentation includes findings consistent with pneumonia, but the description focuses on the left lower lung field without indicating extensive bilateral involvement required for Grade V.	5	not excluded
sigir-201524	NCT00540072	exclusion	Patients in respiratory failure or incipient respiratory failure if the patient is not a candidate for mechanical ventilation (for any reason).	The patient presented with symptoms and findings suggestive of pneumonia, potentially leading to respiratory failure. However, there is no explicit indication that the patient is currently in respiratory failure or unable to receive mechanical ventilation.	0, 5	not excluded
sigir-201524	NCT00540072	exclusion	Known or suspected active tuberculosis	The patient presented with symptoms consistent with a common cold and did not exhibit signs indicative of active tuberculosis.	0, 1	not excluded
sigir-201524	NCT00540072	exclusion	Severe shock (systolic blood pressure <90 mm Hg for >30 minutes not corrected by fluid bolus)	The patient's blood pressure was recorded as 120/80 mm Hg during their visit, which is within the normal range and does not indicate severe shock.	4	not excluded
sigir-201524	NCT00540072	exclusion	Clinical evidence of bacterial meningitis (based on lumbar puncture results)	The patient's symptoms and physical examination suggest a respiratory issue rather than bacterial meningitis. There is no mention of Lumbar Puncture results or neurological symptoms indicative of bacterial meningitis.	0, 1	not excluded
sigir-201524	NCT00540072	exclusion	Severe renal impairment (calculated creatinine clearance <30 mL/min)	The patient note does not provide any information regarding renal function or creatinine clearance.		not enough information
sigir-201524	NCT00540072	exclusion	Moribund clinical condition: high likelihood of death during the first 48 hours.	The patient has a slight fever (103.4°F) and reports worsening cough but shows stable vital signs otherwise. Without evidence of severe complications or life-threatening conditions, the patient does not meet the moribund condition described in the exclusion criterion.	0	not excluded
sigir-201524	NCT00540072	exclusion	If HIV positive, known CD4 counts <200/mm3 or evidence of Pneumocystis carinii pneumonia.	The patient note does not indicate whether the patient is HIV-positive, nor does it provide information regarding CD4 counts or evidence of Pneumocystis carinii pneumonia. Therefore, insufficient information is available to determine eligibility based on this criterion.	0	not enough information
sigir-201524	NCT00540072	exclusion	Inability to tolerate ceftriaxone or history of allergy to beta-lactam antibiotics (history of rash alone will not exclude a patient).	The patient note does not mention any specific details regarding the ability to tolerate ceftriaxone or a history of allergy to beta-lactam antibiotics. There is no indication of a rash or allergic reaction that would meet the exclusion criterion.		not excluded
sigir-201524	NCT00540072	exclusion	> Any individual previously treated with a potentially effective anti-infective agent for > 24 hours (or one dosing day) within 72 hours of enrollment, or prior treatment with any investigational drug (including experimental biologic agents) in previous 30 days or prior therapy with daptomycin.	The patient note does not mention any recent treatment with antibiotics or daptomycin. There is insufficient information about the patient's medication history to confirm whether they meet the exclusion criterion.	0, 1	not enough information
sigir-201524	NCT00540072	exclusion	Patients who must continue HMG-CoA reductase inhibitor therapy (e.g., simvastatin, lovastatin, etc.) during the study treatment period.	The patient note does not indicate whether the patient is currently taking HMG-CoA reductase inhibitor therapy. There is no mention of statins or lipid-lowering medications in the patient's history or current status. As a result, there is insufficient information to determine if the patient meets this exclusion criterion.	0	not enough information
sigir-201524	NCT00540072	exclusion	Anticipation that a second non-protocol systemic antibiotic will be required.	Based on the patient's presenting symptoms including fever, worsening cough, and chest pain, along with the potential bacterial etiology indicated by the use of daptomycin, there is anticipation that additional systemic antibiotics may be required beyond the protocol.	0, 1	excluded
sigir-201524	NCT00540072	exclusion	Induction chemotherapy within 2 weeks prior to enrollment (or exogenous therapies which are anticipated to result in PMN counts of <200 mm3 during Treatment Phase), or patients with severe neutropenia (<200 PMN cells/mm3).	The patient did not receive induction chemotherapy within 2 weeks prior to enrollment nor report using exogenous therapies that would reduce PMN counts below 200 mm³. Additionally, there is no indication of severe neutropenia.	0, 1	not excluded
sigir-201524	NCT00540072	exclusion	Patients considered unreliable to return for visits or to comply with study procedures.	The patient note indicates that the individual has provided informed consent and complies with the trial protocol without any noted practical issues. No information is provided indicating potential unreliability concerning visit attendance or procedure adherence.	6	not excluded
sigir-201524	NCT00540072	exclusion	Progressive neoplastic disease	The patient note does not indicate any presence of progressive neoplastic disease.	0	not excluded
sigir-201524	NCT00540072	exclusion	Women who are pregnant or nursing/lactating.	The patient note does not mention anything regarding pregnancy or lactation status. As a 31-year-old male, there is no indication of him being pregnant or nursing.		not excluded
sigir-201524	NCT00540072	exclusion	Patients presenting with nosocomial pneumonia (i.e., <14 days after discharge from a skilled nursing facility or hospital with an initial hospitalization of >=3 days duration).	The patient reported developing symptoms approximately one week ago, starting with mild cold symptoms that later progressed into fever, chills, and worsening cough. There is no mention of him being hospitalized or in a skilled nursing facility within the preceding 14 days. Additionally, his past medical history indicates no significant issues, suggesting this is likely a community-acquired infection rather than nosocomial.	0, 1	not excluded
sigir-201524	NCT00540072	exclusion	Clinical suspicion of Legionella pneumonia.	The patient presented with symptoms compatible with pneumonia, including fever, cough, and chest pain. While these could indicate bacterial etiology, there was no direct indication of Legionella pneumonia, such as travel history, exposure risks, or diagnostic testing results. Therefore, insufficient evidence exists to suspect Legionella pneumonia.	0, 1	not excluded
